Unnamed: 0,activity_comment,activity_id,assay_chembl_id,assay_description,assay_type,bao_endpoint,bao_format,bao_label,canonical_smiles,document_chembl_id,document_journal,document_year,molecule_chembl_id,molecule_pref_name,parent_molecule_chembl_id,potential_duplicate,qudt_units,record_id,relation,src_id,standard_flag,standard_relation,standard_type,standard_units,standard_value,target_chembl_id,target_organism,target_pref_name,target_tax_id,toid,type,units,uo_units,value
30000,,18473430,CHEMBL4183075,Antibacterial activity against Staphylococcus aureus RN4220 harboring GyrA D83N mutant after 20 to 22 hrs,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4177750,J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3066264,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
30001,,18473432,CHEMBL4183090,Antibacterial activity against Staphylococcus aureus RN4220 harboring GyrA D83N/ParC D79N double mutant after 20 to 22 hrs,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4177750,J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3066264,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.0
30002,,18473434,CHEMBL4183091,Antibacterial activity against Staphylococcus aureus RN4220 harboring GyrB D437N mutant after 20 to 22 hrs,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4177750,J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3066264,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
30003,,18473436,CHEMBL4183092,Antibacterial activity against Staphylococcus aureus RN4220 harboring ParC S80F mutant after 20 to 22 hrs,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4177750,J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3066264,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.0
30004,,18473438,CHEMBL4183093,Antibacterial activity against Staphylococcus aureus RN4220 harboring ParC S80F/GyrA S84L double mutant after 20 to 22 hrs,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4177750,J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3066264,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,64.0
30005,,18473440,CHEMBL4183094,Antibacterial activity against wild type Klebsiella pneumoniae 1161486 after 20 to 22 hrs,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4177750,J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3066264,<,1,1,<,MIC,ug.mL-1,0.063,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,0.063
30006,,18473442,CHEMBL4183095,Antibacterial activity against Klebsiella pneumoniae 1161486 harboring GyrA S83I mutant after 20 to 22 hrs,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4177750,J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3066264,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,1.0
30007,,18473444,CHEMBL4183096,Antibacterial activity against Klebsiella pneumoniae 1161486 harboring GyrA S83I/ParC S80I double mutant after 20 to 22 hrs,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4177750,J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3066264,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,8.0
30008,,18473446,CHEMBL4183097,Antibacterial activity against Klebsiella pneumoniae 1161486 harboring GyrA S83F/D87V/ParC S80I triple mutant after 20 to 22 hrs,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4177750,J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3066264,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,8.0
30009,,18473448,CHEMBL4183098,Antibacterial activity against Escherichia coli K-12 MG1655 harboring GyrA S83L/D87N/ParC S80I triple mutant after 20 to 22 hrs,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4177750,J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3066264,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,32.0
30010,,18473450,CHEMBL4183099,"Resistance factor, ratio of MIC for Staphylococcus aureus RN4220 harboring GyrA D83N mutant to MIC for wild type Staphylococcus aureus RN4220",F,BAO_0000193,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4177750,J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3066264,=,1,0,=,Ratio,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Ratio,,,1.0
30011,,18473452,CHEMBL4183100,"Resistance factor, ratio of MIC for Staphylococcus aureus RN4220 harboring GyrA D83N/ParC D79N double mutant to MIC for wild type Staphylococcus aureus RN4220",F,BAO_0000193,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4177750,J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3066264,=,1,0,=,Ratio,,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Ratio,,,4.0
30012,,18473454,CHEMBL4183101,"Resistance factor, ratio of MIC for Staphylococcus aureus RN4220 harboring GyrB D437N mutant to MIC for wild type Staphylococcus aureus RN4220",F,BAO_0000193,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4177750,J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3066264,=,1,0,=,Ratio,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Ratio,,,1.0
30013,,18473456,CHEMBL4183102,"Resistance factor, ratio of MIC for Staphylococcus aureus RN4220 harboring ParC S80F mutant to MIC for wild type Staphylococcus aureus RN4220",F,BAO_0000193,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4177750,J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3066264,=,1,0,=,Ratio,,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Ratio,,,4.0
30014,,18473458,CHEMBL4183103,"Resistance factor, ratio of MIC for Staphylococcus aureus RN4220 harboring ParC S80F/GyrA S84L double mutant to MIC for wild type Staphylococcus aureus RN4220",F,BAO_0000193,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4177750,J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3066264,=,1,0,=,Ratio,,256.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Ratio,,,256.0
30015,,18473460,CHEMBL4183104,"Resistance factor, ratio of MIC for Klebsiella pneumoniae 1161486 harboring GyrA S83I mutant to MIC for wild type Klebsiella pneumoniae 1161486",F,BAO_0000193,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4177750,J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3066264,>,1,0,>,Ratio,,16.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,Ratio,,,16.0
30016,,18473462,CHEMBL4183105,"Resistance factor, ratio of MIC for Klebsiella pneumoniae 1161486 harboring GyrA S83I/ParC S80I double mutant to MIC for wild type Klebsiella pneumoniae 1161486",F,BAO_0000193,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4177750,J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3066264,>,1,0,>,Ratio,,128.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,Ratio,,,128.0
30017,,18473464,CHEMBL4183106,"Resistance factor, ratio of MIC for Klebsiella pneumoniae 1161486 harboring GyrA S83F/D87V/ParC S80I triple mutant to MIC for wild type Klebsiella pneumoniae 1161486",F,BAO_0000193,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4177750,J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3066264,>,1,0,>,Ratio,,128.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,Ratio,,,128.0
30018,,18473466,CHEMBL4183107,"Resistance factor, ratio of MIC for Escherichia coli K-12 MG1655 harboring GyrA S83L/D87N/ParC S80I triple mutant to MIC for wild type Escherichia coli K-12 MG1655",F,BAO_0000193,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4177750,J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3066264,=,1,0,=,Ratio,,2000.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Ratio,,,2000.0
30019,,18473472,CHEMBL4183108,Antibacterial activity against tolC-deficient fluoroquinolones-sensitive Escherichia coli JC7623 clinical isolate harboring wild type DNA gyrase after 20 to 22 hrs,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4177750,J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3066264,=,1,1,=,MIC,ug.mL-1,0.002,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.002
30020,,18473479,CHEMBL4183109,Antibacterial activity against tolC-deficient fluoroquinolones-resistant Escherichia coli W4753 clinical isolate harboring DNA gyrase S83L/D87N/ParC S80I/ParE S458A mutant after 20 to 22 hrs,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4177750,J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3066264,=,1,1,=,MIC,ug.mL-1,10.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,10.0
30021,,18473486,CHEMBL4183110,"Resistance factor, ratio of MIC for tolC-deficient fluoroquinolones-resistant Escherichia coli W4753 clinical isolate harboring DNA gyrase S83L/D87N/ParC S80I/ParE S458A mutant to MIC for tolC-deficient fluoroquinolones-sensitive Escherichia coli JC7623 clinical isolate harboring wild type DNA gyrase",F,BAO_0000193,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4177750,J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3066264,=,1,0,=,Ratio,,5000.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Ratio,,,5000.0
30022,,18474317,CHEMBL4183327,Antibacterial activity against Salmonella typhimurium ATCC 14028 after 24 hrs,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4177755,J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Micromolar,3066389,=,1,0,=,MIC95,uM,8.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,MIC95,uM,UO_0000064,8.0
30023,,18474358,CHEMBL4183330,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 4330 after 24 hrs,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4177755,J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Micromolar,3066389,=,1,0,=,MIC95,uM,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC95,uM,UO_0000064,1.0
30024,,18474378,CHEMBL4183329,Antibacterial activity against Staphylococcus aureus ATCC 29213 after 24 hrs,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4177755,J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Micromolar,3066389,=,1,0,=,MIC95,uM,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC95,uM,UO_0000064,4.0
30025,,18474398,CHEMBL4183328,Antibacterial activity against Salmonella pullorum ATCC 7913 after 24 hrs,F,BAO_0000179,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4177755,J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Micromolar,3066389,=,1,0,=,MIC95,uM,2.0,CHEMBL612545,,Unchecked,,,MIC95,uM,UO_0000064,2.0
30026,,18474434,CHEMBL4183326,Antibacterial activity against Escherichia coli 1005 after 24 hrs,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4177755,J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Micromolar,3066389,=,1,0,=,MIC95,uM,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC95,uM,UO_0000064,2.0
30027,,18474454,CHEMBL4183325,Antibacterial activity against Escherichia coli ATCC 25922 after 24 hrs,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4177755,J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Micromolar,3066389,=,1,0,=,MIC95,uM,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC95,uM,UO_0000064,2.0
30028,,18474477,CHEMBL4183331,Antibacterial activity against Staphylococcus epidermidis ATCC 12228 after 24 hrs,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4177755,J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Micromolar,3066389,=,1,0,=,MIC95,uM,2.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC95,uM,UO_0000064,2.0
30029,,18474497,CHEMBL4183332,Antibacterial activity against Staphylococcus aureus ATCC 25923 after 24 hrs,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4177755,J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Micromolar,3066389,=,1,0,=,MIC95,uM,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC95,uM,UO_0000064,8.0
30030,,18475214,CHEMBL4183368,Antibacterial activity against Escherichia coli ATCC 25922 after 18 hrs in presence of NaCl by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4177755,J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3066389,=,1,1,=,MIC,nM,2000.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,uM,UO_0000065,2.0
30031,,18475234,CHEMBL4183369,Antibacterial activity against Escherichia coli ATCC 25922 after 18 hrs in presence of KCl by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4177755,J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3066389,=,1,1,=,MIC,nM,2000.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,uM,UO_0000065,2.0
30032,,18475254,CHEMBL4183370,Antibacterial activity against Escherichia coli ATCC 25922 after 18 hrs in presence of NH4Cl by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4177755,J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3066389,=,1,1,=,MIC,nM,2000.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,uM,UO_0000065,2.0
30033,,18475274,CHEMBL4183371,Antibacterial activity against Escherichia coli ATCC 25922 after 18 hrs in presence of MgCl2 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4177755,J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3066389,=,1,1,=,MIC,nM,8000.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,uM,UO_0000065,8.0
30034,,18475294,CHEMBL4183372,Antibacterial activity against Escherichia coli ATCC 25922 after 18 hrs in presence of CaCl2 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4177755,J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3066389,=,1,1,=,MIC,nM,8000.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,uM,UO_0000065,8.0
30035,,18475314,CHEMBL4183373,Antibacterial activity against Escherichia coli ATCC 25922 after 18 hrs in presence of ZnCl2 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4177755,J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3066389,=,1,1,=,MIC,nM,2000.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,uM,UO_0000065,2.0
30036,,18475334,CHEMBL4183374,Antibacterial activity against Escherichia coli ATCC 25922 after 18 hrs in presence of FeCl3 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4177755,J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3066389,=,1,1,=,MIC,nM,4000.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,uM,UO_0000065,4.0
30037,,18475479,CHEMBL4183382,Antibacterial activity against Escherichia coli ATCC 25922 after 18 hrs in presence of 12.5% human heat-inactivated serum by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4177755,J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3066389,=,1,1,=,MIC,nM,2000.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,uM,UO_0000065,2.0
30038,,18475484,CHEMBL4183383,Antibacterial activity against Escherichia coli ATCC 25922 after 18 hrs in presence of 25% human heat-inactivated serum by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4177755,J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3066389,=,1,1,=,MIC,nM,2000.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,uM,UO_0000065,2.0
30039,,18475489,CHEMBL4183384,Antibacterial activity against Escherichia coli ATCC 25922 after 18 hrs in presence of 50% human heat-inactivated serum by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4177755,J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3066389,=,1,1,=,MIC,nM,4000.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,uM,UO_0000065,4.0
30040,Not Active,18475513,CHEMBL4183395,Induction of cell wall permeabilization in Escherichia coli ATCC 25922 assessed as increase in NPN uptake at 1 to 32 uM by fluorescence spectrophotometric method,F,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4177755,J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3066389,,1,0,,Activity,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,,,
30041,Not Active,18475522,CHEMBL4183401,Binding affinity to phosphatidylcholine/cholesterol large unilamellar vesicle assessed as induction of calcein leakage at 2 to 32 uM after 15 mins by spectrofluorophotometric method,A,BAO_0000375,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4177755,J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3066389,,1,0,,Activity,,,CHEMBL4651323,,Lipid bilayer,,,Activity,,,
30042,Not Active,18475525,CHEMBL4183402,Binding affinity to phosphatidylglycerol/cardiolipin/phosphatidylethanolamine large unilamellar vesicle assessed as induction of calcein leakage at 2 to 32 uM after 15 mins by spectrofluorophotometric method,B,BAO_0000375,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4177755,J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3066389,,1,0,,Activity,,,CHEMBL4651323,,Lipid bilayer,,,Activity,,,
30043,Not Active,18475533,CHEMBL4183406,Disruption of cytoplasmic membrane electrical potential in Escherichia coli ATCC 25922 at MBC after 800 secs by DiSC3-5 dye-based fluorescence spectrophotometric method,F,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4177755,J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3066389,,1,0,,Activity,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,,,
30044,,18490346,CHEMBL4187380,Antibacterial activity against Staphylococcus aureus AUMC B-54 by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4184204,Bioorg Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3069064,=,1,1,=,MIC,ug.mL-1,3.4,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,3.4
30045,,18490349,CHEMBL4187381,Antibacterial activity against Bacillus cereus AUMC B-5 by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4184204,Bioorg Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3069064,=,1,1,=,MIC,ug.mL-1,2.9,CHEMBL613070,Bacillus cereus,Bacillus cereus,1396.0,,MIC,ug ml-1,UO_0000274,2.9
30046,,18490352,CHEMBL4187378,Antibacterial activity against Escherichia coli AUMC B-53 by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4184204,Bioorg Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3069064,=,1,1,=,MIC,ug.mL-1,3.9,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,3.9
30047,,18490355,CHEMBL4187379,Antibacterial activity against Pseudomonas aeruginosa AUMC B-73 by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4184204,Bioorg Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3069064,=,1,1,=,MIC,ug.mL-1,6.1,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,6.1
30048,,18490358,CHEMBL4187382,Antibacterial activity against Serratia marcescens AUMC B-55 by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4184204,Bioorg Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3069064,=,1,1,=,MIC,ug.mL-1,9.1,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,MIC,ug ml-1,UO_0000274,9.1
30049,Not Determined,18490361,CHEMBL4187383,Antifungal activity against Candida albicans AUMC 418 by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4184204,Bioorg Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3069064,,1,0,,MIC,,,CHEMBL366,Candida albicans,Candida albicans,5476.0,,MIC,,,
30050,Not Determined,18490364,CHEMBL4187384,Antifungal activity against Geotrichum candidum AUMC 226 by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4184204,Bioorg Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3069064,,1,0,,MIC,,,CHEMBL613775,Geotrichum candidum,Geotrichum candidum,1173061.0,,MIC,,,
30051,Not Determined,18490367,CHEMBL4187385,Antifungal activity against Trichophyton rubrum AUMC 1804 by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4184204,Bioorg Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3069064,,1,0,,MIC,,,CHEMBL612649,Trichophyton rubrum,Trichophyton rubrum,5551.0,,MIC,,,
30052,,18490381,CHEMBL4187392,Antibacterial activity against Staphylococcus aureus AUMC B-54 assessed as diameter of inhibition zone at 10 ug/disc after 24 hrs by agar disc diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4184204,Bioorg Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,3069064,=,1,1,=,IZ,mm,15.3,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,DIZ,mm,UO_0000016,15.3
30053,,18490382,CHEMBL4187393,Antibacterial activity against Bacillus cereus AUMC B-5 assessed as diameter of inhibition zone at 10 ug/disc after 24 hrs by agar disc diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4184204,Bioorg Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,3069064,=,1,1,=,IZ,mm,21.2,CHEMBL613070,Bacillus cereus,Bacillus cereus,1396.0,,DIZ,mm,UO_0000016,21.2
30054,,18490383,CHEMBL4187394,Antibacterial activity against Escherichia coli AUMC B-53 assessed as diameter of inhibition zone at 10 ug/disc after 24 hrs by agar disc diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4184204,Bioorg Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,3069064,=,1,1,=,IZ,mm,25.6,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,DIZ,mm,UO_0000016,25.6
30055,,18490384,CHEMBL4187395,Antibacterial activity against Pseudomonas aeruginosa AUMC B-73 assessed as diameter of inhibition zone at 10 ug/disc after 24 hrs by agar disc diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4184204,Bioorg Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,3069064,=,1,1,=,IZ,mm,14.8,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,DIZ,mm,UO_0000016,14.8
30056,,18490385,CHEMBL4187396,Antibacterial activity against Serratia marcescens AUMC B-55 assessed as diameter of inhibition zone at 10 ug/disc after 24 hrs by agar disc diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4184204,Bioorg Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,3069064,=,1,1,=,IZ,mm,30.1,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,DIZ,mm,UO_0000016,30.1
30057,Not Determined,18490386,CHEMBL4187397,Antifungal activity against Candida albicans AUMC 418 assessed as diameter of inhibition zone at 10 ug/disc after 48 hrs by agar disc diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4184204,Bioorg Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3069064,,1,0,,DIZ,,,CHEMBL366,Candida albicans,Candida albicans,5476.0,,DIZ,,,
30058,Not Determined,18490387,CHEMBL4187398,Antifungal activity against Geotrichum candidum AUMC 226 assessed as diameter of inhibition zone at 10 ug/disc after 48 hrs by agar disc diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4184204,Bioorg Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3069064,,1,0,,DIZ,,,CHEMBL613775,Geotrichum candidum,Geotrichum candidum,1173061.0,,DIZ,,,
30059,Not Determined,18490388,CHEMBL4187399,Antifungal activity against Trichophyton rubrum AUMC 1804 assessed as diameter of inhibition zone at 10 ug/disc after 48 hrs by agar disc diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4184204,Bioorg Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3069064,,1,0,,DIZ,,,CHEMBL612649,Trichophyton rubrum,Trichophyton rubrum,5551.0,,DIZ,,,
30060,,18515464,CHEMBL4192847,Bactericidal activity against methicillin-resistant Staphylococcus aureus subsp. aureus Rosenbach 1884,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4190280,Eur J Med Chem,2017.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3074177,=,1,1,=,MIC,ug.mL-1,256.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/L,UO_0000274,256.0
30061,,18515474,CHEMBL4192846,Antibacterial activity against methicillin-resistant Staphylococcus aureus subsp. aureus Rosenbach 1884,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4190280,Eur J Med Chem,2017.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3074177,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/L,UO_0000274,0.5
30062,,18516264,CHEMBL4193052,Antibacterial activity against Vibrio parahaemolyticus after 18 hrs by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4190288,J Nat Prod,2017.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3074292,=,1,1,=,MIC,ug.mL-1,0.43,CHEMBL614403,Vibrio parahaemolyticus,Vibrio parahaemolyticus,670.0,,MIC,ug ml-1,UO_0000274,0.43
30063,,18516265,CHEMBL4193051,Antibacterial activity against Proteus vulgaris after 18 hrs by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4190288,J Nat Prod,2017.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3074292,=,1,1,=,MIC,ug.mL-1,0.199,CHEMBL614450,Proteus vulgaris,Proteus vulgaris,585.0,,MIC,ug ml-1,UO_0000274,0.199
30064,,18516266,CHEMBL4193050,Antibacterial activity against Bacillus megaterium after 18 hrs by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4190288,J Nat Prod,2017.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3074292,=,1,1,=,MIC,ug.mL-1,1.655,CHEMBL613071,Priestia megaterium,Priestia megaterium,1404.0,,MIC,ug ml-1,UO_0000274,1.655
30065,,18516267,CHEMBL4193049,Antibacterial activity against Bacillus cereus after 18 hrs by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4190288,J Nat Prod,2017.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3074292,=,1,1,=,MIC,ug.mL-1,0.43,CHEMBL613070,Bacillus cereus,Bacillus cereus,1396.0,,MIC,ug ml-1,UO_0000274,0.43
30066,,18516268,CHEMBL4193048,Antibacterial activity against Micrococcus lysodeikticus after 18 hrs by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4190288,J Nat Prod,2017.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3074292,=,1,1,=,MIC,ug.mL-1,0.099,CHEMBL614421,Micrococcus luteus,Micrococcus luteus,1270.0,,MIC,ug ml-1,UO_0000274,0.099
30067,,18516269,CHEMBL4193047,Antibacterial activity against Vibrio anguillarum after 18 hrs by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4190288,J Nat Prod,2017.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3074292,=,1,1,=,MIC,ug.mL-1,0.199,CHEMBL612298,Vibrio anguillarum,Vibrio anguillarum,55601.0,,MIC,ug ml-1,UO_0000274,0.199
30068,,18530062,CHEMBL4195076,Antibacterial activity against Escherichia coli BAS849 by CLSI M100-S17 protocol based method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4190388,J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3076600,=,1,1,=,MIC,ug.mL-1,0.006,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.006
30069,,18530063,CHEMBL4195075,Antibacterial activity against wild type Escherichia coli ATCC 25922 by CLSI M100-S17 protocol based method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4190388,J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3076600,=,1,1,=,MIC,ug.mL-1,0.012,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.012
30070,,18530064,CHEMBL4195074,Antibacterial activity against fluoroquinolone resistant Escherichia coli SKM18 by CLSI M100-S17 protocol based method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4190388,J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3076600,>=,1,1,>=,MIC,ug.mL-1,200.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,200.0
30071,,18530065,CHEMBL4195077,Antibacterial activity against quinolone resistance Escherichia coli isolate ELZ4251 harboring gyrA/parC mutant by CLSI M100-S17 protocol based method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4190388,J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3076600,>,1,1,>,MIC,ug.mL-1,250.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,250.0
30072,,18530066,CHEMBL4195078,Antibacterial activity against wild type Acinetobacter baumannii ATCC BAA-747 by CLSI M100-S17 protocol based method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4190388,J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3076600,=,1,1,=,MIC,ug.mL-1,0.19,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,0.19
30073,,18530067,CHEMBL4195079,Antibacterial activity against fluoroquinolone resistant Acinetobacter baumannii isolate MMX2240 by CLSI M100-S17 protocol based method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4190388,J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3076600,>,1,1,>,MIC,ug.mL-1,25.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,25.0
30074,,18530068,CHEMBL4195080,Antibacterial activity against wild type Klebsiella pneumoniae ATCC 35657 by CLSI M100-S17 protocol based method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4190388,J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3076600,=,1,1,=,MIC,ug.mL-1,0.19,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,0.19
30075,,18530069,CHEMBL4195081,Antibacterial activity against wild type Escherichia coli ATCC 25922 in presence of HSA by CLSI M100-S17 protocol based method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4190388,J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3076600,=,1,1,=,MIC,ug.mL-1,0.012,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.012
30076,,18530070,CHEMBL4195082,Antibacterial activity against Escherichia coli SKM11 by CLSI M100-S17 protocol based method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4190388,J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3076600,=,1,1,=,MIC,ug.mL-1,0.78,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.78
30077,,18530071,CHEMBL4195083,Antibacterial activity against wild type Escherichia coli 1609 by CLSI M100-S17 protocol based method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4190388,J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3076600,=,1,1,=,MIC,ug.mL-1,0.024,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.024
30078,,18530072,CHEMBL4195085,Inhibition of His tagged Escherichia coli ATCC 25922 DNA gyrase A expressed in Escherichia coli BL21 (DE3) pLysS cells assessed as reduction in enzyme-mediated supercoiling of relaxed plasmid DNA pNO1 after 30 mins in presence of biotinylated TFO1 by fluorescence assay,B,BAO_0000190,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4190388,J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3076600,=,1,1,=,IC50,nM,190.0,CHEMBL612545,,Unchecked,,,IC50,uM,UO_0000065,0.19
30079,,18530073,CHEMBL4195084,Inhibition of His tagged Escherichia coli ATCC 25922 DNA gyrase A SD-LY mutant expressed in Escherichia coli BL21 (DE3) pLysS cells assessed as reduction in enzyme-mediated supercoiling of relaxed plasmid DNA pNO1 after 30 mins in presence of biotinylated TFO1 by fluorescence assay,B,BAO_0000190,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4190388,J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3076600,=,1,1,=,IC50,nM,2600.0,CHEMBL1858,Escherichia coli K-12,DNA gyrase subunit A,83333.0,,IC50,uM,UO_0000065,2.6
30080,,18530074,CHEMBL4195086,Inhibition of Escherichia coli DNA topoisomerase 4 assessed as reduction in decatenation activity using kinetoplast concatenated DNA as substrate after 30 mins by picogreen dye based fluorescence assay,B,BAO_0000190,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4190388,J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3076600,=,1,1,=,IC50,nM,3500.0,CHEMBL612545,,Unchecked,,,IC50,uM,UO_0000065,3.5
30081,,18530075,CHEMBL4195090,Selectivity ratio of IC50 for Escherichia coli ATCC 25922 DNA gyrase A SD-LY mutant to IC50 for Escherichia coli ATCC 25922 DNA gyrase A,B,BAO_0000179,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4190388,J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3076600,>,1,0,>,Ratio IC50,,13.0,CHEMBL612545,,Unchecked,,,Ratio IC50,,,13.0
30082,Dose-dependent effect,18530076,CHEMBL4195093,Bactericidal activity against wild type Escherichia coli ATCC 25922 assessed as reduction of bacterial load after 24 hrs by time kill assay,F,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4190388,J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3076600,,1,0,,Activity,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,,,
30083,Dose-dependent effect,18530077,CHEMBL4195094,Bactericidal activity against wild type Acinetobacter baumannii ATCC BAA-747 assessed as reduction of bacterial load after 24 hrs by time kill assay,F,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4190388,J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3076600,,1,0,,Activity,,,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,Activity,,,
30084,,18530078,CHEMBL4195073,"Resistance index, ratio of MIC for Escherichia coli SKM11 to MIC for wild type Escherichia coli ATCC 25922",F,BAO_0000193,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4190388,J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3076600,=,1,0,=,Ratio,,32.0,CHEMBL612545,,Unchecked,,,Ratio,,,32.0
30085,,18530079,CHEMBL4195116,"Resistance index, ratio of MIC for Escherichia coli SKM11 to MIC for fluoroquinolone resistant Escherichia coli SKM18",F,BAO_0000193,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4190388,J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3076600,=,1,0,=,Ratio,,250.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Ratio,,,250.0
30086,,18537598,CHEMBL4196788,Antibacterial activity against Bacillus subtilis PTCC 1023 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4196012,Eur J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3077730,=,1,1,=,MIC,ug.mL-1,0.015,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,MIC,ug ml-1,UO_0000274,0.015
30087,,18537601,CHEMBL4196789,Antibacterial activity against Staphylococcus aureus ATCC 6538P by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4196012,Eur J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3077730,=,1,1,=,MIC,ug.mL-1,0.015,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.015
30088,,18537604,CHEMBL4196790,Antibacterial activity against Staphylococcus epidermidis ATCC 12228 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4196012,Eur J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3077730,=,1,1,=,MIC,ug.mL-1,0.015,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.015
30089,,18537632,CHEMBL4196800,Antibacterial activity against Escherichia coli after 24 hrs by agar streak dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4196012,Eur J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3077730,=,1,1,=,MIC,ug.mL-1,6.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,6.25
30090,,18537634,CHEMBL4196803,Antibacterial activity against Pseudomonas aeruginosa after 24 hrs by agar streak dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4196012,Eur J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3077730,=,1,1,=,MIC,ug.mL-1,6.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,6.25
30091,,18537639,CHEMBL4196805,Antibacterial activity against quinolone-resistant Staphylococcus aureus after 16 to 20 hrs by NCCLS microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4196012,Eur J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3077730,>=,1,1,>=,MIC,ug.mL-1,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,32.0
30092,,18537644,CHEMBL4196809,Antibacterial activity against vancomycin and quinolone-resistant Enterococcus faecium after 16 to 20 hrs by NCCLS microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4196012,Eur J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3077730,>=,1,1,>=,MIC,ug.mL-1,32.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,ug ml-1,UO_0000274,32.0
30093,,18537647,CHEMBL4196811,Antibacterial activity against quinolone-resistant Streptococcus pneumoniae after 16 to 20 hrs by NCCLS microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4196012,Eur J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3077730,>=,1,1,>=,MIC,ug.mL-1,32.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,32.0
30094,,18537676,CHEMBL4196831,Antibacterial activity against Escherichia coli NCTC 10419 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4196012,Eur J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3077730,=,1,1,=,MIC,nM,1.1,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,uM,UO_0000065,0.0011
30095,,18537677,CHEMBL4196832,In vivo antibacterial activity against Escherichia coli NCTC 10419 infected in po dosed mouse administered at 1 and 4 hrs post infection,F,BAO_0000188,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4196012,Eur J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3077730,=,1,0,=,EC50,mg kg-1,1.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,EC50,mg kg-1,UO_0000308,1.25
30096,Active,18547728,CHEMBL4198659,Inhibition of Escherichia coli DNA gyrase-B at 0.66 to 100 uM using relaxed pUC19 DNA as substrate after 1 hr by bromophenol blue dye based agarose gel electrophoresis method,B,BAO_0000201,BAO_0000357,single protein format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4196081,Eur J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,3079339,,1,0,,Inhibition,%,,CHEMBL1826,Escherichia coli,DNA gyrase subunit B,562.0,,INH,,UO_0000187,
30097,,18548342,CHEMBL4198735,Antimycobacterial activity against Mycobacterium tuberculosis H37Rv after 5 days by MABA,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4196086,Eur J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3079537,=,1,1,=,MIC,ug.mL-1,3.125,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,ug ml-1,UO_0000274,3.125
30098,,18548577,CHEMBL4198809,Antibacterial activity against Bacillus subtilis at 37 degC measured after 24 hrs by agar disc diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4196087,Eur J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,3079538,=,1,1,=,IZ,mm,38.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,DIZ,mm,UO_0000016,38.0
30099,,18548596,CHEMBL4198810,Antibacterial activity against Bacillus subtilis at 37 degC measured after 24 hrs by CLSI M7-A4 protocol based method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4196087,Eur J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3079538,=,1,1,=,MIC,ug.mL-1,24.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,MIC,ug ml-1,UO_0000274,24.0
30100,,18548615,CHEMBL4198811,Antibacterial activity against Staphylococcus aureus at 37 degC measured after 24 hrs by agar disc diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4196087,Eur J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,3079538,=,1,1,=,IZ,mm,31.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,DIZ,mm,UO_0000016,31.0
30101,,18548634,CHEMBL4198812,Antibacterial activity against Escherichia coli at 37 degC measured after 24 hrs by agar disc diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4196087,Eur J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,3079538,=,1,1,=,IZ,mm,33.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,DIZ,mm,UO_0000016,33.0
30102,,18548653,CHEMBL4198813,Antibacterial activity against Pseudomonas aeruginosa at 37 degC measured after 24 hrs by agar disc diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4196087,Eur J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,3079538,=,1,1,=,IZ,mm,36.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,DIZ,mm,UO_0000016,36.0
30103,,18548672,CHEMBL4198814,Antibacterial activity against Pseudomonas aeruginosa at 37 degC measured after 24 hrs by CLSI M7-A4 protocol based method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4196087,Eur J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3079538,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,32.0
30104,,18555281,CHEMBL4200263,"Antibacterial activity against Salmonella typhimurium ATCC 14028 infected in ICR mouse model of peritonitis assessed as mouse survival at 1 umol/kg, ip dosed at 2 hrs post infection and measured after 10 hrs post dose",F,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4196141,J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,3080684,=,1,0,=,Activity,%,100.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,Activity,%,UO_0000187,100.0
30105,,18577409,CHEMBL4222184,Antibacterial activity against gram-negative Pseudomonas aeruginosa MTCC 2453 after 24 hrs by agar well diffusion method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4219137,Bioorg Med Chem Lett,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3084785,=,1,1,=,MIC,ug.mL-1,0.9,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.9
30106,,18577410,CHEMBL4222183,Antibacterial activity against gram-negative Klebsiella planticola MTCC 530 after 24 hrs by agar well diffusion method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4219137,Bioorg Med Chem Lett,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3084785,=,1,1,=,MIC,ug.mL-1,0.9,CHEMBL613271,Raoultella planticola,Raoultella planticola,575.0,,MIC,ug ml-1,UO_0000274,0.9
30107,,18577413,CHEMBL4222182,Antibacterial activity against gram-negative Escherichia coli MTCC 739 after 24 hrs by agar well diffusion method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4219137,Bioorg Med Chem Lett,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3084785,=,1,1,=,MIC,ug.mL-1,0.9,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.9
30108,,18577417,CHEMBL4222181,Antibacterial activity against gram-positive Micrococcus luteus MTCC 2470 after 24 hrs by agar well diffusion method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4219137,Bioorg Med Chem Lett,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3084785,=,1,1,=,MIC,ug.mL-1,0.9,CHEMBL614421,Micrococcus luteus,Micrococcus luteus,1270.0,,MIC,ug ml-1,UO_0000274,0.9
30109,,18577422,CHEMBL4222180,Antibacterial activity against gram-positive Staphylococcus aureus MLS-16 MTCC 2940 after 24 hrs by agar well diffusion method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4219137,Bioorg Med Chem Lett,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3084785,=,1,1,=,MIC,ug.mL-1,0.9,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.9
30110,,18577425,CHEMBL4222179,Antibacterial activity against gram-positive Staphylococcus aureus MTCC 96 after 24 hrs by agar well diffusion method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4219137,Bioorg Med Chem Lett,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3084785,=,1,1,=,MIC,ug.mL-1,0.9,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.9
30111,,18577435,CHEMBL4222178,Antibacterial activity against gram-positive Bacillus subtilis MTCC 121 after 24 hrs by agar well diffusion method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4219137,Bioorg Med Chem Lett,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3084785,=,1,1,=,MIC,ug.mL-1,0.9,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,MIC,ug ml-1,UO_0000274,0.9
30112,,18577447,CHEMBL4222186,Bactericidal activity against gram-positive Bacillus subtilis MTCC 121 incubated for 24 hrs followed by microbial sample growth at Mueller Hinton agar plates,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4219137,Bioorg Med Chem Lett,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3084785,=,1,0,=,MBC,ug ml-1,0.9,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,MBC,ug ml-1,UO_0000274,0.9
30113,,18577457,CHEMBL4222187,Bactericidal activity against gram-positive Staphylococcus aureus MTCC 96 incubated for 24 hrs followed by microbial sample growth at Mueller Hinton agar plates,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4219137,Bioorg Med Chem Lett,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3084785,=,1,0,=,MBC,ug ml-1,0.9,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MBC,ug ml-1,UO_0000274,0.9
30114,,18577460,CHEMBL4222188,Bactericidal activity against gram-positive Staphylococcus aureus MLS-16 MTCC 2940 incubated for 24 hrs followed by microbial sample growth at Mueller Hinton agar plates,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4219137,Bioorg Med Chem Lett,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3084785,=,1,0,=,MBC,ug ml-1,0.9,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MBC,ug ml-1,UO_0000274,0.9
30115,,18577465,CHEMBL4222189,Bactericidal activity against gram-positive Micrococcus luteus MTCC 2470 incubated for 24 hrs followed by microbial sample growth at Mueller Hinton agar plates,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4219137,Bioorg Med Chem Lett,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3084785,=,1,0,=,MBC,ug ml-1,0.9,CHEMBL614421,Micrococcus luteus,Micrococcus luteus,1270.0,,MBC,ug ml-1,UO_0000274,0.9
30116,,18577469,CHEMBL4222190,Bactericidal activity against gram-negative Escherichia coli MTCC 739 incubated for 24 hrs followed by microbial sample growth at Mueller Hinton agar plates,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4219137,Bioorg Med Chem Lett,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3084785,=,1,0,=,MBC,ug ml-1,0.9,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MBC,ug ml-1,UO_0000274,0.9
30117,,18577472,CHEMBL4222191,Bactericidal activity against gram-negative Klebsiella planticola MTCC 530 incubated for 24 hrs followed by microbial sample growth at Mueller Hinton agar plates,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4219137,Bioorg Med Chem Lett,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3084785,=,1,0,=,MBC,ug ml-1,0.9,CHEMBL613271,Raoultella planticola,Raoultella planticola,575.0,,MBC,ug ml-1,UO_0000274,0.9
30118,,18577473,CHEMBL4222192,Bactericidal activity against gram-negative Pseudomonas aeruginosa MTCC 2453 incubated for 24 hrs followed by microbial sample growth at Mueller Hinton agar plates,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4219137,Bioorg Med Chem Lett,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3084785,=,1,0,=,MBC,ug ml-1,0.9,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MBC,ug ml-1,UO_0000274,0.9
30119,,18580590,CHEMBL4222735,Antibacterial activity against Corynebacterium striatum FS-1 after 20 hrs by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4219167,Bioorg Med Chem Lett,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3085551,>,1,1,>,MIC,nM,32000.0,CHEMBL615033,Corynebacterium striatum,Corynebacterium striatum,43770.0,,MIC,uM,UO_0000065,32.0
30120,,18580596,CHEMBL4222752,Antibacterial activity against Yersinia pseudotuberculosis P61 after 20 hrs by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4219167,Bioorg Med Chem Lett,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3085551,<=,1,1,<=,MIC,nM,500.0,CHEMBL613185,Yersinia pseudotuberculosis,Yersinia pseudotuberculosis,633.0,,MIC,uM,UO_0000065,0.5
30121,,18580597,CHEMBL4222751,Antibacterial activity against Vibrio cholerae TS D4 after 20 hrs by Todd Hewitt broth broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4219167,Bioorg Med Chem Lett,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3085551,<=,1,1,<=,MIC,nM,500.0,CHEMBL614402,Vibrio cholerae,Vibrio cholerae,666.0,,MIC,uM,UO_0000065,0.5
30122,,18580598,CHEMBL4222748,Antibacterial activity against Salmonella typhi Ty2 after 20 hrs by Todd Hewitt broth broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4219167,Bioorg Med Chem Lett,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3085551,<=,1,1,<=,MIC,nM,500.0,CHEMBL614448,Salmonella enterica subsp. enterica serovar Typhi,Salmonella typhi,90370.0,,MIC,uM,UO_0000065,0.5
30123,,18580599,CHEMBL4222746,Antibacterial activity against Proteus mirabilis HM-752 after 20 hrs by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4219167,Bioorg Med Chem Lett,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3085551,<=,1,1,<=,MIC,nM,500.0,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,MIC,uM,UO_0000065,0.5
30124,,18580600,CHEMBL4222744,Antibacterial activity against Escherichia coli DC10B after 20 hrs by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4219167,Bioorg Med Chem Lett,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3085551,<=,1,1,<=,MIC,nM,500.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,uM,UO_0000065,0.5
30125,,18580601,CHEMBL4222743,Antibacterial activity against Citrobacter freundii 4_7_47CFAA after 20 hrs by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4219167,Bioorg Med Chem Lett,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3085551,<=,1,1,<=,MIC,nM,500.0,CHEMBL612615,Citrobacter freundii,Citrobacter freundii,546.0,,MIC,uM,UO_0000065,0.5
30126,,18580602,CHEMBL4222733,Antibacterial activity against Yersinia pestis Kuma D7 after 20 hrs by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4219167,Bioorg Med Chem Lett,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3085551,<=,1,1,<=,MIC,nM,500.0,CHEMBL614597,Yersinia pestis,Yersinia pestis,632.0,,MIC,uM,UO_0000065,0.5
30127,,18580603,CHEMBL4222732,Antibacterial activity against Yersinia pestis Kim D2 after 20 hrs by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4219167,Bioorg Med Chem Lett,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3085551,<=,1,1,<=,MIC,nM,500.0,CHEMBL614597,Yersinia pestis,Yersinia pestis,632.0,,MIC,uM,UO_0000065,0.5
30128,,18580604,CHEMBL4222731,Antibacterial activity against Francisella tularensis Utah 112 after 20 hrs by broth microdilution assay,F,BAO_0002146,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4219167,Bioorg Med Chem Lett,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3085551,<=,1,1,<=,MIC,nM,500.0,CHEMBL5291655,Francisella tularensis,Francisella tularensis,263.0,,MIC,uM,UO_0000065,0.5
30129,,18580605,CHEMBL4222729,Antibacterial activity against Bacillus anthracis UM23-1 after 20 hrs by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4219167,Bioorg Med Chem Lett,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3085551,<=,1,1,<=,MIC,nM,500.0,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,MIC,uM,UO_0000065,0.5
30130,,18580606,CHEMBL4222728,Antibacterial activity against Bacillus anthracis Sterne 34F2 after 20 hrs by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4219167,Bioorg Med Chem Lett,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3085551,<=,1,1,<=,MIC,nM,500.0,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,MIC,uM,UO_0000065,0.5
30131,,18580865,CHEMBL4222727,Antibacterial activity against Bacillus anthracis Ames 35 after 20 hrs by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4219167,Bioorg Med Chem Lett,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3085551,=,1,1,=,MIC,nM,500.0,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,MIC,uM,UO_0000065,0.5
30132,,18580866,CHEMBL4222730,Antibacterial activity against Bacillus anthracis Weybridge after 20 hrs by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4219167,Bioorg Med Chem Lett,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3085551,=,1,1,=,MIC,nM,500.0,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,MIC,uM,UO_0000065,0.5
30133,,18580867,CHEMBL4222734,Antibacterial activity against Bacillus cereus Gibson 971 after 20 hrs by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4219167,Bioorg Med Chem Lett,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3085551,=,1,1,=,MIC,nM,500.0,CHEMBL613070,Bacillus cereus,Bacillus cereus,1396.0,,MIC,uM,UO_0000065,0.5
30134,,18580868,CHEMBL4222736,Antibacterial activity against Listeria monocytogenes Gibson after 20 hrs by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4219167,Bioorg Med Chem Lett,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3085551,=,1,1,=,MIC,nM,4000.0,CHEMBL614974,Listeria monocytogenes,Listeria monocytogenes,1639.0,,MIC,uM,UO_0000065,4.0
30135,,18580869,CHEMBL4222737,Antibacterial activity against Micrococcus luteus SK58 after 20 hrs by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4219167,Bioorg Med Chem Lett,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3085551,=,1,1,=,MIC,nM,4000.0,CHEMBL614421,Micrococcus luteus,Micrococcus luteus,1270.0,,MIC,uM,UO_0000065,4.0
30136,,18580870,CHEMBL4222738,Antibacterial activity against Rhodococcus erythropolis SK121 after 20 hrs by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4219167,Bioorg Med Chem Lett,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3085551,<=,1,1,<=,MIC,nM,500.0,CHEMBL4296596,Rhodococcus erythropolis,Rhodococcus erythropolis,1833.0,,MIC,uM,UO_0000065,0.5
30137,,18580871,CHEMBL4222739,Antibacterial activity against Acinetobacter baumannii AB5075 after 20 hrs by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4219167,Bioorg Med Chem Lett,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3085551,<=,1,1,<=,MIC,nM,500.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,uM,UO_0000065,0.5
30138,,18580872,CHEMBL4222740,Antibacterial activity against Brucella neotomae 5K33 after 20 hrs by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4219167,Bioorg Med Chem Lett,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3085551,=,1,1,=,MIC,nM,1000.0,CHEMBL4296557,Brucella neotomae,Brucella neotomae,29460.0,,MIC,uM,UO_0000065,1.0
30139,,18580873,CHEMBL4222742,Antibacterial activity against Burkholderia cepacia UCB 717 after 20 hrs by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4219167,Bioorg Med Chem Lett,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3085551,=,1,1,=,MIC,nM,4000.0,CHEMBL612499,Burkholderia cepacia,Burkholderia cepacia,292.0,,MIC,uM,UO_0000065,4.0
30140,,18580874,CHEMBL4222741,Antibacterial activity against Burkholderia multivorans CF2 after 20 hrs by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4219167,Bioorg Med Chem Lett,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3085551,=,1,1,=,MIC,nM,8000.0,CHEMBL4296558,Burkholderia multivorans,Burkholderia multivorans,87883.0,,MIC,uM,UO_0000065,8.0
30141,,18580875,CHEMBL4222745,Antibacterial activity against Klebsiella pneumoniae 700603 after 20 hrs by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4219167,Bioorg Med Chem Lett,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3085551,=,1,1,=,MIC,nM,2000.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,uM,UO_0000065,2.0
30142,,18580876,CHEMBL4222747,Antibacterial activity against Pseudomonas aeruginosa ATCC 15442 after 20 hrs by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4219167,Bioorg Med Chem Lett,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3085551,=,1,1,=,MIC,nM,1000.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,uM,UO_0000065,1.0
30143,,18580877,CHEMBL4222750,Antibacterial activity against Shigella dysenteriae Newcastle 1934 after 20 hrs by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4219167,Bioorg Med Chem Lett,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3085551,=,1,1,=,MIC,nM,4000.0,CHEMBL612619,Shigella dysenteriae,Shigella dysenteriae,622.0,,MIC,uM,UO_0000065,4.0
30144,,18580878,CHEMBL4222749,Antibacterial activity against Yersinia enterocolitica WA-314 after 20 hrs by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4219167,Bioorg Med Chem Lett,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3085551,=,1,1,=,MIC,nM,2000.0,CHEMBL614398,Yersinia enterocolitica,Yersinia enterocolitica,630.0,,MIC,uM,UO_0000065,2.0
30145,,18584051,CHEMBL4223074,Antibacterial activity against Bacillus subtilis MTCC 121 after 24 hrs by well diffusion method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4219190,Bioorg Med Chem Lett,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3086042,=,1,1,=,MIC,ug.mL-1,0.9,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,MIC,ug ml-1,UO_0000274,0.9
30146,,18584052,CHEMBL4223075,Antibacterial activity against Staphylococcus aureus MTCC 96 after 24 hrs by well diffusion method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4219190,Bioorg Med Chem Lett,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3086042,=,1,1,=,MIC,ug.mL-1,0.9,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.9
30147,,18584053,CHEMBL4223076,Antibacterial activity against Staphylococcus aureus MLS16 MTCC 2940 after 24 hrs by well diffusion method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4219190,Bioorg Med Chem Lett,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3086042,=,1,1,=,MIC,ug.mL-1,0.9,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.9
30148,,18584054,CHEMBL4223077,Antibacterial activity against Micrococcus luteus MTCC 2470 after 24 hrs by well diffusion method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4219190,Bioorg Med Chem Lett,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3086042,=,1,1,=,MIC,ug.mL-1,0.9,CHEMBL614421,Micrococcus luteus,Micrococcus luteus,1270.0,,MIC,ug ml-1,UO_0000274,0.9
30149,,18584055,CHEMBL4223078,Antibacterial activity against Klebsiella planticola MTCC 530 after 24 hrs by well diffusion method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4219190,Bioorg Med Chem Lett,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3086042,=,1,1,=,MIC,ug.mL-1,0.9,CHEMBL613271,Raoultella planticola,Raoultella planticola,575.0,,MIC,ug ml-1,UO_0000274,0.9
30150,,18584056,CHEMBL4223079,Antibacterial activity against Escherichia coli MTCC 739 after 24 hrs by well diffusion method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4219190,Bioorg Med Chem Lett,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3086042,=,1,1,=,MIC,ug.mL-1,0.9,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.9
30151,,18584057,CHEMBL4223080,Antibacterial activity against Pseudomonas aeruginosa MTCC 2453 after 24 hrs by well diffusion method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4219190,Bioorg Med Chem Lett,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3086042,=,1,1,=,MIC,ug.mL-1,0.9,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.9
30152,,18584058,CHEMBL4223072,Bactericidal activity against Bacillus subtilis MTCC 121 incubated for 24 hrs followed by transfer of microbial suspension to Mueller Hinton agar plates and measured after 24 hrs post transfer,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4219190,Bioorg Med Chem Lett,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3086042,=,1,0,=,MBC,ug ml-1,0.58,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,MBC,ug ml-1,UO_0000274,0.58
30153,,18584059,CHEMBL4223081,Bactericidal activity against Staphylococcus aureus MTCC 96 incubated for 24 hrs followed by transfer of microbial suspension to Mueller Hinton agar plates and measured after 24 hrs post transfer,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4219190,Bioorg Med Chem Lett,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3086042,=,1,0,=,MBC,ug ml-1,0.58,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MBC,ug ml-1,UO_0000274,0.58
30154,,18584060,CHEMBL4223082,Bactericidal activity against Staphylococcus aureus MLS16 MTCC 2940 incubated for 24 hrs followed by transfer of microbial suspension to Mueller Hinton agar plates and measured after 24 hrs post transfer,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4219190,Bioorg Med Chem Lett,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3086042,=,1,0,=,MBC,ug ml-1,1.17,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MBC,ug ml-1,UO_0000274,1.17
30155,,18584061,CHEMBL4223083,Bactericidal activity against Micrococcus luteus MTCC 2470 incubated for 24 hrs followed by transfer of microbial suspension to Mueller Hinton agar plates and measured after 24 hrs post transfer,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4219190,Bioorg Med Chem Lett,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3086042,=,1,0,=,MBC,ug ml-1,1.17,CHEMBL614421,Micrococcus luteus,Micrococcus luteus,1270.0,,MBC,ug ml-1,UO_0000274,1.17
30156,,18584062,CHEMBL4223084,Bactericidal activity against Klebsiella planticola MTCC 530 incubated for 24 hrs followed by transfer of microbial suspension to Mueller Hinton agar plates and measured after 24 hrs post transfer,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4219190,Bioorg Med Chem Lett,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3086042,=,1,0,=,MBC,ug ml-1,0.58,CHEMBL613271,Raoultella planticola,Raoultella planticola,575.0,,MBC,ug ml-1,UO_0000274,0.58
30157,,18584063,CHEMBL4223085,Bactericidal activity against Escherichia coli MTCC 739 incubated for 24 hrs followed by transfer of microbial suspension to Mueller Hinton agar plates and measured after 24 hrs post transfer,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4219190,Bioorg Med Chem Lett,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3086042,=,1,0,=,MBC,ug ml-1,0.58,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MBC,ug ml-1,UO_0000274,0.58
30158,,18584064,CHEMBL4223086,Bactericidal activity against Pseudomonas aeruginosa MTCC 2453 incubated for 24 hrs followed by transfer of microbial suspension to Mueller Hinton agar plates and measured after 24 hrs post transfer,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4219190,Bioorg Med Chem Lett,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3086042,=,1,0,=,MBC,ug ml-1,1.17,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MBC,ug ml-1,UO_0000274,1.17
30159,,18584065,CHEMBL4223115,Antibiofilm activity against Bacillus subtilis MTCC 121 after 24 hrs by crystal violet staining-based assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4219190,Bioorg Med Chem Lett,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3086042,=,1,1,=,IC50,ug.mL-1,0.23,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,IC50,ug ml-1,UO_0000274,0.23
30160,,18584066,CHEMBL4223116,Antibiofilm activity against Staphylococcus aureus MTCC 96 after 24 hrs by crystal violet staining-based assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4219190,Bioorg Med Chem Lett,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3086042,=,1,1,=,IC50,ug.mL-1,0.21,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,IC50,ug ml-1,UO_0000274,0.21
30161,,18584067,CHEMBL4223117,Antibiofilm activity against Staphylococcus aureus MLS16 MTCC 2940 after 24 hrs by crystal violet staining-based assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4219190,Bioorg Med Chem Lett,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3086042,=,1,1,=,IC50,ug.mL-1,0.24,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,IC50,ug ml-1,UO_0000274,0.24
30162,,18584068,CHEMBL4223118,Antibiofilm activity against Pseudomonas aeruginosa MTCC 2453 after 24 hrs by crystal violet staining-based assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4219190,Bioorg Med Chem Lett,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3086042,=,1,1,=,IC50,ug.mL-1,0.32,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,IC50,ug ml-1,UO_0000274,0.32
30163,,18584069,CHEMBL4223119,Antibiofilm activity against Klebsiella planticola MTCC 530 after 24 hrs by crystal violet staining-based assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4219190,Bioorg Med Chem Lett,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3086042,=,1,1,=,IC50,ug.mL-1,0.29,CHEMBL613271,Raoultella planticola,Raoultella planticola,575.0,,IC50,ug ml-1,UO_0000274,0.29
30164,,18591429,CHEMBL4224587,Inhibition of Staphylococcus aureus topoisomerase-4-mediated kinetoplast DNA decatenation after 30 mins by agarose gel electrophoresis,B,BAO_0000190,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4219269,Bioorg Med Chem Lett,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3087762,=,1,1,=,IC50,nM,14300.0,CHEMBL612545,,Unchecked,,,IC50,uM,UO_0000065,14.3
30165,,18591464,CHEMBL4224583,Antibacterial activity against methicillin-sensitive Staphylococcus aureus ATCC 29213 by CLSI method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4219269,Bioorg Med Chem Lett,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3087762,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.125
30166,,18591480,CHEMBL4224585,Antibacterial activity against methicillin-resistant Staphylococcus aureus USA300 by CLSI method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4219269,Bioorg Med Chem Lett,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3087762,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,16.0
30167,,18591496,CHEMBL4224586,Inhibition of Staphylococcus aureus DNA gyrase supercoiling activity using pBR322 as substrate after 30 mins by agarose gel electrophoresis,B,BAO_0000190,BAO_0000223,protein complex format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4219269,Bioorg Med Chem Lett,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3087762,=,1,1,=,IC50,nM,4800.0,CHEMBL3038482,Staphylococcus aureus,DNA gyrase,1280.0,,IC50,uM,UO_0000065,4.8
30168,Not Determined,18591519,CHEMBL4224589,Inhibition of human topoisomerase-2 in etoposide-resistant K/VP.5 cells assessed as growth inhibition,B,BAO_0000190,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4219269,Bioorg Med Chem Lett,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3087762,,1,0,,IC50,,,CHEMBL612545,,Unchecked,,,IC50,,,
30169,,18591526,CHEMBL4224590,Inhibition of human topoisomerase-2 mediated kinetoplast DNA decatenation assessed as remaining activity at 100 uM relative to control,B,BAO_0001103,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4219269,Bioorg Med Chem Lett,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,3087762,=,1,0,=,Activity,%,85.5,CHEMBL612545,,Unchecked,,,Activity,%,UO_0000187,85.5
30170,,18653872,CHEMBL4230262,Antibacterial activity against multidrug resistant Mycobacterium tuberculosis ATTC 27294 by Alamar Blue assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4229334,Eur J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3098176,=,1,1,=,MIC,ug.mL-1,0.1,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,ug ml-1,UO_0000274,0.1
30171,,18653885,CHEMBL4230273,Antibacterial activity against Corynebacterium ATCC-29355 after 18 hrs by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4229334,Eur J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3098176,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL613080,Corynebacterium,Corynebacterium,1716.0,,MIC,ug ml-1,UO_0000274,1.0
30172,,18653887,CHEMBL4230272,Antibacterial activity against Corynebacterium ATCC-25365 after 18 hrs by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4229334,Eur J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3098176,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL613080,Corynebacterium,Corynebacterium,1716.0,,MIC,ug ml-1,UO_0000274,1.0
30173,,18653889,CHEMBL4230271,Antibacterial activity against Staphylococcus aureus after 18 hrs by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4229334,Eur J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3098176,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.0
30174,,18667858,CHEMBL4233933,Antimicrobial activity against Bacillus subtilis by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4229449,Bioorg Med Chem Lett,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3100656,=,1,1,=,MIC,ug.mL-1,1.56,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,MIC,ug ml-1,UO_0000274,1.56
30175,,18675537,CHEMBL4235607,Inhibition of Mycobacterium tuberculosis DNA gyrase supercoiling activity using relaxed pBR322 as substrate after 30 mins by agarose gel electrophoresis,B,BAO_0000190,BAO_0000223,protein complex format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4229515,Bioorg Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3101823,=,1,1,=,IC50,nM,37725.5,CHEMBL3430898,Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv),DNA gyrase subunit A/DNA gyrase subunit B,83332.0,,IC50,uM,UO_0000065,37.7255
30176,,18690706,CHEMBL4253109,Antibacterial activity against Staphylococcus epidermidis after 18 hrs by agar dilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4251589,Eur J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3104376,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.25
30177,,18690709,CHEMBL4253108,Antibacterial activity against Staphylococcus aureus ATCC 6538P after 18 hrs by agar dilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4251589,Eur J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3104376,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
30178,,18690711,CHEMBL4253107,Antibacterial activity against vancomycin-resistant Staphylococcus aureus GISA 992,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4251589,Eur J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3104376,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.125
30179,,18690713,CHEMBL4253106,Antibacterial activity against methicillin-resistant Staphylococcus aureus 494,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4251589,Eur J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3104376,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.125
30180,,18690715,CHEMBL4253105,Antibacterial activity against Staphylococcus aureus 1199B,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4251589,Eur J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3104376,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.125
30181,,18690717,CHEMBL4253104,Antibacterial activity against Staphylococcus aureus 1199-3,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4251589,Eur J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3104376,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.125
30182,,18690719,CHEMBL4253103,Antibacterial activity against Staphylococcus aureus 1199,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4251589,Eur J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3104376,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.125
30183,,18690728,CHEMBL4253102,Antibacterial activity against Staphylococcus aureus,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4251589,Eur J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3104376,=,1,1,=,MIC,ug.mL-1,0.02,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.02
30184,,18690860,CHEMBL4253139,Antimycobacterial activity against Mycobacterium tuberculosis H37Ra ATCC 25177 after 7 days by Alamar Blue assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4251591,Eur J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3104458,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,ug ml-1,UO_0000274,16.0
30185,,18690913,CHEMBL4253140,Antimycobacterial activity against Mycobacterium avium complex CIT19/06 clinical isolate after 5 days by Alamar Blue assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4251591,Eur J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3104458,=,1,1,=,MIC,ug.mL-1,60.0,CHEMBL612953,Mycobacterium avium complex sp.,Mycobacterium avium complex sp.,37162.0,,MIC,ug ml-1,UO_0000274,60.0
30186,,18690966,CHEMBL4253141,Antimycobacterial activity against Mycobacterium avium subsp. paratuberculosis CIT03 clinical isolate after 11 days by Alamar Blue assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4251591,Eur J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3104458,=,1,1,=,MIC,ug.mL-1,60.0,CHEMBL614982,Mycobacterium avium,Mycobacterium avium,1764.0,,MIC,ug ml-1,UO_0000274,60.0
30187,,18691455,CHEMBL4253165,Antibacterial activity against Staphylococcus aureus ATCC 6538 after 24 hrs by microdilution assay,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4251593,Eur J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Micromolar,3104495,=,1,0,=,MIC95,uM,0.98,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC95,uM,UO_0000064,0.98
30188,,18691481,CHEMBL4253166,Antibacterial activity against methicillin-resistant Staphylococcus aureus HK5996/08 clinical isolate after 24 hrs by microdilution assay,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4251593,Eur J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Micromolar,3104495,=,1,0,=,MIC95,uM,500.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC95,uM,UO_0000064,500.0
30189,,18691507,CHEMBL4253167,Antibacterial activity against Staphylococcus epidermidis HK6966/08 clinical isolate after 24 hrs by microdilution assay,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4251593,Eur J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Micromolar,3104495,=,1,0,=,MIC95,uM,250.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC95,uM,UO_0000064,250.0
30190,,18691533,CHEMBL4253168,Antibacterial activity against Enterococcus sp. HK14365/08 clinical isolate after 24 hrs by microdilution assay,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4251593,Eur J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Micromolar,3104495,=,1,0,=,MIC95,uM,0.98,CHEMBL613770,Enterococcus sp.,Enterococcus sp.,35783.0,,MIC95,uM,UO_0000064,0.98
30191,,18691559,CHEMBL4253169,Antibacterial activity against Escherichia coli ATCC 8739 after 24 hrs by microdilution assay,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4251593,Eur J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Micromolar,3104495,=,1,0,=,MIC95,uM,0.06,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC95,uM,UO_0000064,0.06
30192,,18691585,CHEMBL4253170,Antibacterial activity against Klebsiella pneumoniae HK11750/08 clinical isolate after 24 hrs by microdilution assay,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4251593,Eur J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Micromolar,3104495,=,1,0,=,MIC95,uM,0.12,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC95,uM,UO_0000064,0.12
30193,,18691611,CHEMBL4253171,Antibacterial activity against Klebsiella pneumoniae HK14368/08 clinical isolate after 24 hrs by microdilution assay,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4251593,Eur J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Micromolar,3104495,>,1,0,>,MIC95,uM,500.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC95,uM,UO_0000064,500.0
30194,,18691637,CHEMBL4253172,Antibacterial activity against Pseudomonas aeruginosa ATCC 9027 after 24 hrs by microdilution assay,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4251593,Eur J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Micromolar,3104495,=,1,0,=,MIC95,uM,3.9,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC95,uM,UO_0000064,3.9
30195,,18691663,CHEMBL4253173,Antibacterial activity against Staphylococcus aureus ATCC 6538 after 48 hrs by microdilution assay,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4251593,Eur J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Micromolar,3104495,=,1,0,=,MIC95,uM,0.98,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC95,uM,UO_0000064,0.98
30196,,18691689,CHEMBL4253174,Antibacterial activity against methicillin-resistant Staphylococcus aureus HK5996/08 clinical isolate after 48 hrs by microdilution assay,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4251593,Eur J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Micromolar,3104495,=,1,0,=,MIC95,uM,500.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC95,uM,UO_0000064,500.0
30197,,18691715,CHEMBL4253175,Antibacterial activity against Staphylococcus epidermidis HK6966/08 clinical isolate after 48 hrs by microdilution assay,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4251593,Eur J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Micromolar,3104495,=,1,0,=,MIC95,uM,250.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC95,uM,UO_0000064,250.0
30198,,18691741,CHEMBL4253176,Antibacterial activity against Enterococcus sp. HK14365/08 clinical isolate after 48 hrs by microdilution assay,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4251593,Eur J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Micromolar,3104495,=,1,0,=,MIC95,uM,0.98,CHEMBL613770,Enterococcus sp.,Enterococcus sp.,35783.0,,MIC95,uM,UO_0000064,0.98
30199,,18691767,CHEMBL4253177,Antibacterial activity against Escherichia coli ATCC 8739 after 48 hrs by microdilution assay,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4251593,Eur J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Micromolar,3104495,=,1,0,=,MIC95,uM,0.06,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC95,uM,UO_0000064,0.06
30200,,18691793,CHEMBL4253178,Antibacterial activity against Klebsiella pneumoniae HK11750/08 clinical isolate after 48 hrs by microdilution assay,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4251593,Eur J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Micromolar,3104495,=,1,0,=,MIC95,uM,0.12,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC95,uM,UO_0000064,0.12
30201,,18691819,CHEMBL4253179,Antibacterial activity against Klebsiella pneumoniae HK14368/08 clinical isolate after 48 hrs by microdilution assay,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4251593,Eur J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Micromolar,3104495,>,1,0,>,MIC95,uM,500.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC95,uM,UO_0000064,500.0
30202,,18691845,CHEMBL4253180,Antibacterial activity against Pseudomonas aeruginosa ATCC 9027 after 48 hrs by microdilution assay,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4251593,Eur J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Micromolar,3104495,=,1,0,=,MIC95,uM,7.81,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC95,uM,UO_0000064,7.81
30203,,18692771,CHEMBL4253236,Antibacterial activity against Enterobacter cloacae ATCC 23355 assessed as diameter of inhibition at 30 ug/disk after 24 hrs by disk diffusion assay (Rvb = 0 mm),F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4251596,Eur J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,3104588,=,1,1,=,IZ,mm,27.0,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,DIZ,mm,UO_0000016,27.0
30204,,18692783,CHEMBL4253237,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 assessed as diameter of inhibition at 30 ug/disk after 24 hrs by disk diffusion assay (Rvb = 0 mm),F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4251596,Eur J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,3104588,=,1,1,=,IZ,mm,37.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,DIZ,mm,UO_0000016,37.0
30205,,18692795,CHEMBL4253238,Antibacterial activity against Proteus mirabilis ATCC 15290 assessed as diameter of inhibition at 30 ug/disk after 24 hrs by disk diffusion assay (Rvb = 0 mm),F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4251596,Eur J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,3104588,=,1,1,=,IZ,mm,39.0,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,DIZ,mm,UO_0000016,39.0
30206,,18692807,CHEMBL4253239,Antibacterial activity against Serratia marcescens ATCC 14756 assessed as diameter of inhibition at 30 ug/disk after 24 hrs by disk diffusion assay (Rvb = 0 mm),F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4251596,Eur J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,3104588,=,1,1,=,IZ,mm,29.0,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,DIZ,mm,UO_0000016,29.0
30207,,18692819,CHEMBL4253240,Antibacterial activity against Klebsiella pneumoniae ATCC 4352 assessed as diameter of inhibition at 30 ug/disk after 24 hrs by disk diffusion assay (Rvb = 0 mm),F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4251596,Eur J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,3104588,=,1,1,=,IZ,mm,28.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,DIZ,mm,UO_0000016,28.0
30208,Non-Toxic,18692832,CHEMBL4253246,Hemolytic activity in human erythrocytes at 10 to 200 ug/ml after 3 hrs relative to control,A,BAO_0000375,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4251596,Eur J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3104588,,1,0,,Activity,,,CHEMBL4296518,,Erythrocyte,,,Activity,,,
30209,,18693538,CHEMBL4253369,Antimicrobial activity against methicillin-resistant Staphylococcus aureus by modified CLSI based method,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4251600,Eur J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3104719,=,1,1,=,IC50,ug.mL-1,0.12,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,IC50,ug ml-1,UO_0000274,0.12
30210,,18693539,CHEMBL4253369,Antimicrobial activity against methicillin-resistant Staphylococcus aureus by modified CLSI based method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4251600,Eur J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3104719,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
30211,,18693558,CHEMBL4253370,Antimicrobial activity against Staphylococcus aureus by modified CLSI based method,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4251600,Eur J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3104719,=,1,1,=,IC50,ug.mL-1,0.11,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,IC50,ug ml-1,UO_0000274,0.11
30212,,18693559,CHEMBL4253370,Antimicrobial activity against Staphylococcus aureus by modified CLSI based method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4251600,Eur J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3104719,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
30213,,18700154,CHEMBL4254750,Antibacterial activity against Pseudomonas aeruginosa ATCC 15442 after overnight incubation by microbroth dilution method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4251638,Eur J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3105606,=,1,1,=,MIC90,nM,30200.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC90,uM,UO_0000065,30.2
30214,Not Determined,18700197,CHEMBL4254749,Antibacterial activity against Salmonella typhimurium ATCC 14028 after overnight incubation by microbroth dilution method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4251638,Eur J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3105606,,1,0,,MIC90,,,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,MIC90,,,
30215,,18700219,CHEMBL4254748,Antibacterial activity against Escherichia coli ATCC 25922 after overnight incubation by microbroth dilution method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4251638,Eur J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3105606,=,1,1,=,MIC90,nM,30200.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC90,uM,UO_0000065,30.2
30216,,18700245,CHEMBL4254747,Antibacterial activity against Bacillus subtilis ATCC 6633 after overnight incubation by microbroth dilution method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4251638,Eur J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3105606,=,1,1,=,MIC90,nM,30200.0,CHEMBL613907,Bacillus spizizenii,Bacillus spizizenii,96241.0,,MIC90,uM,UO_0000065,30.2
30217,,18700271,CHEMBL4254746,Antibacterial activity against Staphylococcus aureus ATCC 6538 after overnight incubation by microbroth dilution method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4251638,Eur J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3105606,=,1,1,=,MIC90,nM,30200.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC90,uM,UO_0000065,30.2
30218,,18700804,CHEMBL4254857,Antibacterial activity against Salmonella typhimurium ATCC 14028 at pH 7 after 16 to 18 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4251646,Eur J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3105758,=,1,1,=,MIC,nM,50.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,MIC,uM,UO_0000065,0.05
30219,,18700831,CHEMBL4254872,Antibacterial activity against Salmonella typhimurium ATCC 14028 assessed as survival at 10 uM after 3 hrs by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4251646,Eur J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3105758,=,1,0,=,Survival,10'3CFU/ml,5.5,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,Survival,10'3CFU/ml,,5.5
30220,,18700835,CHEMBL4254873,Bactericidal activity against Salmonella typhimurium ATCC 14028 at 10 uM within 3 to 9 hrs,F,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4251646,Eur J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,3105758,=,1,0,=,Activity,%,98.11,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,Activity,%,UO_0000187,98.11
30221,Active,18700843,CHEMBL4254879,Bactericidal activity against Salmonella typhimurium ATCC 14028 at 0.03125 to 4 times MIC after 24 hrs by dose-kill assay,F,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4251646,Eur J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3105758,,1,0,,Activity,,,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,Activity,,,
30222,,18703814,CHEMBL4255412,Antimicrobial activity against Bacillus subtilis DSM 10 by serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4251671,J Nat Prod,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3106196,=,1,1,=,MIC,ug.mL-1,2.3,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,MIC,ug ml-1,UO_0000274,2.3
30223,,18703815,CHEMBL4255415,Antimicrobial activity against Escherichia coli DSM 498 by serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4251671,J Nat Prod,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3106196,=,1,1,=,MIC,ug.mL-1,2.3,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,2.3
30224,Active,18703913,CHEMBL4255467,Antimicrobial activity against Escherichia coli isolate 458 after 18 hrs,F,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4251676,J Nat Prod,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3106252,,1,0,,Activity,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,,,
30225,Active,18703944,CHEMBL4255468,Antimicrobial activity against Sporidiobolus salmonicolor isolate 549 after 18 hrs,F,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4251676,J Nat Prod,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3106252,,1,0,,Activity,,,CHEMBL613322,Sporobolomyces salmonicolor,Sporobolomyces salmonicolor,5005.0,,Activity,,,
30226,,18725014,CHEMBL4258999,Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 incubated in dark for 5 days by Alamar Blue assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4257500,Medchemcomm,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3110896,=,1,1,=,MIC,ug.mL-1,0.098,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,ug ml-1,UO_0000274,0.098
30227,,18725015,CHEMBL4259000,Antimycobacterial activity against Mycobacterium kansasii Hauduroy ATCC 12478 incubated in dark for 5 days by Alamar Blue assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4257500,Medchemcomm,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3110896,=,1,1,=,MIC,ug.mL-1,0.098,CHEMBL614984,Mycobacterium kansasii,Mycobacterium kansasii,1768.0,,MIC,ug ml-1,UO_0000274,0.098
30228,,18725016,CHEMBL4259001,Antimycobacterial activity against Mycobacterium avium subsp. avium Chester ATCC 15769 incubated in dark for 5 days by Alamar Blue assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4257500,Medchemcomm,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3110896,=,1,1,=,MIC,ug.mL-1,0.098,CHEMBL614982,Mycobacterium avium,Mycobacterium avium,1764.0,,MIC,ug ml-1,UO_0000274,0.098
30229,,18725017,CHEMBL4259002,Antimycobacterial activity against Mycobacterium smegmatis ATCC 607 incubated in dark for 48 hrs by resazurin assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4257500,Medchemcomm,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3110896,=,1,1,=,MIC,ug.mL-1,0.098,CHEMBL613088,Mycolicibacterium smegmatis,Mycolicibacterium smegmatis,1772.0,,MIC,ug ml-1,UO_0000274,0.098
30230,,18732116,CHEMBL4260421,Antibacterial activity against Bacillus subtilis ATCC 9372 after 24 hrs by broth microdilution based CLSI method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4257566,Eur J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3112132,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,MIC,ug ml-1,UO_0000274,2.0
30231,,18732174,CHEMBL4260422,Antibacterial activity against Bacillus pumilus CMCC63202 after 24 hrs by broth microdilution based CLSI method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4257566,Eur J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3112132,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL612429,Bacillus pumilus,Bacillus pumilus,1408.0,,MIC,ug ml-1,UO_0000274,8.0
30232,,18732232,CHEMBL4260423,Antibacterial activity against Staphylococcus aureus ATCC 25923 after 24 hrs by broth microdilution based CLSI method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4257566,Eur J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3112132,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,8.0
30233,,18732291,CHEMBL4260424,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 43300 after 24 hrs by broth microdilution based CLSI method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4257566,Eur J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3112132,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,16.0
30234,,18732349,CHEMBL4260425,Antibacterial activity against clinical isolate of penicillin-resistant Staphylococcus aureus after 24 hrs by broth microdilution based CLSI method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4257566,Eur J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3112132,>,1,1,>,MIC,ug.mL-1,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,64.0
30235,,18732407,CHEMBL4260426,Antibacterial activity against Escherichia coli ATCC 25922 after 24 hrs by broth microdilution based CLSI method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4257566,Eur J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3112132,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,8.0
30236,,18732465,CHEMBL4260427,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 after 24 hrs by broth microdilution based CLSI method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4257566,Eur J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3112132,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,4.0
30237,Not Active,18732515,CHEMBL4260445,Induction of Bacillus subtilis FtsZ polymerization in presence of GTP by microtiter plate-based light-scattering assay,B,BAO_0000375,BAO_0000357,single protein format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4257566,Eur J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3112132,,1,0,,Activity,,,CHEMBL5690,Bacillus subtilis (strain 168),Cell division protein ftsZ,224308.0,,Activity,,,
30238,,18740480,CHEMBL4262199,Antibacterial activity against Escherichia coli overexpressing DNA gyrase,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4261496,Medchemcomm,2017.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3113475,=,1,1,=,MIC,ug.mL-1,0.002,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ng/ml,UO_0000274,2.0
30239,,18740481,CHEMBL4262198,Antibacterial activity against Escherichia coli transfected with empty vector,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4261496,Medchemcomm,2017.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3113475,=,1,1,=,MIC,ug.mL-1,0.009,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ng/ml,UO_0000274,9.0
30240,Active,18740482,CHEMBL4262197,Antibacterial activity against Escherichia coli JW5503 simultaneously overexpressing gyrA/gyrB in presence of IPTG induction after 16 hrs by broth microdilution method,F,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4261496,Medchemcomm,2017.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3113475,,1,0,,Activity,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,,,
30241,,18740483,CHEMBL4262195,Antibacterial activity against Escherichia coli JW5503 overexpressing gyrA/gyrB in absence of IPTG induction after 16 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4261496,Medchemcomm,2017.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3113475,=,1,1,=,MIC,ug.mL-1,0.0021,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ng/ml,UO_0000274,2.1
30242,,18740484,CHEMBL4262194,Antibacterial activity against Escherichia coli JW5503 overexpressing gyrA/gyrB in presence of IPTG induction after 16 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4261496,Medchemcomm,2017.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3113475,=,1,1,=,MIC,ug.mL-1,0.0021,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ng/ml,UO_0000274,2.1
30243,,18740485,CHEMBL4262193,Antibacterial activity against Escherichia coli JW5503 overexpressing gyrB in absence of IPTG induction after 16 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4261496,Medchemcomm,2017.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3113475,=,1,1,=,MIC,ug.mL-1,0.0021,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ng/ml,UO_0000274,2.1
30244,,18740486,CHEMBL4262192,Antibacterial activity against Escherichia coli JW5503 overexpressing gyrB in presence of IPTG induction after 16 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4261496,Medchemcomm,2017.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3113475,=,1,1,=,MIC,ug.mL-1,0.0021,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ng/ml,UO_0000274,2.1
30245,,18740487,CHEMBL4262191,Antibacterial activity against Escherichia coli JW5503 overexpressing gyrA in absence of IPTG induction after 16 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4261496,Medchemcomm,2017.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3113475,=,1,1,=,MIC,ug.mL-1,0.0021,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ng/ml,UO_0000274,2.1
30246,,18740488,CHEMBL4262190,Antibacterial activity against Escherichia coli JW5503 overexpressing gyrA in presence of IPTG induction after 16 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4261496,Medchemcomm,2017.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3113475,=,1,1,=,MIC,ug.mL-1,0.0021,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ng/ml,UO_0000274,2.1
30247,,18740489,CHEMBL4262189,Antibacterial activity against Escherichia coli JW5503 transfected with empty vector in absence of IPTG induction after 16 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4261496,Medchemcomm,2017.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3113475,=,1,1,=,MIC,ug.mL-1,0.0021,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ng/ml,UO_0000274,2.1
30248,,18740490,CHEMBL4262188,Antibacterial activity against Escherichia coli JW5503 transfected with empty vector in presence of IPTG induction after 16 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4261496,Medchemcomm,2017.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3113475,=,1,1,=,MIC,ug.mL-1,0.0021,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ng/ml,UO_0000274,2.1
30249,Not Active,18740491,CHEMBL4262187,Inhibition of Escherichia coli DNA gyrase ATPase activity up to 100 uM using DNA as substrate after 60 mins,B,BAO_0000201,BAO_0000223,protein complex format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4261496,Medchemcomm,2017.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,3113475,,1,0,,Inhibition,%,,CHEMBL2094139,Escherichia coli,DNA gyrase,562.0,,INH,,UO_0000187,
30250,,18740492,CHEMBL4262185,Inhibition of Escherichia coli DNA gyrase assessed as inhibition of pUC19 supercoiling after 30 mins by agarose gel electrophoresis,B,BAO_0000190,BAO_0000223,protein complex format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4261496,Medchemcomm,2017.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3113475,=,1,1,=,IC50,nM,170.0,CHEMBL2094139,Escherichia coli,DNA gyrase,562.0,,IC50,nM,UO_0000065,170.0
30251,,18740493,CHEMBL4262183,Ratio of MIC for novobiocin-resistant Escherichia coli LE316 harboring GyrB Arg136Val mutant to MIC for Escherichia coli HB101,F,BAO_0000193,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4261496,Medchemcomm,2017.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3113475,=,1,0,=,Ratio,,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Ratio,,,16.0
30252,,18740494,CHEMBL4262182,Ratio of MIC for novobiocin-resistant Escherichia coli CC5 harboring GyrB Arg136His mutant to MIC for Escherichia coli HB101,F,BAO_0000193,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4261496,Medchemcomm,2017.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3113475,=,1,0,=,Ratio,,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Ratio,,,8.0
30253,,18740495,CHEMBL4262170,Antibacterial activity against novobiocin-resistant Escherichia coli LE316 harboring GyrB Arg136Val mutant after 16 to 18 hrs in presence of PAbetaN by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4261496,Medchemcomm,2017.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3113475,=,1,1,=,MIC,ug.mL-1,0.026,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ng/ml,UO_0000274,26.0
30254,,18740496,CHEMBL4262169,Antibacterial activity against novobiocin-resistant Escherichia coli CC7 harboring GyrB Arg136Ser mutant after 16 to 18 hrs in presence of PAbetaN by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4261496,Medchemcomm,2017.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3113475,=,1,1,=,MIC,ug.mL-1,0.0032,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ng/ml,UO_0000274,3.2
30255,,18740497,CHEMBL4262168,Antibacterial activity against novobiocin-resistant Escherichia coli CC5 harboring GyrB Arg136His mutant after 16 to 18 hrs in presence of PAbetaN by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4261496,Medchemcomm,2017.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3113475,=,1,1,=,MIC,ug.mL-1,0.013,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ng/ml,UO_0000274,13.0
30256,,18740498,CHEMBL4262167,Antibacterial activity against Escherichia coli HB101 after 16 to 18 hrs in presence of PAbetaN by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4261496,Medchemcomm,2017.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3113475,=,1,1,=,MIC,ug.mL-1,0.0016,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ng/ml,UO_0000274,1.6
30257,,18740499,CHEMBL4262166,Antibacterial activity against Escherichia coli HB101 after 16 to 18 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4261496,Medchemcomm,2017.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3113475,=,1,1,=,MIC,ug.mL-1,0.0016,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ng/ml,UO_0000274,1.6
30258,,18740500,CHEMBL4262165,Antibacterial activity against ciprofloxacin-resistant Escherichia coli JW5503 harboring GyrB Ser464Phe mutant after 16 to 18 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4261496,Medchemcomm,2017.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3113475,=,1,1,=,MIC,ug.mL-1,0.016,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ng/ml,UO_0000274,16.0
30259,,18740501,CHEMBL4262164,Antibacterial activity against ciprofloxacin-resistant Escherichia coli JW5503 harboring GyrA Asp87Tyr mutant after 16 to 18 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4261496,Medchemcomm,2017.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3113475,=,1,1,=,MIC,ug.mL-1,0.032,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ng/ml,UO_0000274,32.0
30260,,18740502,CHEMBL4262163,Antibacterial activity against ciprofloxacin-resistant Escherichia coli JW5503 harboring GyrA Asp87Gly mutant after 16 to 18 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4261496,Medchemcomm,2017.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3113475,=,1,1,=,MIC,ug.mL-1,0.016,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ng/ml,UO_0000274,16.0
30261,,18740503,CHEMBL4262162,Antibacterial activity against ciprofloxacin-resistant Escherichia coli JW5503 harboring GyrA Ser83Leu mutant after 16 to 18 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4261496,Medchemcomm,2017.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3113475,=,1,1,=,MIC,ug.mL-1,0.0064,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ng/ml,UO_0000274,6.4
30262,,18740504,CHEMBL4262161,Antibacterial activity against gyramide-resistant Escherichia coli JW5503 harboring GyrB Thr508Met mutant after 16 to 18 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4261496,Medchemcomm,2017.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3113475,=,1,1,=,MIC,ug.mL-1,0.0032,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ng/ml,UO_0000274,3.2
30263,,18740505,CHEMBL4262160,Antibacterial activity against gyramide-resistant Escherichia coli JW5503 harboring GyrA His45Tyr mutant after 16 to 18 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4261496,Medchemcomm,2017.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3113475,=,1,1,=,MIC,ug.mL-1,0.0032,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ng/ml,UO_0000274,3.2
30264,,18740506,CHEMBL4262159,Antibacterial activity against gyramide-resistant Escherichia coli JW5503 harboring GyrA Phe96Leu mutant after 16 to 18 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4261496,Medchemcomm,2017.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3113475,=,1,1,=,MIC,ug.mL-1,0.0032,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ng/ml,UO_0000274,3.2
30265,,18740507,CHEMBL4262158,Antibacterial activity against gyramide-resistant Escherichia coli JW5503 harboring GyrA Ser97Pro mutant after 16 to 18 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4261496,Medchemcomm,2017.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3113475,=,1,1,=,MIC,ug.mL-1,0.0016,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ng/ml,UO_0000274,1.6
30266,,18740508,CHEMBL4262157,Antibacterial activity against gyramide-resistant Escherichia coli JW5503 harboring GyrA Pro35Thr mutant after 16 to 18 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4261496,Medchemcomm,2017.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3113475,=,1,1,=,MIC,ug.mL-1,0.0016,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ng/ml,UO_0000274,1.6
30267,,18740658,CHEMBL4262136,Antibacterial activity against Escherichia coli JW5503 after 16 to 18 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4261496,Medchemcomm,2017.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3113475,=,1,1,=,MIC,ug.mL-1,0.0016,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ng/ml,UO_0000274,1.6
30268,,18750118,CHEMBL4263611,Antibacterial activity against Enterobacter aerogenes assessed as diameter of inhibition zone measured after 18 hrs by Kirby-Bauer disk diffusion test,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4261586,Eur J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,3115463,=,1,1,=,IZ,mm,26.0,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,DIZ,mm,UO_0000016,26.0
30269,,18750120,CHEMBL4263610,Antibacterial activity against Pseudomonas aeruginosa assessed as diameter of inhibition zone measured after 18 hrs by Kirby-Bauer disk diffusion test,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4261586,Eur J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,3115463,=,1,1,=,IZ,mm,25.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,DIZ,mm,UO_0000016,25.0
30270,,18750122,CHEMBL4263609,Antibacterial activity against Acinetobacter baumannii assessed as diameter of inhibition zone measured after 18 hrs by Kirby-Bauer disk diffusion test,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4261586,Eur J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,3115463,=,1,1,=,IZ,mm,31.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,DIZ,mm,UO_0000016,31.0
30271,,18750124,CHEMBL4263608,Antibacterial activity against Klebsiella pneumoniae assessed as diameter of inhibition zone measured after 18 hrs by Kirby-Bauer disk diffusion test,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4261586,Eur J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,3115463,=,1,1,=,IZ,mm,26.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,DIZ,mm,UO_0000016,26.0
30272,,18750126,CHEMBL4263607,Antibacterial activity against Staphylococcus aureus assessed as diameter of inhibition zone after 18 hrs by Kirby-Bauer disk diffusion test,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4261586,Eur J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,3115463,=,1,1,=,IZ,mm,27.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,DIZ,mm,UO_0000016,27.0
30273,,18750128,CHEMBL4263606,Antibacterial activity against Enterococcus faecium assessed as diameter of inhibition zone after 18 hrs by Kirby-Bauer disk diffusion test,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4261586,Eur J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,3115463,=,1,1,=,IZ,mm,25.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,DIZ,mm,UO_0000016,25.0
30274,,18775458,CHEMBL4269002,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 after 6 to 24 days by microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4265973,Eur J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3119625,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,16.0
30275,Active,18775460,CHEMBL4269003,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 measured over 1 month by microdilution assay,F,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4265973,Eur J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3119625,,1,0,,Activity,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,,,
30276,,18777721,CHEMBL4269373,Antibacterial activity against methicillin-resistant Staphylococcus aureus CCARM 3167 after 24 hrs by two-fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4265993,J Nat Prod,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3120061,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,4.0
30277,,18777722,CHEMBL4269374,Antibacterial activity against methicillin-resistant Staphylococcus aureus CCARM 3506 after 24 hrs by two-fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4265993,J Nat Prod,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3120061,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.125
30278,,18777723,CHEMBL4269375,Antibacterial activity against quinolone-resistant Staphylococcus aureus CCARM 3505 after 24 hrs by two-fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4265993,J Nat Prod,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3120061,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,32.0
30279,,18777724,CHEMBL4269376,Antibacterial activity against quinolone-resistant Staphylococcus aureus CCARM 3519 after 24 hrs by two-fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4265993,J Nat Prod,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3120061,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,16.0
30280,,18777725,CHEMBL4269377,Antibacterial activity against Staphylococcus aureus RN4220 after 24 hrs by two-fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4265993,J Nat Prod,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3120061,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.125
30281,,18777726,CHEMBL4269378,Antibacterial activity against Streptococcus pneumoniae KCTC 5412 after 24 hrs by two-fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4265993,J Nat Prod,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3120061,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.5
30282,,18777727,CHEMBL4269379,Antibacterial activity against Enterococcus faecalis KCTC 5191 after 24 hrs by two-fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4265993,J Nat Prod,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3120061,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,1.0
30283,,18777728,CHEMBL4269380,Antibacterial activity against Bacillus subtilis KCTC 1021 after 24 hrs by two-fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4265993,J Nat Prod,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3120061,=,1,1,=,MIC,ug.mL-1,0.03125,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,MIC,ug ml-1,UO_0000274,0.03125
30284,,18777729,CHEMBL4269381,Antibacterial activity against Acinetobacter baumannii KCTC 2508 after 24 hrs by two-fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4265993,J Nat Prod,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3120061,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,0.25
30285,,18777730,CHEMBL4269382,Antibacterial activity against Escherichia coli CCARM 1356 after 24 hrs by two-fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4265993,J Nat Prod,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3120061,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,64.0
30286,,18777731,CHEMBL4269383,Antibacterial activity against Pseudomonas aeruginosa KCTC 2004 after 24 hrs by two-fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4265993,J Nat Prod,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3120061,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.5
30287,,18789070,CHEMBL4272408,Antimicrobial activity against Pseudomonas aeruginosa INCQS 00099 ATCC 27853 assessed as zone of inhibition at 5 mg/ml after 18 to 24 hrs by disc diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4270541,Eur J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,3122362,=,1,1,=,IZ,mm,36.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,IZ,mm,UO_0000016,36.0
30288,,18789095,CHEMBL4272407,Antimicrobial activity against Klebsiella pneumoniae INCQS 00083 ATCC 4352 assessed as zone of inhibition at 5 mg/ml after 18 to 24 hrs by disc diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4270541,Eur J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,3122362,=,1,1,=,IZ,mm,27.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,IZ,mm,UO_0000016,27.0
30289,,18789200,CHEMBL4272406,Antimicrobial activity against Proteus mirabilis INCQS 00095 ATCC 15290 assessed as zone of inhibition at 5 mg/ml after 18 to 24 hrs by disc diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4270541,Eur J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,3122362,=,1,1,=,IZ,mm,28.0,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,IZ,mm,UO_0000016,28.0
30290,,18789227,CHEMBL4272405,Antimicrobial activity against Escherichia coli INCQS 00033 ATCC 25922 assessed as zone of inhibition at 5 mg/ml after 18 to 24 hrs by disc diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4270541,Eur J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,3122362,=,1,1,=,IZ,mm,35.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,IZ,mm,UO_0000016,35.0
30291,,18789299,CHEMBL4272414,Antimicrobial activity against Pseudomonas aeruginosa INCQS 00099 ATCC 27853 after 24 hrs by microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4270541,Eur J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3122362,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.25
30292,,18789310,CHEMBL4272413,Antimicrobial activity against Escherichia coli INCQS 00033 ATCC 25922 after 24 hrs by microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4270541,Eur J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3122362,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.25
30293,,18793235,CHEMBL4273281,Antibacterial activity against methicillin-sensitive Staphylococcus epidermidis ATCC 12228 after 18 to 24 hrs by two-fold serial dilution method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4270565,Eur J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3123110,=,1,1,=,MIC90,ug.mL-1,0.125,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC90,ug ml-1,UO_0000274,0.125
30294,,18793254,CHEMBL4273284,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 33591 after 18 to 24 hrs by two-fold serial dilution method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4270565,Eur J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3123110,=,1,1,=,MIC90,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC90,ug ml-1,UO_0000274,0.5
30295,,18793268,CHEMBL4273283,Antibacterial activity against methicillin-sensitive Staphylococcus aureus ATCC 29213 after 18 to 24 hrs by two-fold serial dilution method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4270565,Eur J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3123110,=,1,1,=,MIC90,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC90,ug ml-1,UO_0000274,0.25
30296,,18793282,CHEMBL4273282,Antibacterial activity against methicillin-resistant Staphylococcus epidermidis 13-3 after 18 to 24 hrs by two-fold serial dilution method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4270565,Eur J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3123110,=,1,1,=,MIC90,ug.mL-1,64.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC90,ug ml-1,UO_0000274,64.0
30297,,18793291,CHEMBL4273285,Antibacterial activity against Enterococcus faecalis ATCC 29212 after 18 to 24 hrs by two-fold serial dilution method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4270565,Eur J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3123110,=,1,1,=,MIC90,ug.mL-1,0.5,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC90,ug ml-1,UO_0000274,0.5
30298,,18793305,CHEMBL4273286,Antibacterial activity against Enterococcus faecalis ATCC 51299 after 18 to 24 hrs by two-fold serial dilution method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4270565,Eur J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3123110,=,1,1,=,MIC90,ug.mL-1,0.5,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC90,ug ml-1,UO_0000274,0.5
30299,,18793319,CHEMBL4273287,Antibacterial activity against Enterococcus faecium ATCC 700221 after 18 to 24 hrs by two-fold serial dilution method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4270565,Eur J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3123110,=,1,1,=,MIC90,ug.mL-1,8.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC90,ug ml-1,UO_0000274,8.0
30300,,18793333,CHEMBL4273288,Antibacterial activity against Enterococcus faecium 13-7 after 18 to 24 hrs by two-fold serial dilution method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4270565,Eur J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3123110,=,1,1,=,MIC90,ug.mL-1,128.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC90,ug ml-1,UO_0000274,128.0
30301,,18793347,CHEMBL4273289,Antibacterial activity against extended-spectrum beta-lactamase deficient Escherichia coli ATCC 25922 after 18 to 24 hrs by two-fold serial dilution method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4270565,Eur J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3123110,<=,1,1,<=,MIC90,ug.mL-1,0.03,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC90,ug ml-1,UO_0000274,0.03
30302,,18793361,CHEMBL4273290,Antibacterial activity against extended-spectrum beta-lactamase harboring Escherichia coli ATCC 35218 after 18 to 24 hrs by two-fold serial dilution method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4270565,Eur J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3123110,<=,1,1,<=,MIC90,ug.mL-1,0.03,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC90,ug ml-1,UO_0000274,0.03
30303,,18793375,CHEMBL4273291,Antibacterial activity against extended-spectrum beta-lactamase harboring Klebsiella pneumoniae ATCC 700603 after 18 to 24 hrs by two-fold serial dilution method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4270565,Eur J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3123110,=,1,1,=,MIC90,ug.mL-1,0.5,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC90,ug ml-1,UO_0000274,0.5
30304,,18793389,CHEMBL4273292,Antibacterial activity against extended-spectrum beta-lactamase deficient Klebsiella pneumoniae 15-2 after 18 to 24 hrs by two-fold serial dilution method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4270565,Eur J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3123110,<=,1,1,<=,MIC90,ug.mL-1,0.03,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC90,ug ml-1,UO_0000274,0.03
30305,,18793403,CHEMBL4273293,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 after 18 to 24 hrs by two-fold serial dilution method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4270565,Eur J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3123110,=,1,1,=,MIC90,ug.mL-1,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC90,ug ml-1,UO_0000274,0.25
30306,,18793417,CHEMBL4273294,Antibacterial activity against Acinetobacter calcoaceticus ATCC 19606 after 18 to 24 hrs by two-fold serial dilution method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4270565,Eur J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3123110,=,1,1,=,MIC90,ug.mL-1,0.5,CHEMBL614426,Acinetobacter calcoaceticus,Acinetobacter calcoaceticus,471.0,,MIC90,ug ml-1,UO_0000274,0.5
30307,,18793431,CHEMBL4273295,Antibacterial activity against Enterobacter cloacae ATCC 43560 after 18 to 24 hrs by two-fold serial dilution method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4270565,Eur J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3123110,<=,1,1,<=,MIC90,ug.mL-1,0.03,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,MIC90,ug ml-1,UO_0000274,0.03
30308,,18793445,CHEMBL4273296,Antibacterial activity against Enterobacter aerogenes ATCC 13048 after 18 to 24 hrs by two-fold serial dilution method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4270565,Eur J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3123110,<=,1,1,<=,MIC90,ug.mL-1,0.03,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,MIC90,ug ml-1,UO_0000274,0.03
30309,,18793459,CHEMBL4273297,Antibacterial activity against Serratia marcescens ATCC 21074 after 18 to 24 hrs by two-fold serial dilution method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4270565,Eur J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3123110,=,1,1,=,MIC90,ug.mL-1,0.06,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,MIC90,ug ml-1,UO_0000274,0.06
30310,,18793473,CHEMBL4273298,Antibacterial activity against Morganella morganii ATCC 25830 after 18 to 24 hrs by two-fold serial dilution method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4270565,Eur J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3123110,<=,1,1,<=,MIC90,ug.mL-1,0.03,CHEMBL614443,Morganella morganii,Morganella morganii,582.0,,MIC90,ug ml-1,UO_0000274,0.03
30311,,18793487,CHEMBL4273299,Antibacterial activity against Providencia rettgeri ATCC 31052 after 18 to 24 hrs by two-fold serial dilution method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4270565,Eur J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3123110,<=,1,1,<=,MIC90,ug.mL-1,0.03,CHEMBL612537,Providencia rettgeri,Providencia rettgeri,587.0,,MIC90,ug ml-1,UO_0000274,0.03
30312,,18793501,CHEMBL4273300,Antibacterial activity against Proteus vulgaris ATCC 29905 after 18 to 24 hrs by two-fold serial dilution method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4270565,Eur J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3123110,<=,1,1,<=,MIC90,ug.mL-1,0.03,CHEMBL614450,Proteus vulgaris,Proteus vulgaris,585.0,,MIC90,ug ml-1,UO_0000274,0.03
30313,,18793515,CHEMBL4273301,Antibacterial activity against Proteus mirabilis 13-1 after 18 to 24 hrs by two-fold serial dilution method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4270565,Eur J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3123110,<=,1,1,<=,MIC90,ug.mL-1,0.03,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,MIC90,ug ml-1,UO_0000274,0.03
30314,,18793529,CHEMBL4273302,Antibacterial activity against Stenotrophomonas maltophilia ATCC 13636 after 18 to 24 hrs by two-fold serial dilution method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4270565,Eur J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3123110,=,1,1,=,MIC90,ug.mL-1,2.0,CHEMBL612366,Stenotrophomonas maltophilia,Stenotrophomonas maltophilia,40324.0,,MIC90,ug ml-1,UO_0000274,2.0
30315,,18793543,CHEMBL4273303,Antibacterial activity against extended-spectrum beta-lactamase harboring Citrobacter freundii ATCC 43864 after 18 to 24 hrs by two-fold serial dilution method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4270565,Eur J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3123110,<=,1,1,<=,MIC90,ug.mL-1,0.03,CHEMBL612615,Citrobacter freundii,Citrobacter freundii,546.0,,MIC90,ug ml-1,UO_0000274,0.03
30316,,18793569,CHEMBL4273316,Antimycobacterial activity against Mycobacterium tuberculosis H37Rv after 7 days,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4270565,Eur J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3123110,=,1,1,=,MIC90,ug.mL-1,0.78,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC90,ug ml-1,UO_0000274,0.78
30317,,18793584,CHEMBL4273317,Antimycobacterial activity against isoniazid/rifampicin/ethambutol-resistant Mycobacterium tuberculosis after 7 days,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4270565,Eur J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3123110,=,1,1,=,MIC90,ug.mL-1,2.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC90,ug ml-1,UO_0000274,2.0
30318,,18793599,CHEMBL4273318,Cytotoxicity against African green monkey Vero cells assessed as reduction in cell viability after 72 hrs by MTT assay,A,BAO_0000187,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4270565,Eur J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3123110,=,1,1,=,CC50,ug.mL-1,128.0,CHEMBL391,Chlorocebus sabaeus,Vero,60711.0,,CC50,ug ml-1,UO_0000274,128.0
30319,,18793621,CHEMBL4273328,Half life in mouse microsomes,A,BAO_0002115,BAO_0000251,microsome format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4270565,Eur J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Hour,3123110,>,1,1,>,T1/2,hr,1.0,CHEMBL612558,,ADMET,,,t1/2,min,UO_0000032,60.0
30320,,18797389,CHEMBL4274000,Antibacterial activity against Staphylococcus aureus ATCC 12600 after 24 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4270589,Eur J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3123838,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/L,UO_0000274,0.125
30321,,18797461,CHEMBL4274001,Antibacterial activity against Listeria monocytogenes ATCC 15313 after 24 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4270589,Eur J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3123838,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL614974,Listeria monocytogenes,Listeria monocytogenes,1639.0,,MIC,mg/L,UO_0000274,1.0
30322,,18797533,CHEMBL4274002,Antibacterial activity against Escherichia coli ATCC 25922 after 24 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4270589,Eur J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3123838,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,mg/L,UO_0000274,0.5
30323,,18797605,CHEMBL4274003,Antibacterial activity against Salmonella enterica ATCC 9184 after 24 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4270589,Eur J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3123838,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL613762,Salmonella enterica,Salmonella enterica,28901.0,,MIC,mg/L,UO_0000274,0.25
30324,,18797610,CHEMBL4273998,Inhibition of Escherichia coli DNA topoisomerase-2 mediated DNA relaxation using supercoiled pBR322 plasmid DNA as substrate after 60 mins by ethidium bromide staining based agarose gel electrophoresis,B,BAO_0000190,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4270589,Eur J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3123838,=,1,1,=,IC50,ug.mL-1,0.5,CHEMBL612545,,Unchecked,,,IC50,mg/L,UO_0000274,0.5
30325,,18797615,CHEMBL4274004,Inhibition of Escherichia coli DNA topoisomerase-4 mediated decatenation using kinetoplast DNA as substrate after 30 mins agarose gel electrophoresis method,B,BAO_0000190,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4270589,Eur J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3123838,=,1,1,=,IC50,ug.mL-1,8.0,CHEMBL612545,,Unchecked,,,IC50,mg/L,UO_0000274,8.0
30326,,18802904,CHEMBL4274749,Antibacterial activity against Staphylococcus aureus CGMCC 1.8721 measured after 12 to 14 hrs,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4270603,Eur J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3124222,=,1,1,=,MIC,nM,3125.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,umol/L,UO_0000065,3.125
30327,,18802939,CHEMBL4274750,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 43300 measured after 12 to 14 hrs,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4270603,Eur J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3124222,=,1,1,=,MIC,nM,12500.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,umol/L,UO_0000065,12.5
30328,,18802974,CHEMBL4274751,Antibacterial activity against Bacillus cereus CGMCC 1.1846 measured after 12 to 14 hrs,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4270603,Eur J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3124222,=,1,1,=,MIC,nM,6250.0,CHEMBL613070,Bacillus cereus,Bacillus cereus,1396.0,,MIC,umol/L,UO_0000065,6.25
30329,,18803009,CHEMBL4274752,Antibacterial activity against Ralstonia solanacearum CGMCC 1.12711 measured after 12 to 14 hrs,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4270603,Eur J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3124222,=,1,1,=,MIC,nM,3125.0,CHEMBL612602,Ralstonia solanacearum,Ralstonia solanacearum,305.0,,MIC,umol/L,UO_0000065,3.125
30330,,18829047,CHEMBL4303805,Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of Caco-2 cells at 10 uM after 48 hours by high content imaging,F,BAO_0000201,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4303101,,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,3135545,=,52,1,=,Inhibition,%,2.89,CHEMBL4303835,Severe acute respiratory syndrome coronavirus 2,SARS-CoV-2,2697049.0,,Inhibition,%,UO_0000187,2.89
30331,,18853835,CHEMBL4306919,Antibacterial activity against Streptococcus pyogenes,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4304773,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3147037,=,1,1,=,MIC,nM,189000.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC,uM,UO_0000065,189.0
30332,,18853836,CHEMBL4306931,Antibacterial activity against Escherichia coli infected in mouse,F,BAO_0003036,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4304773,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3147037,=,1,1,=,ED50,mg.kg-1,4.53,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,ED50,mg kg-1,UO_0000308,4.53
30333,,18872828,CHEMBL4310283,Antibacterial activity against Staphylococcus aureus RCMB 010028 assessed as diameter of zone inhibition after 24 hrs by agar well diffusion assay,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4308854,Eur J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,3149342,=,1,1,=,IZ,mm,22.2,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,DIZ,mm,UO_0000016,22.2
30334,,18872854,CHEMBL4310284,Antibacterial activity against Staphylococcus aureus RCMB 010028 after 24 hrs by serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4308854,Eur J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3149342,=,1,1,=,MIC,ug.mL-1,1.95,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.95
30335,,18872880,CHEMBL4310285,Antibacterial activity against Pseudomonas aeruginosa RCMB 010043 assessed as diameter of zone inhibition after 24 hrs by agar well diffusion assay,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4308854,Eur J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,3149342,=,1,1,=,IZ,mm,23.1,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,DIZ,mm,UO_0000016,23.1
30336,,18872906,CHEMBL4310286,Antibacterial activity against Escherichia coli RCMB 010052 assessed as diameter of zone inhibition after 24 hrs by agar well diffusion assay,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4308854,Eur J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,3149342,=,1,1,=,IZ,mm,24.3,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,DIZ,mm,UO_0000016,24.3
30337,,18872932,CHEMBL4310287,Antibacterial activity against Pseudomonas aeruginosa RCMB 010043 after 24 hrs by serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4308854,Eur J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3149342,=,1,1,=,MIC,ug.mL-1,3.9,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,3.9
30338,,18872958,CHEMBL4310288,Antibacterial activity against Escherichia coli RCMB 010052 after 24 hrs by serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4308854,Eur J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3149342,=,1,1,=,MIC,ug.mL-1,1.95,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,1.95
30339,,18873092,CHEMBL4310297,Antibacterial activity against vancomycin-resistant Enterococcus faecium ATCC 700221 after 24 hrs by serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4308854,Eur J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3149342,=,1,1,=,MIC,ug.mL-1,3.9,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,ug ml-1,UO_0000274,3.9
30340,,18875704,CHEMBL4310742,Antibacterial activity against Escherichia coli ATCC 25922 after 15 days by turbidometric method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4308875,Bioorg Med Chem Lett,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3149807,=,1,1,=,MIC,ug.mL-1,0.007,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.007
30341,,18875710,CHEMBL4310746,Antibacterial activity against Acinetobacter baumannii ATCC 19606 after 15 days by turbidometric method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4308875,Bioorg Med Chem Lett,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3149807,<,1,1,<,MIC,ug.mL-1,1.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,1.0
30342,,18875716,CHEMBL4310747,Antibacterial activity against Staphylococcus aureus ATCC 33591 after 15 days by turbidometric method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4308875,Bioorg Med Chem Lett,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3149807,<,1,1,<,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.0
30343,,18875722,CHEMBL4310748,Antibacterial activity against Enterococcus faecium ATCC 51559 after 15 days by turbidometric method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4308875,Bioorg Med Chem Lett,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3149807,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,ug ml-1,UO_0000274,8.0
30344,,18875728,CHEMBL4310749,Antibacterial activity against Pseudomonas aeruginosa ATCC 15442 after 15 days by turbidometric method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4308875,Bioorg Med Chem Lett,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3149807,<,1,1,<,MIC,ug.mL-1,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,1.0
30345,,18875734,CHEMBL4310750,Antibacterial activity against Klebsiella pneumoniae ATCC 700603 after 15 days by turbidometric method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4308875,Bioorg Med Chem Lett,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3149807,<,1,1,<,MIC,ug.mL-1,1.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,1.0
30346,,18882755,CHEMBL4312434,Antibacterial activity against Staphylococcus aureus 11011 incubated for 18 to 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4311942,J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3150904,=,1,1,=,MIC,nM,500.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,uM,UO_0000065,0.5
30347,,18882764,CHEMBL4312424,Antibacterial activity against Staphylococcus aureus ATCC 25923 incubated for 18 to 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4311942,J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3150904,=,1,1,=,MIC,nM,500.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,uM,UO_0000065,0.5
30348,,18882799,CHEMBL4312429,Antibacterial activity against Staphylococcus epidermidis ATCC 12228 incubated for 18 to 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4311942,J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3150904,=,1,1,=,MIC,nM,500.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,uM,UO_0000065,0.5
30349,,18882823,CHEMBL4312430,Antibacterial activity against Escherichia coli 20411 clinical isolate incubated for 18 to 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4311942,J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3150904,=,1,1,=,MIC,nM,250.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,uM,UO_0000065,0.25
30350,,18882847,CHEMBL4312431,Antibacterial activity against Acinetobacter baumannii AB1901 clinical isolate incubated for 18 to 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4311942,J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3150904,>,1,1,>,MIC,nM,128000.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,uM,UO_0000065,128.0
30351,,18882925,CHEMBL4312425,Antibacterial activity against Staphylococcus aureus ATCC 29213 incubated for 18 to 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4311942,J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3150904,=,1,1,=,MIC,nM,500.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,uM,UO_0000065,0.5
30352,,18882955,CHEMBL4312428,Antibacterial activity against Escherichia coli ATCC 25922 incubated for 18 to 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4311942,J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3150904,=,1,1,=,MIC,nM,2000.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,uM,UO_0000065,2.0
30353,,18882990,CHEMBL4312427,Antibacterial activity against Escherichia coli UB1005 incubated for 18 to 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4311942,J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3150904,=,1,1,=,MIC,nM,2000.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,uM,UO_0000065,2.0
30354,,18883025,CHEMBL4312426,Antibacterial activity against Salmonella enterica serovar typhimurium C77-31 incubated for 18 to 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4311942,J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3150904,=,1,1,=,MIC,nM,4000.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,MIC,uM,UO_0000065,4.0
30355,,18883030,CHEMBL4312433,Antibacterial activity against Pseudomonas aeruginosa 25349 clinical isolate incubated for 18 to 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4311942,J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3150904,=,1,1,=,MIC,nM,500.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,uM,UO_0000065,0.5
30356,,18883054,CHEMBL4312432,Antibacterial activity against Acinetobacter baumannii AB1902 clinical isolate incubated for 18 to 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4311942,J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3150904,>,1,1,>,MIC,nM,128000.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,uM,UO_0000065,128.0
30357,,18883303,CHEMBL4312489,"Resistance index, ratio of MIC for antibacterial activity against Escherichia coli ATCC 25922 treated over 35 serial passage by sequential passaging method to MIC for antibacterial activity against Escherichia coli ATCC 25922 incubated for 18 to 24 hrs by broth microdilution method",F,BAO_0000193,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4311942,J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3150904,=,1,0,=,Ratio,,128.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Ratio,,,128.0
30358,,18883307,CHEMBL4312490,Antibacterial activity against ciprofloxacin-resistant Escherichia coli ATCC 25922 incubated for 18 to 24 hrs,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4311942,J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3150904,=,1,1,=,MIC,nM,256000.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,uM,UO_0000065,256.0
30359,,18883317,CHEMBL4312491,"Resistance index, ratio of MIC for antibacterial activity against ciprofloxacin-resistant Escherichia coli to MIC for Escherichia coli ATCC 25922 incubated for 18 to 24 hrs by broth microdilution method",F,BAO_0000193,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4311942,J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3150904,=,1,0,=,Ratio,,128.0,CHEMBL612545,,Unchecked,,,Ratio,,,128.0
30360,,18883326,CHEMBL4312493,Displacement of BODIPY-TR-cadaverine from Escherichia coli O111:B4 LPS assessed as increase in fluorescence intensity at 64 uM by spectrofluorophotometric method relative to control,B,BAO_0001103,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4311942,J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,3150904,=,1,0,=,Activity,%,1.6,CHEMBL3580508,Bacteria,Lipopolysaccharide (LPS),2.0,,Activity,%,UO_0000187,1.6
30361,,18886520,CHEMBL4313554,Antimycobacterial activity against multidrug (INH and RIF)-resistant Mycobacterium tuberculosis clinical isolate 1 assessed as inhibition of bacterial growth incubated for 7 days by rapid direct susceptibility test technique,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4311962,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3151358,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,ug ml-1,UO_0000274,1.0
30362,,18886543,CHEMBL4313555,"Antimycobacterial activity against multidrug (ethambutol, INH and RIF)-resistant Mycobacterium tuberculosis clinical isolate 2 assessed as inhibition of bacterial growth incubated for 7 days by rapid direct susceptibility test technique",F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4311962,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3151358,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,ug ml-1,UO_0000274,4.0
30363,,18886566,CHEMBL4313556,Cytotoxicity against CHO cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,A,BAO_0000187,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4311962,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3151358,=,1,1,=,CC50,nM,512000.0,CHEMBL613853,Cricetulus griseus,CHO,10029.0,,CC50,uM,UO_0000065,512.0
30364,,18886589,CHEMBL4313557,"Selectivity index, ratio of CC50 for CHO cells to MIC for multidrug (INH and RIF)-resistant Mycobacterium tuberculosis clinical isolate 1",T,BAO_0000179,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4311962,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3151358,=,1,0,=,Selectivity Index,,512.0,CHEMBL612545,,Unchecked,,,Selectivity Index,,,512.0
30365,,18896276,CHEMBL4315761,"Selectivity index, ratio of IC50 for human HaCaT cells to IC50 for human SW480 cells",U,BAO_0000179,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4312013,Eur J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3152674,=,1,0,=,Ratio IC50,,1.38,CHEMBL612545,,Unchecked,,,Ratio IC50,,,1.38
30366,,18896287,CHEMBL4315762,"Selectivity index, ratio of IC50 for human HaCaT cells to IC50 for human SW620 cells",U,BAO_0000179,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4312013,Eur J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3152674,=,1,0,=,Ratio IC50,,1.11,CHEMBL612545,,Unchecked,,,Ratio IC50,,,1.11
30367,,18896298,CHEMBL4315754,"Selectivity index, ratio of IC50 for human HaCaT cells to IC50 for human PC3 cells",T,BAO_0000179,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4312013,Eur J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3152674,=,1,0,=,Ratio IC50,,2.19,CHEMBL612545,,Unchecked,,,Ratio IC50,,,2.19
30368,,18896610,CHEMBL4315796,Antibacterial activity against Staphylococcus aureus NCTC 4163 assessed as reduction in bacterial cell growth incubated for 18 hrs by two fold serial microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4312013,Eur J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3152674,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
30369,,18896611,CHEMBL4315797,Antibacterial activity against Staphylococcus aureus ATCC 29213 assessed as reduction in bacterial cell growth incubated for 18 hrs by two fold serial microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4312013,Eur J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3152674,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
30370,,18896612,CHEMBL4315798,Antibacterial activity against Staphylococcus aureus ATCC 6538 assessed as reduction in bacterial cell growth incubated for 18 hrs by two fold serial microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4312013,Eur J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3152674,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
30371,,18896613,CHEMBL4315799,Antibacterial activity against Staphylococcus epidermidis ATCC 12228 assessed as reduction in bacterial cell growth incubated for 18 hrs by two fold serial microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4312013,Eur J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3152674,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.25
30372,,18896614,CHEMBL4315800,Antibacterial activity against Enterococcus hirae ATCC 10541 assessed as reduction in bacterial cell growth incubated for 18 hrs by two fold serial microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4312013,Eur J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3152674,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL614623,Enterococcus hirae,Enterococcus hirae,1354.0,,MIC,ug ml-1,UO_0000274,8.0
30373,,18896615,CHEMBL4315801,Antibacterial activity against Escherichia coli ATCC 25922 assessed as reduction in bacterial cell growth incubated for 18 hrs by two fold serial microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4312013,Eur J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3152674,=,1,1,=,MIC,ug.mL-1,0.031,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.031
30374,,18896616,CHEMBL4315802,Antibacterial activity against Escherichia coli NCTC 8196 assessed as reduction in bacterial cell growth incubated for 18 hrs by two fold serial microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4312013,Eur J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3152674,=,1,1,=,MIC,ug.mL-1,0.031,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.031
30375,,18896617,CHEMBL4315803,Antibacterial activity against Pseudomonas aeruginosa ATCC 15442 assessed as reduction in bacterial cell growth incubated for 18 hrs by two fold serial microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4312013,Eur J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3152674,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.25
30376,,18896618,CHEMBL4315804,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 assessed as reduction in bacterial cell growth incubated for 18 hrs by two fold serial microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4312013,Eur J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3152674,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.5
30377,,18903456,CHEMBL4316976,Inhibition of Staphylococcus aureus DNA gyrase supercoiling activity using relaxed pHOT-1 DNA as substrate after 60 mins by ethidium bromide-based gel electrophoresis,B,BAO_0000190,BAO_0000223,protein complex format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4316588,J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3154043,=,1,1,=,IC50,nM,120500.0,CHEMBL3038482,Staphylococcus aureus,DNA gyrase,1280.0,,IC50,uM,UO_0000065,120.5
30378,,18903888,CHEMBL4316982,Antibacterial activity against Enterococcus faecium assessed as bacterial growth inhibition zone diameter at 5 ug after 18 hrs by Kirby-Bauer disk diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4316589,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,3154068,=,1,1,=,IZ,mm,23.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,DIZ,mm,UO_0000016,23.0
30379,,18903890,CHEMBL4316983,Antibacterial activity against Staphylococcus aureus assessed as bacterial growth inhibition zone diameter at 5 ug after 18 hrs by Kirby-Bauer disk diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4316589,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,3154068,=,1,1,=,IZ,mm,23.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,DIZ,mm,UO_0000016,23.0
30380,,18903892,CHEMBL4316984,Antibacterial activity against Klebsiella pneumoniae assessed as bacterial growth inhibition zone diameter at 5 ug after 18 hrs by Kirby-Bauer disk diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4316589,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,3154068,=,1,1,=,IZ,mm,25.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,DIZ,mm,UO_0000016,25.0
30381,,18903894,CHEMBL4316985,Antibacterial activity against Acinetobacter baumannii assessed as bacterial growth inhibition zone diameter at 5 ug after 18 hrs by Kirby-Bauer disk diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4316589,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,3154068,=,1,1,=,IZ,mm,30.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,DIZ,mm,UO_0000016,30.0
30382,,18903896,CHEMBL4316986,Antibacterial activity against Pseudomonas aeruginosa assessed as bacterial growth inhibition zone diameter at 5 ug after 18 hrs by Kirby-Bauer disk diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4316589,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,3154068,=,1,1,=,IZ,mm,23.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,DIZ,mm,UO_0000016,23.0
30383,,18903898,CHEMBL4316987,Antibacterial activity against Enterobacter aerogenes assessed as bacterial growth inhibition zone diameter at 5 ug after 18 hrs by Kirby-Bauer disk diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4316589,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,3154068,=,1,1,=,IZ,mm,25.0,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,DIZ,mm,UO_0000016,25.0
30384,,18914944,CHEMBL4321579,Antimicrobial activity against Bacillus subtilis DSM 10 by serial dilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4316643,J Nat Prod,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3155297,=,1,1,=,MIC,ug.mL-1,3.1,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,MIC,ug ml-1,UO_0000274,3.1
30385,,18923620,CHEMBL4324113,Antimicrobial activity against Proteus mirabilis assessed as zone of inhibition after 18 hrs by disk diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4321839,Eur J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,3156901,=,1,1,=,IZ,mm,22.0,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,IZ,mm,UO_0000016,22.0
30386,,18923623,CHEMBL4324114,Antimicrobial activity against Escherichia coli assessed as zone of inhibition after 18 hrs by disk diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4321839,Eur J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,3156901,=,1,1,=,IZ,mm,23.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,IZ,mm,UO_0000016,23.0
30387,,18923627,CHEMBL4324117,Antimicrobial activity methicillin-resistant against Staphylococcus aureus,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4321839,Eur J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3156901,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,4.0
30388,,18927941,CHEMBL4325047,Antibacterial activity against Citrobacter freundii assessed as reduction in bacterial growth by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4321867,J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3157650,=,1,1,=,MIC90,ug.mL-1,0.125,CHEMBL612615,Citrobacter freundii,Citrobacter freundii,546.0,,MIC90,ug ml-1,UO_0000274,0.125
30389,,18927942,CHEMBL4325048,Antibacterial activity against Enterobacter aerogenes assessed as reduction in bacterial growth by broth microdilution method,F,BAO_0000179,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4321867,J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3157650,=,1,1,=,MIC90,ug.mL-1,0.03,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,MIC90,ug ml-1,UO_0000274,0.03
30390,,18927943,CHEMBL4325049,Antibacterial activity against Enterobacter cloacae assessed as reduction in bacterial growth by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4321867,J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3157650,=,1,1,=,MIC90,ug.mL-1,0.06,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,MIC90,ug ml-1,UO_0000274,0.06
30391,,18927944,CHEMBL4325050,Antibacterial activity against Escherichia coli assessed as reduction in bacterial growth by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4321867,J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3157650,>,1,1,>,MIC90,ug.mL-1,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC90,ug ml-1,UO_0000274,8.0
30392,,18927945,CHEMBL4325051,Antibacterial activity against Klebsiella oxytoca assessed as reduction in bacterial growth by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4321867,J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3157650,<=,1,1,<=,MIC90,ug.mL-1,0.016,CHEMBL614441,Klebsiella oxytoca,Klebsiella oxytoca,571.0,,MIC90,ug ml-1,UO_0000274,0.016
30393,,18927946,CHEMBL4325052,Antibacterial activity against Klebsiella pneumoniae assessed as reduction in bacterial growth by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4321867,J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3157650,>,1,1,>,MIC90,ug.mL-1,8.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC90,ug ml-1,UO_0000274,8.0
30394,,18927947,CHEMBL4325053,Antibacterial activity against Morganella morganii assessed as reduction in bacterial growth by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4321867,J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3157650,<=,1,1,<=,MIC90,ug.mL-1,0.016,CHEMBL614443,Morganella morganii,Morganella morganii,582.0,,MIC90,ug ml-1,UO_0000274,0.016
30395,,18927948,CHEMBL4325054,Antibacterial activity against Proteus mirabilis assessed as reduction in bacterial growth by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4321867,J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3157650,=,1,1,=,MIC90,ug.mL-1,0.125,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,MIC90,ug ml-1,UO_0000274,0.125
30396,,18927949,CHEMBL4325055,Antibacterial activity against Serratia marcescens assessed as reduction in bacterial growth by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4321867,J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3157650,=,1,1,=,MIC90,ug.mL-1,0.25,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,MIC90,ug ml-1,UO_0000274,0.25
30397,,18927950,CHEMBL4325056,Antibacterial activity against Acinetobacter baumannii assessed as reduction in bacterial growth by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4321867,J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3157650,>,1,1,>,MIC90,ug.mL-1,8.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC90,ug ml-1,UO_0000274,8.0
30398,,18927951,CHEMBL4325057,Antibacterial activity against Burkholderia cepacia assessed as reduction in bacterial growth by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4321867,J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3157650,=,1,1,=,MIC90,ug.mL-1,8.0,CHEMBL612499,Burkholderia cepacia,Burkholderia cepacia,292.0,,MIC90,ug ml-1,UO_0000274,8.0
30399,,18927952,CHEMBL4325058,Antibacterial activity against Haemophilus influenzae assessed as reduction in bacterial growth by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4321867,J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3157650,<=,1,1,<=,MIC90,ug.mL-1,0.016,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MIC90,ug ml-1,UO_0000274,0.016
30400,,18927953,CHEMBL4325059,Antibacterial activity against Moraxella catarrhalis assessed as reduction in bacterial growth by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4321867,J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3157650,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL614429,Moraxella catarrhalis,Moraxella catarrhalis,480.0,,MIC90,ug ml-1,UO_0000274,1.0
30401,,18927954,CHEMBL4325060,Antibacterial activity against Pseudomonas aeruginosa assessed as reduction in bacterial growth by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4321867,J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3157650,>,1,1,>,MIC90,ug.mL-1,8.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC90,ug ml-1,UO_0000274,8.0
30402,,18927955,CHEMBL4325061,Antibacterial activity against Stenotrophomonas maltophilia assessed as reduction in bacterial growth by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4321867,J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3157650,=,1,1,=,MIC90,ug.mL-1,8.0,CHEMBL612366,Stenotrophomonas maltophilia,Stenotrophomonas maltophilia,40324.0,,MIC90,ug ml-1,UO_0000274,8.0
30403,,18934610,CHEMBL4326752,Antibacterial activity against Klebsiella pneumoniae,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4325848,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3158826,<=,1,1,<=,MIC,ug.mL-1,0.125,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,0.125
30404,,18934613,CHEMBL4326751,Antibacterial activity against Shigella,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4325848,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3158826,<=,1,1,<=,MIC,ug.mL-1,0.125,CHEMBL614594,Shigella,Shigella,620.0,,MIC,ug ml-1,UO_0000274,0.125
30405,,18934616,CHEMBL4326750,Antibacterial activity against Proteus,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4325848,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3158826,<=,1,1,<=,MIC,ug.mL-1,0.125,CHEMBL612536,Proteus,Proteus,583.0,,MIC,ug ml-1,UO_0000274,0.125
30406,,18934619,CHEMBL4326749,Antibacterial activity against Escherichia coli,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4325848,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3158826,<=,1,1,<=,MIC,ug.mL-1,0.125,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.125
30407,,18934622,CHEMBL4326748,Antibacterial activity against Enterococcus,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4325848,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3158826,<=,1,1,<=,MIC,ug.mL-1,0.125,CHEMBL612318,Enterococcus,Enterococcus,1350.0,,MIC,ug ml-1,UO_0000274,0.125
30408,,18934625,CHEMBL4326747,Antibacterial activity against Staphylococcus aureus,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4325848,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3158826,<=,1,1,<=,MIC,ug.mL-1,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.125
30409,,18934628,CHEMBL4326746,Antibacterial activity against glycopeptide-intermediate Staphylococcus aureus,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4325848,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3158826,>,1,1,>,MIC,ug.mL-1,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,16.0
30410,,18934631,CHEMBL4326745,Antibacterial activity against Staphylococcus aureus 1199B,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4325848,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3158826,>=,1,1,>=,MIC,ug.mL-1,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.125
30411,,18934634,CHEMBL4326744,Antibacterial activity against Staphylococcus aureus 1199-3,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4325848,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3158826,>=,1,1,>=,MIC,ug.mL-1,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.125
30412,,18934637,CHEMBL4326743,Antibacterial activity against Staphylococcus aureus 1199,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4325848,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3158826,>=,1,1,>=,MIC,ug.mL-1,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.125
30413,,18934638,CHEMBL4326742,Antibacterial activity against Staphylococcus aureus ATCC 6538 assessed as zone of inhibition at 100 ug/disc,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4325848,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,3158826,=,1,1,=,IZ,mm,38.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,DIZ,mm,UO_0000016,38.0
30414,,18934652,CHEMBL4326741,Antibacterial activity against Escherichia coli ATCC 8739 assessed as zone of inhibition at 50 ug/disc,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4325848,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,3158826,=,1,1,=,IZ,mm,36.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,DIZ,mm,UO_0000016,36.0
30415,,18937415,CHEMBL4327456,Antitubercular activity against Mycobacterium tuberculosis H37Rv after 7 days by resazurin microtiter assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4325868,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3159488,=,1,1,=,MIC,nM,1500.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,uM,UO_0000065,1.5
30416,,18937416,CHEMBL4327457,Cytotoxicity against African green monkey Vero cells assessed as cell viability at 100 uM after 72 hrs by MTT assay relative to control,A,BAO_0001103,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4325868,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,3159488,=,1,0,=,Activity,%,95.2,CHEMBL391,Chlorocebus sabaeus,Vero,60711.0,,Activity,%,UO_0000187,95.2
30417,,18937417,CHEMBL4327459,Antitubercular activity against ciprofloxacin resistant Mycobacterium tuberculosis isolate 1670 after 7 days by resazurin microtiter assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4325868,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3159488,=,1,1,=,MIC,nM,16000.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,uM,UO_0000065,16.0
30418,,18937418,CHEMBL4327460,Antitubercular activity against multidrug resistant Mycobacterium tuberculosis isolate 512 after 7 days by resazurin microtiter assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4325868,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3159488,=,1,1,=,MIC,nM,8000.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,uM,UO_0000065,8.0
30419,,18937419,CHEMBL4327474,Antitubercular activity against ciprofloxacin resistant Mycobacterium tuberculosis isolate 600 after 7 days by resazurin microtiter assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4325868,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3159488,=,1,1,=,MIC,nM,4000.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,uM,UO_0000065,4.0
30420,,18937420,CHEMBL4327479,Inhibition of Mycobacterium tuberculosis DNA gyrase assessed as reduction in supercoiling of relaxed pBR322 DNA substrate after 30 mins by ethidium bromide staining based agarose gel electrophoresis method,B,BAO_0000190,BAO_0000223,protein complex format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4325868,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3159488,=,1,1,=,IC50,nM,10600.0,CHEMBL3430898,Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv),DNA gyrase subunit A/DNA gyrase subunit B,83332.0,,IC50,uM,UO_0000065,10.6
30421,,18949333,CHEMBL4330633,Antibacterial activity against Pseudomonas aeruginosa MTCC 2453 after 24 hrs by broth dilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4330067,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3161182,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.25
30422,,18949345,CHEMBL4330634,Antibacterial activity against Salmonella typhimurium MTCC 3224 after 24 hrs by broth dilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4330067,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3161182,=,1,1,=,MIC,ug.mL-1,0.0156,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,MIC,ug ml-1,UO_0000274,0.0156
30423,,18949357,CHEMBL4330635,Antibacterial activity against Streptococcus pneumoniae MTCC 655 after 24 hrs by broth dilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4330067,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3161182,=,1,1,=,MIC,ug.mL-1,0.312,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.312
30424,,18949369,CHEMBL4330636,Antibacterial activity against Enterococcus faecalis MTCC 439 after 24 hrs by broth dilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4330067,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3161182,=,1,1,=,MIC,ug.mL-1,0.0625,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,0.0625
30425,,18949381,CHEMBL4330637,Antibacterial activity against Klebsiella pneumoniae ATCC 700603 after 24 hrs by broth dilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4330067,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3161182,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,0.25
30426,,18949393,CHEMBL4330638,Antibacterial activity against Escherichia coli ATCC 25922 after 24 hrs by broth dilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4330067,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3161182,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.125
30427,,18949412,CHEMBL4330647,Antibacterial activity against Escherichia coli MRA11 after overnight incubation,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4330067,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3161182,=,1,1,=,MIC,ug.mL-1,128.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,128.0
30428,,18949415,CHEMBL4330648,Antibacterial activity against Escherichia coli MRC17 after overnight incubation,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4330067,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3161182,=,1,1,=,MIC,ug.mL-1,128.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,128.0
30429,,18949418,CHEMBL4330652,Antibacterial activity against Escherichia coli MRAE33 after overnight incubation,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4330067,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3161182,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,2.0
30430,,18954919,CHEMBL4332208,Antibacterial activity against Escherichia coli NCIM 2256 after 24 hrs by two-fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4330104,Bioorg Med Chem Lett,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3162128,=,1,1,=,MIC,ug.mL-1,50.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,50.0
30431,,18954930,CHEMBL4332209,Antibacterial activity against Pseudomonas aeruginosa NCIM 2036 after 24 hrs by two-fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4330104,Bioorg Med Chem Lett,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3162128,=,1,1,=,MIC,ug.mL-1,50.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,50.0
30432,,18954941,CHEMBL4332210,Antibacterial activity against Bacillus subtilis NCIM 2063 after 24 hrs by two-fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4330104,Bioorg Med Chem Lett,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3162128,=,1,1,=,MIC,ug.mL-1,50.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,MIC,ug ml-1,UO_0000274,50.0
30433,,18954952,CHEMBL4332211,Antibacterial activity against Staphylococcus aureus NCIM 2901 after 24 hrs by two-fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4330104,Bioorg Med Chem Lett,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3162128,=,1,1,=,MIC,ug.mL-1,25.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,25.0
30434,,18959686,CHEMBL4333792,Antitubercular activity against Mycobacterium tuberculosis H37Rv measured after 1 week by microplate alamar blue assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4330141,Bioorg Med Chem Lett,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3163205,=,1,1,=,MIC,ug.mL-1,1.56,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,ug ml-1,UO_0000274,1.56
30435,,18960579,CHEMBL4334111,Antibacterial activity against Escherichia coli ATCC 25922 by XTT dye based assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4330155,J Nat Prod,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3163371,=,1,1,=,MIC,ug.mL-1,1.56,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,1.56
30436,,18960786,CHEMBL4334147,Antibacterial activity against Bacillus cereus after 3 to 7 days by broth dilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4330160,J Nat Prod,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3163409,=,1,1,=,MIC,ug.mL-1,0.78,CHEMBL613070,Bacillus cereus,Bacillus cereus,1396.0,,MIC,ug ml-1,UO_0000274,0.78
30437,,18960790,CHEMBL4334148,Antibacterial activity against Methicillin-resistant Staphylococcus aureus after 3 to 7 days by broth dilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4330160,J Nat Prod,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3163409,=,1,1,=,MIC,ug.mL-1,1.56,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.56
30438,,18960792,CHEMBL4334149,Antibacterial activity against Micrococcus lysodeikticus after 3 to 7 days by broth dilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4330160,J Nat Prod,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3163409,=,1,1,=,MIC,ug.mL-1,0.78,CHEMBL614421,Micrococcus luteus,Micrococcus luteus,1270.0,,MIC,ug ml-1,UO_0000274,0.78
30439,,18960794,CHEMBL4334150,Antibacterial activity against Bacterium paratyphosum after 3 to 7 days by broth dilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4330160,J Nat Prod,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3163409,=,1,1,=,MIC,ug.mL-1,0.78,CHEMBL612293,Salmonella enterica subsp. enterica serovar Paratyphi A,Salmonella paratyphi,54388.0,,MIC,ug ml-1,UO_0000274,0.78
30440,,18960796,CHEMBL4334151,Antibacterial activity against Bacillus subtilis after 3 to 7 days by broth dilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4330160,J Nat Prod,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3163409,=,1,1,=,MIC,ug.mL-1,0.78,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,MIC,ug ml-1,UO_0000274,0.78
30441,,18960798,CHEMBL4334152,Antibacterial activity against Enterobacter aerogenes after 3 to 7 days by broth dilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4330160,J Nat Prod,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3163409,=,1,1,=,MIC,ug.mL-1,0.78,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,MIC,ug ml-1,UO_0000274,0.78
30442,,18960978,CHEMBL4334200,Antibacterial activity against Vibrio anguillarum CICC 10475 after 48 hrs by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4330165,J Nat Prod,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3163448,=,1,1,=,MIC,ug.mL-1,6.3,CHEMBL612298,Vibrio anguillarum,Vibrio anguillarum,55601.0,,MIC,ug ml-1,UO_0000274,6.3
30443,,18960979,CHEMBL4334201,Antibacterial activity against Vibrio parahaemolyticus CICC 10552 after 48 hrs by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4330165,J Nat Prod,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3163448,=,1,1,=,MIC,ug.mL-1,3.1,CHEMBL614403,Vibrio parahaemolyticus,Vibrio parahaemolyticus,670.0,,MIC,ug ml-1,UO_0000274,3.1
30444,,18960982,CHEMBL4334202,Antibacterial activity against Vibrio alginolyticus CICC 21664 after 48 hrs by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4330165,J Nat Prod,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3163448,=,1,1,=,MIC,ug.mL-1,13.0,CHEMBL614599,Vibrio alginolyticus,Vibrio alginolyticus,663.0,,MIC,ug ml-1,UO_0000274,13.0
30445,,18962583,CHEMBL4334718,Antibacterial activity against Escherichia coli UTI89 incubated for 18 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4334425,Medchemcomm,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3163793,<=,1,1,<=,MIC,nM,45.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,uM,UO_0000065,0.045
30446,,18962603,CHEMBL4334733,Antibiofilm activity against Escherichia coli UTI89 assessed as log reduction in CFU at 400 uM incubated for 24 hrs,F,BAO_0000181,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4334425,Medchemcomm,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3163793,=,1,0,=,Activity,log10CFU,2.99,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,log10CFU,,2.99
30447,,18965193,CHEMBL4335444,Growth inhibition of Escherichia coli CFT073 harboring pSU18 and CTX-M-15 incubated for 18 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4334441,J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3164198,=,1,1,=,MIC,ug.mL-1,0.01,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.01
30448,Active,18965217,CHEMBL4335448,Inhibition of recombinant Escherichia coli DNA gyrase in presence of recombinant bacterial N-terminal His6-tagged CTX-M-15 at 1 uM by SYBR Safe DNA gel staining-based agarose gel electrophoresis,B,BAO_0000201,BAO_0000223,protein complex format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4334441,J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,3164198,,1,0,,Inhibition,%,,CHEMBL2094139,Escherichia coli,DNA gyrase,562.0,,INH,,UO_0000187,
30449,Toxic,18965227,CHEMBL4335458,Effect on growth of Enterococcus faecalis ATCC 29212 incubated for 18 hrs by broth microdilution method,A,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4334441,J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3164198,,1,0,,Activity,,,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,Activity,,,
30450,Toxic,18965229,CHEMBL4335459,Effect on growth of Enterococcus faecalis GW01 incubated for 18 hrs by broth microdilution method,A,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4334441,J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3164198,,1,0,,Activity,,,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,Activity,,,
30451,Active,18965233,CHEMBL4335462,Bactericidal activity against Escherichia coli CFT073 expressing CTX-M-1 assessed as reduction in colony forming units at 78 nM measured after 6 hrs,F,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4334441,J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3164198,,1,0,,Activity,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,,,
30452,,18965234,CHEMBL4335463,Antibacterial activity against Escherichia coli CFT073 incubated for 18 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4334441,J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3164198,=,1,1,=,MIC,ug.mL-1,0.01,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.01
30453,,18965257,CHEMBL4335466,Antibacterial activity against ciprofloxacin-susceptible Escherichia coli CFT073 harboring pSU18 incubated for 18 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4334441,J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3164198,=,1,1,=,MIC,ug.mL-1,0.01,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.01
30454,,18965258,CHEMBL4335467,Antibacterial activity against ciprofloxacin-susceptible Escherichia coli CFT073 harboring NDM1 incubated for 18 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4334441,J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3164198,=,1,1,=,MIC,ug.mL-1,0.01,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.01
30455,,18965259,CHEMBL4335468,Antibacterial activity against ciprofloxacin-susceptible Escherichia coli CFT073 harboring KPC3 incubated for 18 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4334441,J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3164198,=,1,1,=,MIC,ug.mL-1,0.01,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.01
30456,Not Active,18965260,CHEMBL4335469,Antibacterial activity against ciprofloxacin-resistant Escherichia coli isolate EC12 expressing bacterial beta lactamase CTX-M-15 incubated for 18 hrs by broth microdilution method,F,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4334441,J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3164198,,1,0,,Activity,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,,,
30457,Not Active,18965261,CHEMBL4335470,Antibacterial activity against ciprofloxacin-resistant Escherichia coli isolate EC13 expressing bacterial beta lactamase CTX-M-15 incubated for 18 hrs by broth microdilution method,F,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4334441,J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3164198,,1,0,,Activity,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,,,
30458,Not Active,18965262,CHEMBL4335471,Antibacterial activity against ciprofloxacin-resistant Escherichia coli isolate EC19 expressing bacterial beta lactamase CTX-M-15 incubated for 18 hrs by broth microdilution method,F,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4334441,J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3164198,,1,0,,Activity,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,,,
30459,Active,18965264,CHEMBL4335473,Prodrug activation in Escherichia coli CFT073 expressing beta lactamase CTX-M-1 assessed as bacterial CTX-M-1-mediated ciprofloxacin release by measuring bactericidal activity at 78 nM measured after 6 hrs,A,BAO_0000375,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4334441,J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3164198,,1,0,,Activity,,,CHEMBL612545,,Unchecked,,,Activity,,,
30460,,18987546,CHEMBL4340353,Antimicrobial activity against Mycobacterium phlei by BSAC standardized disc susceptibility testing method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4339248,J Nat Prod,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3167571,=,1,1,=,MIC,nM,1560.0,CHEMBL614985,Mycolicibacterium phlei,Mycolicibacterium phlei,1771.0,,MIC,uM,UO_0000065,1.56
30461,,18987547,CHEMBL4340354,Antimicrobial activity against Bacillus subtilis by BSAC standardized disc susceptibility testing method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4339248,J Nat Prod,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3167571,=,1,1,=,MIC,nM,1560.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,MIC,uM,UO_0000065,1.56
30462,,18987575,CHEMBL4340355,Antimicrobial activity against Vibrio parahaemolyticus by BSAC standardized disc susceptibility testing method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4339248,J Nat Prod,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3167571,=,1,1,=,MIC,nM,12500.0,CHEMBL614403,Vibrio parahaemolyticus,Vibrio parahaemolyticus,670.0,,MIC,uM,UO_0000065,12.5
30463,,18988032,CHEMBL4340459,Antimicrobial activity against Candida albicans ATCC 90028 assessed as inhibition of microbial growth by CLSI based method,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4339253,J Nat Prod,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3167639,>,1,1,>,IC50,nM,30.0,CHEMBL366,Candida albicans,Candida albicans,5476.0,,IC50,uM,UO_0000065,0.03
30464,,18988040,CHEMBL4340460,Antimicrobial activity against Aspergillus fumigatus ATCC 90906 assessed as inhibition of microbial growth by CLSI based method,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4339253,J Nat Prod,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3167639,>,1,1,>,IC50,nM,30.0,CHEMBL363,Aspergillus fumigatus,Aspergillus fumigatus,746128.0,,IC50,uM,UO_0000065,0.03
30465,,18988048,CHEMBL4340461,Antimicrobial activity against Cryptococcus neoformans ATCC 90113 assessed as inhibition of microbial growth by CLSI based method,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4339253,J Nat Prod,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3167639,>,1,1,>,IC50,nM,30.0,CHEMBL365,Cryptococcus neoformans,Cryptococcus neoformans,5207.0,,IC50,uM,UO_0000065,0.03
30466,,18988056,CHEMBL4340462,Antimicrobial activity against methicillin-resistant Staphylococcus aureus ATCC 43300 assessed as inhibition of microbial growth by CLSI based method,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4339253,J Nat Prod,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3167639,>,1,1,>,IC50,nM,30.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,IC50,uM,UO_0000065,0.03
30467,,18988064,CHEMBL4340463,Antimicrobial activity against Escherichia coli ATCC 35218 assessed as inhibition of microbial growth by CLSI based method,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4339253,J Nat Prod,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3167639,<,1,1,<,IC50,nM,0.03,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,IC50,uM,UO_0000065,3e-05
30468,,18988072,CHEMBL4340464,Antimicrobial activity against Pseudomonas aeruginosa ATCC 27853 assessed as inhibition of microbial growth by CLSI based method,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4339253,J Nat Prod,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3167639,=,1,1,=,IC50,nM,0.3,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,IC50,uM,UO_0000065,0.0003
30469,,19000967,CHEMBL4343477,Antimicrobial activity against Escherichia coli,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4342421,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3170488,=,1,1,=,MIC,ug.mL-1,25.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,25.0
30470,,19000968,CHEMBL4343478,Antimicrobial activity against Pseudomonas aeruginosa,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4342421,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3170488,=,1,1,=,MIC,ug.mL-1,25.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,25.0
30471,,19000969,CHEMBL4343479,Antimicrobial activity against Staphylococcus aureus,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4342421,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3170488,=,1,1,=,MIC,ug.mL-1,25.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,25.0
30472,,19000970,CHEMBL4343495,Antimicrobial activity against Bacillus subtilis,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4342421,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3170488,=,1,1,=,MIC,ug.mL-1,50.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,MIC,ug ml-1,UO_0000274,50.0
30473,,19000971,CHEMBL4343501,Antimicrobial activity against Salmonella typhimurium,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4342421,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3170488,=,1,1,=,MIC,ug.mL-1,25.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,MIC,ug ml-1,UO_0000274,25.0
30474,,19000972,CHEMBL4343504,Antifungal activity against Candida albicans,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4342421,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3170488,=,1,1,=,MIC,ug.mL-1,25.0,CHEMBL366,Candida albicans,Candida albicans,5476.0,,MIC,ug ml-1,UO_0000274,25.0
30475,,19000973,CHEMBL4343514,Antimicrobial activity against Escherichia coli assessed as zone of inhibition at 50 ug/ml,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4342421,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,3170488,=,1,1,=,IZ,mm,19.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,IZ,mm,UO_0000016,19.0
30476,,19000974,CHEMBL4343515,Antimicrobial activity against Staphylococcus aureus assessed as zone of inhibition at 50 ug/ml,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4342421,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,3170488,=,1,1,=,IZ,mm,19.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,IZ,mm,UO_0000016,19.0
30477,,19000975,CHEMBL4343516,Antifungal activity against Aspergillus niger assessed as zone of inhibition at 50 ug/ml,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4342421,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,3170488,=,1,1,=,IZ,mm,19.0,CHEMBL358,Aspergillus niger,Aspergillus niger,5061.0,,IZ,mm,UO_0000016,19.0
30478,,19000976,CHEMBL4343517,Antifungal activity against Candida albicans assessed as zone of inhibition at 50 ug/ml,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4342421,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,3170488,=,1,1,=,IZ,mm,19.0,CHEMBL366,Candida albicans,Candida albicans,5476.0,,IZ,mm,UO_0000016,19.0
30479,,19000977,CHEMBL4343551,Antifungal activity against Aspergillus niger,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4342421,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3170488,=,1,1,=,MIC,ug.mL-1,25.0,CHEMBL358,Aspergillus niger,Aspergillus niger,5061.0,,MIC,ug ml-1,UO_0000274,25.0
30480,,19000978,CHEMBL4343553,Antimicrobial activity against Bacillus megaterium,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4342421,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3170488,=,1,1,=,MIC,ug.mL-1,25.0,CHEMBL613071,Priestia megaterium,Priestia megaterium,1404.0,,MIC,ug ml-1,UO_0000274,25.0
30481,,19000979,CHEMBL4343565,Antibacterial activity against Micrococcus luteus,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4342421,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3170488,=,1,1,=,MIC,ug.mL-1,25.0,CHEMBL614421,Micrococcus luteus,Micrococcus luteus,1270.0,,MIC,ug ml-1,UO_0000274,25.0
30482,,19004455,CHEMBL4344029,Antitubercular activity against Mycobacterium tuberculosis H37Rv assessed as log reduction in bacterial population at 10 ug/ml under starvation condition after 7 days by MPN assay,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4342442,J Nat Prod,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3171200,=,1,0,=,FC,,1.8,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,FC,,,1.8
30483,,19016485,CHEMBL4346868,Antibacterial activity against erythromycin-susceptible Streptococcus pneumoniae ATCC49619 assessed as reduction in microbial growth by CLSI based two-fold broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4346654,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3173325,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.5
30484,,19016525,CHEMBL4346869,Bactericidal activity against erythromycin-susceptible Streptococcus pneumoniae ATCC49619 pretreated followed by subculture in absence of compound measured after 24 hrs,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4346654,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3173325,=,1,0,=,MBC,ug ml-1,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MBC,ug ml-1,UO_0000274,2.0
30485,,19016605,CHEMBL4346873,Antibacterial activity against penicillin-susceptible Streptococcus pneumoniae PU 09 expressing mef gene assessed as reduction in microbial growth by CLSI based two-fold broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4346654,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3173325,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,2.0
30486,,19016645,CHEMBL4346874,Bactericidal activity against penicillin-susceptible Streptococcus pneumoniae PU 09 expressing mef gene pretreated followed by subculture in absence of compound measured after 24 hrs,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4346654,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3173325,=,1,0,=,MBC,ug ml-1,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MBC,ug ml-1,UO_0000274,4.0
30487,,19016724,CHEMBL4346872,Antibacterial activity against Streptococcus pneumoniae 07P390 expressing constitutive ermB gene assessed as reduction in microbial growth by CLSI based two-fold broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4346654,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3173325,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,2.0
30488,,19016754,CHEMBL4346876,Bactericidal activity against Streptococcus pneumoniae 07P390 expressing constitutive ermB gene pretreated followed by subculture in absence of compound measured after 24 hrs,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4346654,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3173325,=,1,0,=,MBC,ug ml-1,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MBC,ug ml-1,UO_0000274,4.0
30489,,19016817,CHEMBL4346870,Antibacterial activity against azithromycin-susceptible Haemophilus influenzae ATCC 49247 assessed as reduction in microbial growth by CLSI based two-fold broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4346654,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3173325,=,1,1,=,MIC,ug.mL-1,0.004,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MIC,ug ml-1,UO_0000274,0.004
30490,,19016857,CHEMBL4346878,Bactericidal activity against azithromycin-susceptible Haemophilus influenzae ATCC 49247 pretreated followed by subculture in absence of compound measured after 24 hrs,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4346654,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3173325,=,1,0,=,MBC,ug ml-1,0.004,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MBC,ug ml-1,UO_0000274,0.004
30491,,19016936,CHEMBL4346880,Antibacterial activity against MLS-resistant Streptococcus pyogenes 01-968 expressing inducible ermB gene assessed as reduction in microbial growth by CLSI based two-fold broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4346654,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3173325,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC,ug ml-1,UO_0000274,0.25
30492,,19016976,CHEMBL4346881,Bactericidal activity against MLS-resistant Streptococcus pyogenes 01-968 expressing inducible ermB gene pretreated followed by subculture in absence of compound measured after 24 hrs,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4346654,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3173325,>=,1,0,>=,MBC,ug ml-1,0.5,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MBC,ug ml-1,UO_0000274,0.5
30493,,19017056,CHEMBL4346867,Antibacterial activity against MLS-resistant Staphylococcus aureus PU 32 expressing inducible ermA gene assessed as reduction in microbial growth by CLSI based two-fold broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4346654,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3173325,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,64.0
30494,,19017096,CHEMBL4346883,Bactericidal activity against MLS/methicillin-resistant Staphylococcus aureus PU 32 expressing inducible ermA gene pretreated followed by subculture in absence of compound measured after 24 hrs,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4346654,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3173325,>,1,0,>,MBC,ug ml-1,256.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MBC,ug ml-1,UO_0000274,256.0
30495,,19017176,CHEMBL4346885,Antibacterial activity against MLS-resistant Staphylococcus aureus PU 20 expressing constitutive ermC gene assessed as reduction in microbial growth by CLSI based two-fold broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4346654,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3173325,>=,1,1,>=,MIC,ug.mL-1,128.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,128.0
30496,,19017203,CHEMBL4346886,Bactericidal activity against MLS-resistant Staphylococcus aureus PU 20 expressing constitutive ermC gene pretreated followed by subculture in absence of compound measured after 24 hrs,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4346654,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3173325,>,1,0,>,MBC,ug ml-1,256.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MBC,ug ml-1,UO_0000274,256.0
30497,,19017220,CHEMBL4346888,Antibacterial activity against MLS-resistant Streptococcus pyogenes 12-206 expressing constitutive ermA gene assessed as reduction in microbial growth by CLSI based two-fold broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4346654,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3173325,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC,ug ml-1,UO_0000274,0.125
30498,,19017232,CHEMBL4346889,Bactericidal activity against MLS-resistant Streptococcus pyogenes 12-206 expressing constitutive ermA gene pretreated followed by subculture in absence of compound measured after 24 hrs,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4346654,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3173325,>,1,0,>,MBC,ug ml-1,1.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MBC,ug ml-1,UO_0000274,1.0
30499,,19017257,CHEMBL4346891,Antibacterial activity against Streptococcus pyogenes 12-207 expressing mef gene assessed as reduction in microbial growth by CLSI based two-fold broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4346654,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3173325,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC,ug ml-1,UO_0000274,1.0
30500,,19017270,CHEMBL4346892,Bactericidal activity against Streptococcus pyogenes 12-207 expressing mef gene pretreated followed by subculture in absence of compound measured after 24 hrs,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4346654,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3173325,=,1,0,=,MBC,ug ml-1,2.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MBC,ug ml-1,UO_0000274,2.0
30501,,19017296,CHEMBL4346894,Antibacterial activity against erythromycin-susceptible Moraxella catarrhalis 13L332 assessed as reduction in microbial growth by CLSI based two-fold broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4346654,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3173325,=,1,1,=,MIC,ug.mL-1,0.062,CHEMBL614429,Moraxella catarrhalis,Moraxella catarrhalis,480.0,,MIC,ug ml-1,UO_0000274,0.062
30502,,19017309,CHEMBL4346895,Bactericidal activity against erythromycin-susceptible Moraxella catarrhalis 13L332 pretreated followed by subculture in absence of compound measured after 24 hrs,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4346654,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3173325,=,1,0,=,MBC,ug ml-1,0.5,CHEMBL614429,Moraxella catarrhalis,Moraxella catarrhalis,480.0,,MBC,ug ml-1,UO_0000274,0.5
30503,,19024963,CHEMBL4348320,Antimicrobial activity against erythromycin-susceptible Streptococcus pneumoniae ATCC 49619 incubated in CAMHB medium for 20 to 24 hrs by two-fold microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4346684,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3174115,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.5
30504,,19025001,CHEMBL4348321,Antimicrobial activity against mef-encoded erythromycin resistant Streptococcus pneumoniae PU09 incubated in CAMHB medium for 20 to 24 hrs by two-fold microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4346684,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3174115,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,2.0
30505,,19025120,CHEMBL4348330,Bactericidal activity against erythromycin-susceptible Streptococcus pneumoniae ATCC 49619 assessed as reduction in colony formation incubated in CAMHB medium for 20 to 24 hrs followed by 24 hrs subculturing in the medium without test compound,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4346684,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3174115,=,1,0,=,MBC,ug ml-1,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MBC,ug ml-1,UO_0000274,2.0
30506,,19025143,CHEMBL4348331,Ratio of MBC to MIC for erythromycin-susceptible Streptococcus pneumoniae ATCC 49619,F,BAO_0000193,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4346684,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3174115,=,1,0,=,Ratio,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Ratio,,,4.0
30507,,19025166,CHEMBL4348332,Bactericidal activity against mef-encoded erythromycin resistant Streptococcus pneumoniae PU09 assessed as reduction in colony formation incubated in CAMHB medium for 20 to 24 hrs followed by 24 hrs subculturing in the medium without test compound,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4346684,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3174115,=,1,0,=,MBC,ug ml-1,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MBC,ug ml-1,UO_0000274,4.0
30508,,19025189,CHEMBL4348333,Ratio of MBC to MIC for mef-encoded erythromycin resistant Streptococcus pneumoniae PU09,F,BAO_0000193,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4346684,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3174115,=,1,0,=,Ratio,,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Ratio,,,2.0
30509,,19025211,CHEMBL4348334,Antimicrobial activity against inducibly erythromycin resistant Streptococcus pyogenes 01-968 expressing i-ermA incubated in CAMHB medium for 20 to 24 hrs by two-fold microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4346684,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3174115,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC,ug ml-1,UO_0000274,0.5
30510,,19025233,CHEMBL4348335,Bactericidal activity against inducibly erythromycin resistant Streptococcus pyogenes 01-968 expressing i-ermA assessed as reduction in colony formation incubated in CAMHB medium for 20 to 24 hrs followed by 24 hrs subculturing in the medium without test compound,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4346684,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3174115,=,1,0,=,MBC,ug ml-1,0.5,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MBC,ug ml-1,UO_0000274,0.5
30511,,19025255,CHEMBL4348336,Ratio of MBC to MIC for inducibly erythromycin resistant Streptococcus pyogenes 01-968 expressing i-ermA,F,BAO_0000193,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4346684,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3174115,=,1,0,=,Ratio,,1.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,Ratio,,,1.0
30512,,19025277,CHEMBL4348337,Antimicrobial activity against constitutively erythromycin resistant and methicillin resistant Staphylococcus aureus PU20 expressing c-ermC incubated in CAMHB medium for 20 hrs by two-fold microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4346684,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3174115,=,1,1,=,MIC,ug.mL-1,256.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,256.0
30513,,19025293,CHEMBL4348338,Bactericidal activity against constitutively erythromycin resistant and methicillin-resistant Staphylococcus aureus PU20 expressing c-ermC assessed as reduction in colony formation incubated in CAMHB medium for 20 hrs followed by 24 hrs subculturing in the medium without test compound,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4346684,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3174115,>,1,0,>,MBC,ug ml-1,256.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MBC,ug ml-1,UO_0000274,256.0
30514,,19025318,CHEMBL4348340,Antimicrobial activity against inducibly erythromycin-resistant and methicillin resistant Staphylococcus aureus PU32 expressing i-ermA incubated in CAMHB medium for 20 hrs by two-fold microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4346684,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3174115,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,64.0
30515,,19025340,CHEMBL4348341,Bactericidal activity against inducibly erythromycin-resistant and methicillin resistant Staphylococcus aureus PU32 expressing i-ermA assessed as reduction in colony formation incubated in CAMHB medium for 20 hrs followed by 24 hrs subculturing in the medium without test compound,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4346684,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3174115,>,1,0,>,MBC,ug ml-1,256.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MBC,ug ml-1,UO_0000274,256.0
30516,,19025353,CHEMBL4348342,Ratio of MBC to MIC for inducibly erythromycin-resistant and methicillin resistant Staphylococcus aureus PU32 expressing i-ermA,F,BAO_0000193,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4346684,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3174115,>,1,0,>,Ratio,,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Ratio,,,4.0
30517,,19025391,CHEMBL4348346,Antimicrobial activity against azithromycin-susceptible Haemophilus influenzae ATCC 49247 incubated in HTM broth medium for 20 to 24 hrs by two-fold microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4346684,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3174115,=,1,1,=,MIC,ug.mL-1,0.004,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MIC,ug ml-1,UO_0000274,0.004
30518,,19025407,CHEMBL4348347,Bactericidal activity against azithromycin-susceptible Haemophilus influenzae ATCC 49247 assessed as reduction in colony formation incubated in HTM broth medium for 20 to 24 hrs followed by 24 hrs subculturing in the medium without test compound,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4346684,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3174115,=,1,0,=,MBC,ug ml-1,0.004,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MBC,ug ml-1,UO_0000274,0.004
30519,,19025423,CHEMBL4348348,Ratio of MBC to MIC for azithromycin-susceptible Haemophilus influenzae ATCC 49247,F,BAO_0000193,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4346684,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3174115,=,1,0,=,Ratio,,1.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,Ratio,,,1.0
30520,,19030514,CHEMBL4349295,Antibacterial activity against Listeria monocytogenes ATCC 35152 after 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4346715,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3174826,=,1,1,=,MIC,ug.mL-1,3.9,CHEMBL614974,Listeria monocytogenes,Listeria monocytogenes,1639.0,,MIC,ug ml-1,UO_0000274,3.9
30521,,19030540,CHEMBL4349297,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 after 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4346715,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3174826,=,1,1,=,MIC,ug.mL-1,3.9,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,3.9
30522,,19030579,CHEMBL4349302,Antibacterial activity against Bacillus cereus ATCC 10876 after 24 hrs by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4346715,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3174826,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL613070,Bacillus cereus,Bacillus cereus,1396.0,,MIC,ug ml-1,UO_0000274,1.0
30523,,19030589,CHEMBL4349303,Antibacterial activity against Enterococcus faecalis ATCC 29212 after 24 hrs by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4346715,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3174826,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,1.0
30524,,19030599,CHEMBL4349304,Antibacterial activity against Staphylococcus aureus ATCC 25923 after 24 hrs by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4346715,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3174826,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.0
30525,,19030609,CHEMBL4349305,Antibacterial activity against Proteus mirabilis ATCC 35659 after 24 hrs by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4346715,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3174826,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,MIC,ug ml-1,UO_0000274,1.0
30526,,19030619,CHEMBL4349306,Antibacterial activity against Escherichia coli ATCC 25922 after 24 hrs by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4346715,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3174826,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,1.0
30527,,19030629,CHEMBL4349307,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 after 24 hrs by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4346715,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3174826,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,1.0
30528,,19030639,CHEMBL4349308,Antifungal activity against Candida albicans ATCC 50193 after 24 hrs by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4346715,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3174826,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL366,Candida albicans,Candida albicans,5476.0,,MIC,ug ml-1,UO_0000274,1.0
30529,,19030649,CHEMBL4349309,Antifungal activity against Aspergillus brasiliensis ATCC 16404 after 24 hrs by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4346715,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3174826,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL4296554,Aspergillus brasiliensis,Aspergillus brasiliensis,319629.0,,MIC,ug ml-1,UO_0000274,1.0
30530,,19030818,CHEMBL4349344,Antibacterial activity against Staphylococcus epidermidis assessed as zone of inhibition at 100 ug/ml,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4346717,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,3174888,=,1,1,=,IZ,mm,23.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,IZ,mm,UO_0000016,23.0
30531,,19030819,CHEMBL4349345,Antibacterial activity against Bacillus cereus assessed as zone of inhibition at 100 ug/ml,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4346717,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,3174888,=,1,1,=,IZ,mm,23.0,CHEMBL613070,Bacillus cereus,Bacillus cereus,1396.0,,IZ,mm,UO_0000016,23.0
30532,,19030820,CHEMBL4349346,Antibacterial activity against Escherichia coli assessed as zone of inhibition at 100 ug/ml,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4346717,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,3174888,=,1,1,=,IZ,mm,23.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,IZ,mm,UO_0000016,23.0
30533,,19030821,CHEMBL4349347,Antibacterial activity against Pseudomonas aeruginosa assessed as zone of inhibition at 100 ug/ml,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4346717,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,3174888,=,1,1,=,IZ,mm,23.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,IZ,mm,UO_0000016,23.0
30534,,19031113,CHEMBL4349362,Antibacterial activity against Escherichia coli,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4346717,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3174888,<=,1,1,<=,MIC,ug.mL-1,0.03,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.03
30535,,19031144,CHEMBL4349363,Antibacterial activity against Pseudomonas aeruginosa,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4346717,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3174888,<=,1,1,<=,MIC,ug.mL-1,0.03,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.03
30536,,19031167,CHEMBL4349364,Antibacterial activity against Yersinia pseudotuberculosis,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4346717,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3174888,<=,1,1,<=,MIC,ug.mL-1,0.03,CHEMBL613185,Yersinia pseudotuberculosis,Yersinia pseudotuberculosis,633.0,,MIC,ug ml-1,UO_0000274,0.03
30537,,19031180,CHEMBL4349365,Antibacterial activity against Staphylococcus aureus,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4346717,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3174888,<=,1,1,<=,MIC,ug.mL-1,0.03,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.03
30538,,19031211,CHEMBL4349366,Antibacterial activity against Enterococcus faecalis,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4346717,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3174888,<=,1,1,<=,MIC,ug.mL-1,0.03,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,0.03
30539,,19031224,CHEMBL4349367,Antibacterial activity against Bacillus cereus,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4346717,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3174888,<=,1,1,<=,MIC,ug.mL-1,0.03,CHEMBL613070,Bacillus cereus,Bacillus cereus,1396.0,,MIC,ug ml-1,UO_0000274,0.03
30540,,19031237,CHEMBL4349368,Antibacterial activity against Mycobacterium smegmatis,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4346717,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3174888,<=,1,1,<=,MIC,ug.mL-1,0.03,CHEMBL613088,Mycolicibacterium smegmatis,Mycolicibacterium smegmatis,1772.0,,MIC,ug ml-1,UO_0000274,0.03
30541,,19031250,CHEMBL4349369,Antibacterial activity against methicillin-resistant Staphylococcus aureus,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4346717,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3174888,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
30542,,19031259,CHEMBL4349370,Antibacterial activity against multi drug-resistant Escherichia coli,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4346717,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3174888,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.25
30543,,19051590,CHEMBL4354972,Antibacterial activity against Pseudomonas aeruginosa by agar diffusion method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4354782,Medchemcomm,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3178401,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC90,mg/L,UO_0000274,1.0
30544,,19051604,CHEMBL4354971,Antibacterial activity against Escherichia coli by agar diffusion method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4354782,Medchemcomm,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3178401,=,1,1,=,MIC90,ug.mL-1,0.03,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC90,mg/L,UO_0000274,0.03
30545,,19051606,CHEMBL4354973,Antibacterial activity against Klebsiella by agar diffusion method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4354782,Medchemcomm,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3178401,=,1,1,=,MIC90,ug.mL-1,0.25,CHEMBL612535,Klebsiella,Klebsiella,570.0,,MIC90,mg/L,UO_0000274,0.25
30546,,19051620,CHEMBL4354974,Antibacterial activity against Bacteroides fragilis by agar diffusion method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4354782,Medchemcomm,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3178401,=,1,1,=,MIC90,ug.mL-1,16.0,CHEMBL614411,Bacteroides fragilis,Bacteroides fragilis,817.0,,MIC90,mg/L,UO_0000274,16.0
30547,,19051634,CHEMBL4354975,Antibacterial activity against Haemophilus influenzae with horse blood by agar diffusion method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4354782,Medchemcomm,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3178401,=,1,1,=,MIC90,ug.mL-1,0.03,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MIC90,mg/L,UO_0000274,0.03
30548,,19051648,CHEMBL4354976,Antibacterial activity against Staphylococcus aureus by agar diffusion method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4354782,Medchemcomm,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3178401,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC90,mg/L,UO_0000274,1.0
30549,,19051662,CHEMBL4354977,Antibacterial activity against Streptococcus pneumoniae by agar diffusion method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4354782,Medchemcomm,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3178401,=,1,1,=,MIC90,ug.mL-1,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,mg/L,UO_0000274,2.0
30550,,19051676,CHEMBL4354978,Antibacterial activity against Streptococcus pyogenes by agar diffusion method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4354782,Medchemcomm,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3178401,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC90,mg/L,UO_0000274,1.0
30551,,19051690,CHEMBL4354979,Antibacterial activity against Enterococcus by agar diffusion method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4354782,Medchemcomm,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3178401,=,1,1,=,MIC90,ug.mL-1,4.0,CHEMBL612318,Enterococcus,Enterococcus,1350.0,,MIC90,mg/L,UO_0000274,4.0
30552,,19051704,CHEMBL4354980,Antibacterial activity against Clostridium perfringens by agar diffusion method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4354782,Medchemcomm,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3178401,=,1,1,=,MIC90,ug.mL-1,0.5,CHEMBL614967,Clostridium perfringens,Clostridium perfringens,1502.0,,MIC90,mg/L,UO_0000274,0.5
30553,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,19051732,CHEMBL4354991,"Cmax in human at 0.75 g, po bid",A,BAO_0002119,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4354782,Medchemcomm,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3178401,=,1,1,=,Cmax,nM,10562.85,CHEMBL612558,,ADMET,,,Cmax,mg/L,UO_0000065,3.5
30554,,19051733,CHEMBL4354992,"AUC in human at 0.75 g, po bid",A,BAO_0002120,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4354782,Medchemcomm,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3178401,=,1,1,=,AUC,ng.hr.mL-1,30000.0,CHEMBL612558,,ADMET,,,AUC,mg.hr/L,,30.0
30555,,19051734,CHEMBL4354993,"Half life in human at 0.75 g, po bid",A,BAO_0002115,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4354782,Medchemcomm,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Hour,3178401,=,1,1,=,T1/2,hr,4.0,CHEMBL612558,,ADMET,,,t1/2,hr,UO_0000032,4.0
30556,,19068503,CHEMBL4360913,Antibacterial activity against Escherichia coli ATCC 25922 after 16 to 18 hrs by CLSI M07-A10 protocol based dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4359831,J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3181371,<,1,1,<,MIC,ug.mL-1,0.01,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.01
30557,,19068505,CHEMBL4360914,Antibacterial activity against Klebsiella pneumoniae ATCC BAA-1705 after 16 to 18 hrs by CLSI M07-A10 protocol based dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4359831,J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3181371,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,64.0
30558,,19068509,CHEMBL4360916,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 after 16 to 18 hrs by CLSI M07-A10 protocol based dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4359831,J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3181371,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.5
30559,,19068511,CHEMBL4360917,Antibacterial activity against Acinetobacter baumannii BAA-1605 after 16 to 18 hrs by CLSI M07-A10 protocol based dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4359831,J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3181371,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,8.0
30560,Not Determined,19073450,CHEMBL4362173,Antibacterial activity against Mycobacterium tuberculosis H37Ra ATCC 25177 incubated for 7 days by resazurin dye based fluorimetric assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4359864,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3182228,,1,0,,IC50,,,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,IC50,,,
30561,Not Determined,19073462,CHEMBL4362172,Antibacterial activity against Streptococcus pneumoniae ATCC BAA-334 incubated for 24 hrs by resazurin dye based fluorimetric assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4359864,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3182228,,1,0,,IC50,,,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,IC50,,,
30562,Not Determined,19073472,CHEMBL4362171,Antibacterial activity against Staphylococcus aureus ATCC 6538 incubated for 24 hrs by resazurin dye based fluorimetric assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4359864,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3182228,,1,0,,IC50,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,IC50,,,
30563,Not Determined,19073480,CHEMBL4362167,Antibacterial activity against Escherichia coli ATCC 8739 incubated for 24 hrs by resazurin dye based fluorimetric assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4359864,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3182228,,1,0,,IC50,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,IC50,,,
30564,Not Determined,19073491,CHEMBL4362168,Antibacterial activity against Pseudomonas aeruginosa ATCC 9027 incubated for 24 hrs by resazurin dye based fluorimetric assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4359864,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3182228,,1,0,,IC50,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,IC50,,,
30565,,19073502,CHEMBL4362169,Antibacterial activity against Klebsiella pneumoniae ATCC 13883 incubated for 24 hrs by resazurin dye based fluorimetric assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4359864,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3182228,<,1,1,<,IC50,nM,250.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,IC50,uM,UO_0000065,0.25
30566,Not Determined,19073513,CHEMBL4362170,Antibacterial activity against Enterococcus faecium ATCC 19434 incubated for 24 hrs by resazurin dye based fluorimetric assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4359864,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3182228,,1,0,,IC50,,,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,IC50,,,
30567,,19075600,CHEMBL4362770,Antibacterial activity against Escherichia coli ATCC 25922 assessed as bacterial growth inhibition incubated for 24 hrs by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4359884,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3182622,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.03
30568,,19075623,CHEMBL4362771,Antibacterial activity against Escherichia coli 9-1 assessed as bacterial growth inhibition incubated for 24 hrs by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4359884,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3182622,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.06
30569,,19087207,CHEMBL4365056,Antimicrobial activity against Enterococcus faecium ATCC 19433 incubated for 20 hrs by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4364256,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3184428,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,ug ml-1,UO_0000274,4.0
30570,,19087272,CHEMBL4365057,Antimicrobial activity against Staphylococcus aureus ATCC 29213 incubated for 20 hrs by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4364256,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3184428,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
30571,,19087337,CHEMBL4365058,Antimicrobial activity against Streptococcus pneumoniae ATCC 49619 incubated for 20 hrs by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4364256,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3184428,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.5
30572,,19087402,CHEMBL4365059,Antimicrobial activity against Acinetobacter baumannii ATCC 19606 incubated for 20 hrs by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4364256,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3184428,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,2.0
30573,,19087467,CHEMBL4365060,Antimicrobial activity against Pseudomonas aeruginosa ATCC 27853 incubated for 20 hrs by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4364256,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3184428,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.5
30574,,19087532,CHEMBL4365061,Antimicrobial activity against Enterobacter cloacae ATCC 13047 incubated for 20 hrs by microdilution method,F,BAO_0002146,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4364256,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3184428,=,1,1,=,MIC,ug.mL-1,0.0125,CHEMBL612545,,Unchecked,,,MIC,ug ml-1,UO_0000274,0.0125
30575,,19087544,CHEMBL4365062,Antimicrobial activity against Enterococcus casseliflavus ATCC 25788 incubated for 20 hrs by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4364256,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3184428,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL4523080,Enterococcus casseliflavus,Enterococcus casseliflavus,37734.0,,MIC,ug ml-1,UO_0000274,4.0
30576,,19087555,CHEMBL4365063,Antimicrobial activity against Staphylococcus epidermidis ATCC 12228 incubated for 20 hrs by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4364256,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3184428,=,1,1,=,MIC,ug.mL-1,0.0625,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.0625
30577,,19087566,CHEMBL4365064,Antimicrobial activity against Staphylococcus saprophyticus ATCC 15305 incubated for 20 hrs by microdilution method,F,BAO_0002146,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4364256,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3184428,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL612545,,Unchecked,,,MIC,ug ml-1,UO_0000274,0.5
30578,,19087577,CHEMBL4365065,Antimicrobial activity against Streptococcus pyogenes ATCC 19615 incubated for 20 hrs by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4364256,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3184428,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC,ug ml-1,UO_0000274,0.5
30579,,19087588,CHEMBL4365066,Antimicrobial activity against Streptococcus agalactiae ATCC 12386 incubated for 20 hrs by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4364256,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3184428,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,MIC,ug ml-1,UO_0000274,4.0
30580,,19087599,CHEMBL4365067,Antimicrobial activity against Staphylococcus aureus ST239 incubated for 20 hrs by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4364256,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3184428,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,4.0
30581,,19087610,CHEMBL4365068,Antimicrobial activity against Staphylococcus aureus ATCC BAA44 incubated for 20 hrs by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4364256,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3184428,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,4.0
30582,,19087621,CHEMBL4365069,Antimicrobial activity against Staphylococcus aureus HA W231 ST45 incubated for 20 hrs by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4364256,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3184428,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,2.0
30583,,19087632,CHEMBL4365070,Antimicrobial activity against CA-methicillin-resistant Staphylococcus aureus W47 ST30 incubated for 20 hrs by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4364256,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3184428,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
30584,,19087643,CHEMBL4365071,Antimicrobial activity against CA-methicillin-resistant Staphylococcus aureus W45 ST59 incubated for 20 hrs by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4364256,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3184428,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
30585,,19087654,CHEMBL4365072,Antimicrobial activity against CA-methicillin-resistant Staphylococcus aureus W46 ST59 incubated for 20 hrs by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4364256,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3184428,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
30586,,19087665,CHEMBL4365073,Antimicrobial activity against Staphylococcus aureus USA300/ST8 incubated for 20 hrs by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4364256,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3184428,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,4.0
30587,,19087676,CHEMBL4365074,Antimicrobial activity against Staphylococcus aureus ST22 11B086169 incubated for 20 hrs by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4364256,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3184428,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,4.0
30588,,19087687,CHEMBL4365075,Antimicrobial activity against CA-methicillin-resistant Staphylococcus aureus W4 ST338 incubated for 20 hrs by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4364256,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3184428,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
30589,,19087698,CHEMBL4365076,Antimicrobial activity against CA-methicillin-resistant Staphylococcus aureus W48 ST217 incubated for 20 hrs by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4364256,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3184428,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,4.0
30590,,19087709,CHEMBL4365077,Antimicrobial activity against Staphylococcus aureus HA W235 ST5 incubated for 20 hrs by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4364256,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3184428,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,4.0
30591,,19087767,CHEMBL4365052,Antimicrobial activity against Staphylococcus aureus ATCC BAA43 incubated for 20 hrs by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4364256,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3184428,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,2.0
30592,,19087772,CHEMBL4365053,Antimicrobial activity against Staphylococcus aureus ATCC 25923 incubated for 20 hrs by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4364256,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3184428,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
30593,,19116246,CHEMBL4371853,Antimicrobial activity against Mycobacterium tuberculosis H37Rv after 7 days by microplate alamar blue assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4371020,Bioorg Med Chem Lett,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3190183,=,1,1,=,MIC,ug.mL-1,1.56,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,ug ml-1,UO_0000274,1.56
30594,,19126532,CHEMBL4374051,Antibacterial activity against Staphylococcus aureus ATCC 25923 assessed as reduction in bacterial growth incubated for 18 to 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4373642,Medchemcomm,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3192149,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.125
30595,,19126533,CHEMBL4374052,Antibacterial activity against Bacillus subtilis ATCC 6051 assessed as reduction in bacterial growth incubated for 18 to 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4373642,Medchemcomm,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3192149,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,MIC,ug ml-1,UO_0000274,0.06
30596,,19126534,CHEMBL4374053,Antibacterial activity against Enterococcus faecium ATCC 35667 assessed as reduction in bacterial growth incubated for 18 to 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4373642,Medchemcomm,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3192149,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,ug ml-1,UO_0000274,1.0
30597,,19126535,CHEMBL4374054,Antibacterial activity against Klebsiella pneumoniae ATCC 13883 assessed as reduction in bacterial growth incubated for 18 to 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4373642,Medchemcomm,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3192149,=,1,1,=,MIC,ug.mL-1,0.015,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,0.015
30598,,19126536,CHEMBL4374055,Antibacterial activity against Acinetobacter baumannii ATCC 19606 assessed as reduction in bacterial growth incubated for 18 to 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4373642,Medchemcomm,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3192149,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,0.5
30599,,19126537,CHEMBL4374056,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 assessed as reduction in bacterial growth incubated for 18 to 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4373642,Medchemcomm,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3192149,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.25
30600,,19126538,CHEMBL4374057,Antibacterial activity against Pseudomonas aeruginosa PAO750 PAO397 harbouring delta efflux pump mutant assessed as reduction in bacterial growth incubated for 18 to 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4373642,Medchemcomm,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3192149,<=,1,1,<=,MIC,ug.mL-1,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.25
30601,,19126539,CHEMBL4374058,Antibacterial activity against Escherichia coli ATCC 25922 assessed as reduction in bacterial growth incubated for 18 to 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4373642,Medchemcomm,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3192149,<=,1,1,<=,MIC,ug.mL-1,0.004,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.004
30602,,19126540,CHEMBL4374059,Antibacterial activity against Escherichia coli MB4902 harbouring lpxC mutant assessed as reduction in bacterial growth incubated for 18 to 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4373642,Medchemcomm,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3192149,<=,1,1,<=,MIC,ug.mL-1,0.004,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.004
30603,,19126541,CHEMBL4374060,Antibacterial activity against Escherichia coli MB5747 harbouring tolC mutant assessed as reduction in bacterial growth incubated for 18 to 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4373642,Medchemcomm,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3192149,<=,1,1,<=,MIC,ug.mL-1,0.004,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.004
30604,,19126542,CHEMBL4374061,Antibacterial activity against Escherichia coli MB5746 harbouring lpxC and tolC double mutant assessed as reduction in bacterial growth incubated for 18 to 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4373642,Medchemcomm,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3192149,<=,1,1,<=,MIC,ug.mL-1,0.004,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.004
30605,,19126892,CHEMBL4374129,Antibacterial activity against Micrococcus luteus MTCC 2470 assessed as inhibition of bacterial growth incubated for 24 hrs by agar well diffusion method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4373647,Medchemcomm,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3192224,=,1,1,=,MIC,ug.mL-1,0.9,CHEMBL614421,Micrococcus luteus,Micrococcus luteus,1270.0,,MIC,ug ml-1,UO_0000274,0.9
30606,,19126915,CHEMBL4374130,Antibacterial activity against Staphylococcus aureus MTCC 96 assessed as inhibition of bacterial growth incubated for 24 hrs by agar well diffusion method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4373647,Medchemcomm,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3192224,=,1,1,=,MIC,ug.mL-1,0.9,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.9
30607,,19126938,CHEMBL4374131,Antibacterial activity against Staphylococcus aureus MLS-16 MTCC 2940 assessed as inhibition of bacterial growth incubated for 24 hrs by agar well diffusion method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4373647,Medchemcomm,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3192224,=,1,1,=,MIC,ug.mL-1,0.9,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.9
30608,,19126961,CHEMBL4374132,Antibacterial activity against Bacillus subtilis MTCC 121 assessed as inhibition of bacterial growth incubated for 24 hrs by agar well diffusion method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4373647,Medchemcomm,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3192224,=,1,1,=,MIC,ug.mL-1,0.9,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,MIC,ug ml-1,UO_0000274,0.9
30609,,19126984,CHEMBL4374133,Antibacterial activity against Escherichia coli MTCC 739 assessed as inhibition of bacterial growth incubated for 24 hrs by agar well diffusion method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4373647,Medchemcomm,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3192224,=,1,1,=,MIC,ug.mL-1,0.9,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.9
30610,,19127007,CHEMBL4374134,Antibacterial activity against Pseudomonas aeruginosa MTCC 2453 assessed as inhibition of bacterial growth incubated for 24 hrs by agar well diffusion method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4373647,Medchemcomm,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3192224,=,1,1,=,MIC,ug.mL-1,0.9,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.9
30611,,19127030,CHEMBL4374135,Antibacterial activity against Klebsiella planticola MTCC 530 assessed as inhibition of bacterial growth incubated for 24 hrs by agar well diffusion method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4373647,Medchemcomm,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3192224,=,1,1,=,MIC,ug.mL-1,0.9,CHEMBL613271,Raoultella planticola,Raoultella planticola,575.0,,MIC,ug ml-1,UO_0000274,0.9
30612,Not Active,19127053,CHEMBL4374136,Antifungal activity against Candida albicans MTCC 3017 assessed as inhibition of fungal growth incubated for 24 hrs by agar well diffusion method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4373647,Medchemcomm,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3192224,,1,0,,MIC,,,CHEMBL366,Candida albicans,Candida albicans,5476.0,,MIC,,,
30613,,19127108,CHEMBL4374146,Bactericidal activity against Micrococcus luteus MTCC 2470 assessed as bacterial killing incubated for 24 hrs,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4373647,Medchemcomm,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3192224,=,1,0,=,MBC,ug ml-1,1.9,CHEMBL614421,Micrococcus luteus,Micrococcus luteus,1270.0,,MBC,ug ml-1,UO_0000274,1.9
30614,,19127114,CHEMBL4374147,Bactericidal activity against Staphylococcus aureus MTCC 96 assessed as bacterial killing incubated for 24 hrs,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4373647,Medchemcomm,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3192224,=,1,0,=,MBC,ug ml-1,1.9,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MBC,ug ml-1,UO_0000274,1.9
30615,,19127120,CHEMBL4374148,Bactericidal activity against Staphylococcus aureus MLS-16 MTCC 2940 assessed as bacterial killing incubated for 24 hrs,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4373647,Medchemcomm,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3192224,=,1,0,=,MBC,ug ml-1,1.9,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MBC,ug ml-1,UO_0000274,1.9
30616,,19127126,CHEMBL4374149,Bactericidal activity against Bacillus subtilis MTCC 121 assessed as bacterial killing incubated for 24 hrs,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4373647,Medchemcomm,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3192224,=,1,0,=,MBC,ug ml-1,1.9,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,MBC,ug ml-1,UO_0000274,1.9
30617,,19127132,CHEMBL4374150,Bactericidal activity against Escherichia coli MTCC 739 assessed as bacterial killing incubated for 24 hrs,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4373647,Medchemcomm,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3192224,=,1,0,=,MBC,ug ml-1,1.9,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MBC,ug ml-1,UO_0000274,1.9
30618,,19127138,CHEMBL4374151,Bactericidal activity against Pseudomonas aeruginosa MTCC 2453 assessed as bacterial killing incubated for 24 hrs,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4373647,Medchemcomm,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3192224,=,1,0,=,MBC,ug ml-1,1.9,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MBC,ug ml-1,UO_0000274,1.9
30619,,19127144,CHEMBL4374152,Bactericidal activity against Klebsiella planticola MTCC 530 assessed as bacterial killing incubated for 24 hrs,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4373647,Medchemcomm,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3192224,=,1,0,=,MBC,ug ml-1,1.9,CHEMBL613271,Raoultella planticola,Raoultella planticola,575.0,,MBC,ug ml-1,UO_0000274,1.9
30620,,19127325,CHEMBL4374128,Ratio of MBC to MIC against Micrococcus luteus MTCC 2470,F,BAO_0000193,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4373647,Medchemcomm,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3192224,=,1,0,=,Ratio,,2.0,CHEMBL614421,Micrococcus luteus,Micrococcus luteus,1270.0,,Ratio,,,2.0
30621,,19127326,CHEMBL4374127,Ratio of MBC to MIC against Staphylococcus aureus MTCC 96,F,BAO_0000193,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4373647,Medchemcomm,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3192224,=,1,0,=,Ratio,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Ratio,,,2.0
30622,,19127327,CHEMBL4374167,Ratio of MBC to MIC against Staphylococcus aureus MLS-16 MTCC 2940,F,BAO_0000193,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4373647,Medchemcomm,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3192224,=,1,0,=,Ratio,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Ratio,,,2.0
30623,,19127328,CHEMBL4374168,Ratio of MBC to MIC against Bacillus subtilis MTCC 121,F,BAO_0000193,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4373647,Medchemcomm,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3192224,=,1,0,=,Ratio,,2.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,Ratio,,,2.0
30624,,19127329,CHEMBL4374182,Ratio of MBC to MIC for Escherichia coli MTCC 739,F,BAO_0000193,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4373647,Medchemcomm,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3192224,=,1,0,=,Ratio,,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Ratio,,,2.0
30625,,19127330,CHEMBL4374183,Ratio of MBC to MIC for Pseudomonas aeruginosa MTCC 2453,F,BAO_0000193,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4373647,Medchemcomm,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3192224,=,1,0,=,Ratio,,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Ratio,,,2.0
30626,,19127331,CHEMBL4374184,Ratio of MBC to MIC for Klebsiella planticola MTCC 530,F,BAO_0000193,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4373647,Medchemcomm,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3192224,=,1,0,=,Ratio,,2.0,CHEMBL613271,Raoultella planticola,Raoultella planticola,575.0,,Ratio,,,2.0
30627,,19128348,CHEMBL4374358,Antibacterial activity against fluoroquinolone sensitive Staphylococcus aureus SH1000 assessed as zone of inhibition at 1 mmol after 24 hrs Kirby-Bauer disc diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4373659,Medchemcomm,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,3192480,=,1,1,=,IZ,mm,18.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,IZ,cm,UO_0000016,1.8
30628,,19128355,CHEMBL4374359,Antibacterial activity against fluoroquinolone sensitive Staphylococcus aureus SH1000 assessed as zone of inhibition at 10 mmol after 24 hrs Kirby-Bauer disc diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4373659,Medchemcomm,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,3192480,=,1,1,=,IZ,mm,31.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,IZ,cm,UO_0000016,3.1
30629,,19128362,CHEMBL4374360,Antibacterial activity against fluoroquinolone resistant Staphylococcus aureus USA300 JE2 assessed as zone of inhibition at 1 mmol after 24 hrs Kirby-Bauer disc diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4373659,Medchemcomm,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,3192480,=,1,1,=,IZ,mm,0.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,IZ,cm,UO_0000016,0.0
30630,,19128369,CHEMBL4374361,Antibacterial activity against fluoroquinolone resistant Staphylococcus aureus USA300 JE2 assessed as zone of inhibition at 10 mmol after 24 hrs Kirby-Bauer disc diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4373659,Medchemcomm,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,3192480,=,1,1,=,IZ,mm,12.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,IZ,cm,UO_0000016,1.2
30631,,19131508,CHEMBL4374982,Inhibition of Staphylococcus aureus ATCC 29213 DNA topoisomerase 4 subunit ParC assessed as reduction in decatenation of kinetoplast DNA incubated for 30 mins by ethidium bromide staining based gel electrophoresis method,B,BAO_0000190,BAO_0000357,single protein format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4373693,J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3193042,=,1,1,=,IC50,nM,13000.0,CHEMBL4088,Staphylococcus aureus,Topoisomerase IV subunit A,1280.0,,IC50,uM,UO_0000065,13.0
30632,,19131548,CHEMBL4374981,Inhibition of Escherichia coli ATCC 25922 DNA topoisomerase 4 subunit ParC assessed as reduction in decatenation of kinetoplast DNA incubated for 30 mins by ethidium bromide staining based gel electrophoresis method,B,BAO_0000190,BAO_0000357,single protein format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4373693,J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3193042,=,1,1,=,IC50,nM,51000.0,CHEMBL1895,Escherichia coli K-12,Topoisomerase IV subunit A,83333.0,,IC50,uM,UO_0000065,51.0
30633,,19131588,CHEMBL4374980,Inhibition of Staphylococcus aureus ATCC 29213 DNA gyrase A assessed as reduction in enzyme-mediated supercoiling of relaxed pBR322 DNA by ethidium bromide staining based gel electrophoresis method,B,BAO_0000190,BAO_0000357,single protein format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4373693,J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3193042,=,1,1,=,IC50,nM,187000.0,CHEMBL2424506,Staphylococcus aureus,DNA gyrase subunit A,1280.0,,IC50,uM,UO_0000065,187.0
30634,,19131628,CHEMBL4374979,Inhibition of Escherichia coli ATCC 25922 DNA gyrase A assessed as reduction in enzyme-mediated supercoiling of relaxed pBR322 DNA by ethidium bromide staining based gel electrophoresis method,B,BAO_0000190,BAO_0000357,single protein format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4373693,J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,1,http://www.openphacts.org/units/Nanomolar,3193042,=,1,1,=,IC50,nM,1000.0,CHEMBL1858,Escherichia coli K-12,DNA gyrase subunit A,83333.0,,IC50,uM,UO_0000065,1.0
30635,,19131675,CHEMBL4374983,Antibacterial activity against Escherichia coli ATCC 25922 after 16 to 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4373693,J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3193042,=,1,1,=,MIC,ug.mL-1,0.004,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.004
30636,,19131692,CHEMBL4374984,Antibacterial activity against Staphylococcus aureus ATCC 29213 after 16 to 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4373693,J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3193042,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
30637,,19131709,CHEMBL4374985,Antibacterial activity against Staphylococcus aureus BAA-1720 after 16 to 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4373693,J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3193042,>,1,1,>,MIC,ug.mL-1,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,4.0
30638,,19131739,CHEMBL4374987,Antibacterial activity against Escherichia coli ATCC 25922 in presence of 50% human serum after 16 to 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4373693,J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3193042,=,1,1,=,MIC,ug.mL-1,0.004,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.004
30639,,19131743,CHEMBL4374988,Antibacterial activity against Staphylococcus aureus ATCC 29213 in presence of 50% human serum after 16 to 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4373693,J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3193042,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
30640,,19131747,CHEMBL4374989,Antibacterial activity against Staphylococcus aureus BAA-1720 in presence of 50% human serum after 16 to 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4373693,J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3193042,>,1,1,>,MIC,ug.mL-1,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,4.0
30641,,19131751,CHEMBL4374990,Antibacterial activity against vancomycin resistant and teicoplanin sensitive Enterococcus faecium APV 00420 after 16 to 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4373693,J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3193042,>,1,1,>,MIC,ug.mL-1,32.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,ug ml-1,UO_0000274,32.0
30642,,19131756,CHEMBL4374991,Antibacterial activity against Enterococcus faecalis ATCC 29212 after 16 to 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4373693,J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3193042,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,1.0
30643,,19131761,CHEMBL4374992,Antibacterial activity against vancomycin-sensitive Enterococcus faecalis APV 00404 after 16 to 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4373693,J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3193042,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,2.0
30644,,19131766,CHEMBL4374993,Antibacterial activity against vancomycin-sensitive Enterococcus faecalis APV 00406 after 16 to 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4373693,J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3193042,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,64.0
30645,,19131771,CHEMBL4374994,Antibacterial activity against vancomycin and teicoplanin-resistant Enterococcus faecalis APV 00408 after 16 to 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4373693,J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3193042,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,64.0
30646,,19131776,CHEMBL4374995,Antibacterial activity against vancomycin and teicoplanin-resistant Enterococcus faecalis APV 00409 after 16 to 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4373693,J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3193042,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,32.0
30647,,19131781,CHEMBL4374996,Antibacterial activity against vancomycin and teicoplanin-resistant Enterococcus faecium APV 00422 after 16 to 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4373693,J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3193042,=,1,1,=,MIC,ug.mL-1,128.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,ug ml-1,UO_0000274,128.0
30648,,19131786,CHEMBL4374997,Antibacterial activity against vancomycin and teicoplanin-resistant Enterococcus faecium APV 00424 after 16 to 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4373693,J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3193042,>,1,1,>,MIC,ug.mL-1,128.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,ug ml-1,UO_0000274,128.0
30649,,19131791,CHEMBL4374998,Antibacterial activity against vancomycin resistant and teicoplanin sensitive Enterococcus faecium APV 00553 after 16 to 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4373693,J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3193042,=,1,1,=,MIC,ug.mL-1,128.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,ug ml-1,UO_0000274,128.0
30650,,19131796,CHEMBL4374999,Antibacterial activity against vancomycin-sensitive Enterococcus faecalis APV 00623 after 16 to 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4373693,J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3193042,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,2.0
30651,,19131801,CHEMBL4375000,Antibacterial activity against Enterococcus faecium APV 00626 after 16 to 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4373693,J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3193042,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,ug ml-1,UO_0000274,16.0
30652,,19131806,CHEMBL4375001,Antibacterial activity against Enterococcus faecium APV 00627 after 16 to 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4373693,J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3193042,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,ug ml-1,UO_0000274,4.0
30653,,19131811,CHEMBL4375002,Antibacterial activity against quinolone-sensitive Haemophilus influenzae H128 after 16 to 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4373693,J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3193042,=,1,1,=,MIC,ug.mL-1,0.008,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MIC,ug ml-1,UO_0000274,0.008
30654,,19131816,CHEMBL4375003,Antibacterial activity against quinolone-sensitive Haemophilus influenzae ATCC 49766 after 16 to 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4373693,J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3193042,=,1,1,=,MIC,ug.mL-1,0.015,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MIC,ug ml-1,UO_0000274,0.015
30655,,19131821,CHEMBL4375004,Antibacterial activity against Neisseria gonorrhoeae ATCC 19424 after 16 to 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4373693,J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3193042,<=,1,1,<=,MIC,ug.mL-1,0.06,CHEMBL614430,Neisseria gonorrhoeae,Neisseria gonorrhoeae,485.0,,MIC,ug ml-1,UO_0000274,0.06
30656,,19131825,CHEMBL4375005,Antibacterial activity against quinolone-sensitive Klebsiella pneumoniae ATCC 700603 after 16 to 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4373693,J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3193042,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,0.125
30657,,19131887,CHEMBL4374986,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 after 16 to 24 hrs by CLSI method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4373693,J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3193042,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.5
30658,,19138892,CHEMBL4376218,Antimicrobial activity against Enterococcus faecium NCTC after 18 hrs by CLSI protocol based broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4373724,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3194237,=,1,1,=,MIC,nM,8000.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,uM,UO_0000065,8.0
30659,,19138948,CHEMBL4376219,Antimicrobial activity against Staphylococcus aureus SG 511 after 18 hrs by CLSI protocol based broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4373724,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3194237,=,1,1,=,MIC,nM,500.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,uM,UO_0000065,0.5
30660,,19138956,CHEMBL4376220,Antimicrobial activity against Klebsiella pneumoniae 700603 after 18 hrs by CLSI protocol based broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4373724,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3194237,=,1,1,=,MIC,nM,250.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,uM,UO_0000065,0.25
30661,,19138964,CHEMBL4376221,Antimicrobial activity against Acinetobacter baumannii ATCC 17961 after 18 hrs by CLSI protocol based broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4373724,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3194237,=,1,1,=,MIC,nM,250.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,uM,UO_0000065,0.25
30662,,19138972,CHEMBL4376222,Antimicrobial activity against Pseudomonas aeruginosa ATCC 27853 after 18 hrs by CLSI protocol based broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4373724,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3194237,=,1,1,=,MIC,nM,125.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,uM,UO_0000065,0.125
30663,,19138980,CHEMBL4376223,Antimicrobial activity against Enterobacter aerogenes ATCC 35029 after 18 hrs by CLSI protocol based broth microdilution method,F,BAO_0002146,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4373724,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3194237,<,1,1,<,MIC,nM,15.0,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,MIC,uM,UO_0000065,0.015
30664,,19138988,CHEMBL4376224,Antimicrobial activity against Escherichia coli ATCC 25922 after 18 hrs by CLSI protocol based broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4373724,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3194237,<,1,1,<,MIC,nM,15.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,uM,UO_0000065,0.015
30665,,19145928,CHEMBL4378447,Antibacterial activity against novobiocin-resistant Acinetobacter baumannii ATCC 17978 mutant generated from seven serial passages by checkerboard assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4376820,J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3195338,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,16.0
30666,,19145937,CHEMBL4378448,Antibacterial activity against colistin-resistant Acinetobacter baumannii ATCC 17978 mutant generated from seven serial passages by checkerboard assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4376820,J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3195338,=,1,1,=,MIC,ug.mL-1,0.0625,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,0.0625
30667,,19145946,CHEMBL4378449,Antibacterial activity against novobiocin and test compound-resistant Acinetobacter baumannii ATCC 17978 mutant generated from seven serial passages in presence of novobiocin by checkerboard assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4376820,J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3195338,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,1.0
30668,,19145959,CHEMBL4378453,Antibacterial activity against wild type Acinetobacter baumannii ATCC 17978 by checkerboard assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4376820,J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3195338,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,1.0
30669,Not Determined,19161070,CHEMBL4383299,Antibacterial activity against vancomycin-resistant Enterococcus faecalis BM 4390 after 18 to 24 hrs by microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4382202,Eur J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3197798,,1,0,,MIC,,,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,,,
30670,Not Determined,19161096,CHEMBL4383300,Antibacterial activity against vancomycin-resistant Enterococcus faecalis JH2-2::C1 after 18 to 24 hrs by microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4382202,Eur J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3197798,,1,0,,MIC,,,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,,,
30671,Not Determined,19161122,CHEMBL4383301,Antibacterial activity against vancomycin-resistant Enterococcus faecalis BM 4575 clinical isolate after 18 to 24 hrs by microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4382202,Eur J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3197798,,1,0,,MIC,,,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,,,
30672,Not Determined,19161148,CHEMBL4383302,Antibacterial activity against methicillin and vancomycin intermediate resistant Staphylococcus aureus MU50 after 18 to 24 hrs by microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4382202,Eur J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3197798,,1,0,,MIC,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,,,
30673,Not Determined,19161174,CHEMBL4383303,Antibacterial activity against methicillin and linezolid resistant Staphylococcus aureus NRS 119 clinical isolate after 18 to 24 hrs by microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4382202,Eur J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3197798,,1,0,,MIC,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,,,
30674,Not Determined,19161200,CHEMBL4383304,Antibacterial activity against community-acquired methicillin and erythromycin resistant Staphylococcus aureus SA 325 after 18 to 24 hrs by microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4382202,Eur J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3197798,,1,0,,MIC,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,,,
30675,,19161226,CHEMBL4383305,Antibacterial activity against hospital-acquired methicillin/ciprofloxacin/moxifloxacin resistant Staphylococcus aureus SA 481 after 18 to 24 hrs by microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4382202,Eur J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3197798,=,1,1,=,MIC,nM,770000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mM,UO_0000065,0.77
30676,Not Determined,19161252,CHEMBL4383306,Antibacterial activity against hospital-acquired methicillin and vacomycin resistant Staphylococcus aureus VRS-1 after 18 to 24 hrs by microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4382202,Eur J Med Chem,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3197798,,1,0,,MIC,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,,,
30677,,19164278,CHEMBL4383989,Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 after 5 days by microplate alamar blue assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4382229,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3198394,=,1,1,=,MIC,ug.mL-1,3.125,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,ug ml-1,UO_0000274,3.125
30678,,19164426,CHEMBL4384025,Antibacterial activity against Pseudomonas aeruginosa by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4382229,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3198394,<,1,1,<,MIC,ug.mL-1,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,4.0
30679,,19164440,CHEMBL4384029,Antibacterial activity against Staphylococcus aureus MTCC 96 assessed as zone of inhibition at 100 ug/ml by disc diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4382229,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,3198394,=,1,1,=,IZ,mm,21.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,IZ,mm,UO_0000016,21.0
30680,,19164449,CHEMBL4384030,Antibacterial activity against Streptococcus pyogenes MTCC 442 assessed as zone of inhibition at 100 ug/ml by disc diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4382229,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,3198394,=,1,1,=,IZ,mm,21.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,IZ,mm,UO_0000016,21.0
30681,,19164458,CHEMBL4384031,Antibacterial activity against Escherichia coli MTCC 443 assessed as zone of inhibition at 100 ug/ml by disc diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4382229,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,3198394,=,1,1,=,IZ,mm,21.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,IZ,mm,UO_0000016,21.0
30682,,19164467,CHEMBL4384032,Antibacterial activity against Pseudomonas aeruginosa MTCC 424 assessed as zone of inhibition at 100 ug/ml by disc diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4382229,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,3198394,=,1,1,=,IZ,mm,21.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,IZ,mm,UO_0000016,21.0
30683,,19164489,CHEMBL4383998,Antibacterial activity against Escherichia coli assessed as zone of inhibition at 50 ug/ml after 3 days by filter paper disc method,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4382229,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,3198394,=,1,1,=,IZ,mm,25.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,IZ,mm,UO_0000016,25.0
30684,,19164491,CHEMBL4383999,Antibacterial activity against Pseudomonas aeruginosa assessed as zone of inhibition at 50 ug/ml after 3 days by filter paper disc method,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4382229,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,3198394,=,1,1,=,IZ,mm,25.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,IZ,mm,UO_0000016,25.0
30685,Active,19166049,CHEMBL4384137,Antibiofilm activity against methicillin-resistant Staphylococcus aureus at 2 times MIC after 24 hrs by crystal violet staining-based UV-visible spectrophotometric analysis,F,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4382233,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3198682,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
30686,,19166090,CHEMBL4384146,Antibacterial activity against Salmonella typhi by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4382234,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3198683,=,1,1,=,MIC,ug.mL-1,0.1,CHEMBL614448,Salmonella enterica subsp. enterica serovar Typhi,Salmonella typhi,90370.0,,MIC,ug ml-1,UO_0000274,0.1
30687,,19166096,CHEMBL4384147,Antibacterial activity against Escherichia coli by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4382234,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3198683,=,1,1,=,MIC,ug.mL-1,0.1,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.1
30688,,19166102,CHEMBL4384148,Antibacterial activity against Vibrio cholerae by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4382234,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3198683,=,1,1,=,MIC,ug.mL-1,0.1,CHEMBL614402,Vibrio cholerae,Vibrio cholerae,666.0,,MIC,ug ml-1,UO_0000274,0.1
30689,,19166108,CHEMBL4384149,Antibacterial activity against Staphylococcus aureus by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4382234,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3198683,=,1,1,=,MIC,ug.mL-1,0.1,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.1
30690,,19166114,CHEMBL4384150,Antibacterial activity against Staphylococcus epidermidis by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4382234,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3198683,=,1,1,=,MIC,ug.mL-1,0.1,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.1
30691,,19166120,CHEMBL4384151,Antibacterial activity against Klebsiella pneumoniae by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4382234,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3198683,=,1,1,=,MIC,ug.mL-1,0.1,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,0.1
30692,,19166126,CHEMBL4384152,Antibacterial activity against Pseudomonas aeruginosa by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4382234,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3198683,=,1,1,=,MIC,ug.mL-1,0.1,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.1
30693,,19166132,CHEMBL4384153,Antibacterial activity against Shigella flexneri by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4382234,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3198683,=,1,1,=,MIC,ug.mL-1,0.1,CHEMBL614396,Shigella flexneri,Shigella flexneri,623.0,,MIC,ug ml-1,UO_0000274,0.1
30694,,19166138,CHEMBL4384154,Antibacterial activity against Citrobacter freundii by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4382234,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3198683,=,1,1,=,MIC,ug.mL-1,0.1,CHEMBL612615,Citrobacter freundii,Citrobacter freundii,546.0,,MIC,ug ml-1,UO_0000274,0.1
30695,,19166151,CHEMBL4384158,Antitubercular activity against Mycobacterium tuberculosis H37Rv by microplate alamar blue assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4382234,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3198683,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,ug ml-1,UO_0000274,2.0
30696,,19166167,CHEMBL4384159,Antitubercular activity against Mycobacterium tuberculosis infected in IFNgamma-deficient C57BL/6 mouse assessed bacterial load in lung at 25 mg/kg administered once daily for 8 days measured 28 days post infection,F,BAO_0000181,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4382234,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3198683,=,1,0,=,Activity,log10CFU,6.82,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,Activity,log10CFU,,6.82
30697,,19166169,CHEMBL4384160,Antitubercular activity against Mycobacterium tuberculosis infected in IFNgamma-deficient C57BL/6 mouse assessed bacterial load in spleen at 25 mg/kg administered once daily for 8 days measured 28 days post infection,F,BAO_0000181,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4382234,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3198683,=,1,0,=,Activity,log10CFU,4.64,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,Activity,log10CFU,,4.64
30698,,19169736,CHEMBL4384575,Antibacterial activity against Bacillus cereus ATCC 10987 NRS 248 measured after overnight incubation,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4382253,J Nat Prod,2018.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3199321,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL613070,Bacillus cereus,Bacillus cereus,1396.0,,MIC,ug ml-1,UO_0000274,0.03
30699,,19179340,CHEMBL4386878,Antimicrobial activity against Staphylococcus aureus incubated for 16 hrs by agar-well diffusion method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4385627,Bioorg Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3201157,=,1,1,=,MIC,ug.mL-1,10.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,10.0
30700,,19182245,CHEMBL4387555,Anti-mycobacterial activity against Mycobacterium tuberculosis H37Rv,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4385656,Bioorg Med Chem Lett,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3201802,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,ug ml-1,UO_0000274,1.0
30701,,19182260,CHEMBL4387556,Anti-mycobacterial activity against isoniazid and rifampicin-resistant Mycobacterium tuberculosis,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4385656,Bioorg Med Chem Lett,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3201802,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,ug ml-1,UO_0000274,2.0
30702,,19182275,CHEMBL4387557,Cytotoxicity in African green monkey Vero cells,A,BAO_0000187,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4385656,Bioorg Med Chem Lett,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3201802,=,1,1,=,CC50,ug.mL-1,128.0,CHEMBL391,Chlorocebus sabaeus,Vero,60711.0,,CC50,ug ml-1,UO_0000274,128.0
30703,,19182290,CHEMBL4387558,"Selectivity index, ratio of CC50 for cytotoxicity in African green monkey Vero cells to MIC for anti-mycobacterial activity against Mycobacterium tuberculosis H37Rv",T,BAO_0000179,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4385656,Bioorg Med Chem Lett,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3201802,=,1,0,=,Selectivity Index,,128.0,CHEMBL612545,,Unchecked,,,Selectivity Index,,,128.0
30704,,19182441,CHEMBL4387598,Antimycobacterial against Mycobacterium tuberculosis H37Rv incubated for 7 days by MABA assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4385660,Bioorg Med Chem Lett,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3201896,=,1,1,=,MIC,ug.mL-1,1.56,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,ug ml-1,UO_0000274,1.56
30705,,19193158,CHEMBL4390178,Antibacterial activity against Bacillus subtilis ATCC 9372 incubated for 24 hrs by CLSI protocol based broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4387753,Bioorg Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3203490,<=,1,1,<=,MIC,ug.mL-1,0.125,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,MIC,ug ml-1,UO_0000274,0.125
30706,,19193197,CHEMBL4390179,Antibacterial activity against Bacillus pumilus CMCC63202 incubated for 24 hrs by CLSI protocol based broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4387753,Bioorg Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3203490,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL612429,Bacillus pumilus,Bacillus pumilus,1408.0,,MIC,ug ml-1,UO_0000274,0.25
30707,,19193245,CHEMBL4390180,Antibacterial activity against Staphylococcus aureus ATCC 25923 incubated for 24 hrs by CLSI protocol based broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4387753,Bioorg Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3203490,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
30708,,19193293,CHEMBL4390181,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 43300 incubated for 24 hrs by CLSI protocol based broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4387753,Bioorg Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3203490,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
30709,,19193341,CHEMBL4390182,Antibacterial activity against penicillin-resistant Staphylococcus aureus clinical isolate incubated for 24 hrs by CLSI protocol based broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4387753,Bioorg Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3203490,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,32.0
30710,,19193389,CHEMBL4390183,Antibacterial activity against Staphylococcus aureus clinical isolate incubated for 24 hrs by CLSI protocol based broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4387753,Bioorg Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3203490,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
30711,,19193422,CHEMBL4390184,Antibacterial activity against Escherichia coli ATCC 25922 incubated for 24 hrs by CLSI protocol based broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4387753,Bioorg Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3203490,<=,1,1,<=,MIC,ug.mL-1,0.125,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.125
30712,,19193470,CHEMBL4390185,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 incubated for 24 hrs by CLSI protocol based broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4387753,Bioorg Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3203490,<=,1,1,<=,MIC,ug.mL-1,0.125,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.125
30713,,19198304,CHEMBL4391046,Antibacterial activity against Bacillus subtilis ATCC 11774 after 18 to 20 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4390647,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3204627,=,1,1,=,MIC,nM,3120.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,MIC,uM,UO_0000065,3.12
30714,,19198327,CHEMBL4391047,Antibacterial activity against Staphylococcus aureus ATCC 11632 after 18 to 20 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4390647,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3204627,=,1,1,=,MIC,nM,3120.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,uM,UO_0000065,3.12
30715,,19198350,CHEMBL4391048,Antibacterial activity against Staphylococcus epidermidis ATCC 12228 after 18 to 20 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4390647,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3204627,=,1,1,=,MIC,nM,3120.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,uM,UO_0000065,3.12
30716,,19198373,CHEMBL4391049,Antibacterial activity against Escherichia coli ATCC 25922 measured after 18 to 20 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4390647,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3204627,=,1,1,=,MIC,nM,1560.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,uM,UO_0000065,1.56
30717,,19198396,CHEMBL4391050,Antibacterial activity against measured after Klebsiella pneumoniae ATCC 4352 measured after 18 to 20 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4390647,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3204627,=,1,1,=,MIC,nM,1560.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,uM,UO_0000065,1.56
30718,,19198419,CHEMBL4391051,Antibacterial activity against Pseudomonas aeruginosa ATCC 25923 measured after 18 to 20 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4390647,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3204627,=,1,1,=,MIC,nM,1560.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,uM,UO_0000065,1.56
30719,,19198442,CHEMBL4391052,Antibacterial activity against Salmonella typhimurium ATCC 14028 measured after 18 to 20 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4390647,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3204627,=,1,1,=,MIC,nM,1560.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,MIC,uM,UO_0000065,1.56
30720,,19198465,CHEMBL4391053,Antibacterial activity against Staphylococcus aureus MRSA198 clinical isolate-1 measured after 18 to 20 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4390647,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3204627,=,1,1,=,MIC,nM,400000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,uM,UO_0000065,400.0
30721,,19198488,CHEMBL4391054,Antibacterial activity against Staphylococcus aureus MRSA198 clinical isolate-2 measured after 18 to 20 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4390647,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3204627,=,1,1,=,MIC,nM,400000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,uM,UO_0000065,400.0
30722,,19198511,CHEMBL4391055,Antibacterial activity against Staphylococcus aureus MRSA198 clinical isolate-3 measured after 18 to 20 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4390647,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3204627,=,1,1,=,MIC,nM,400000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,uM,UO_0000065,400.0
30723,,19200865,CHEMBL4391674,Antibacterial activity against multi-drug resistant Escherichia coli NMI 3548/14 assessed as reduction in microbial growth incubated for 20 hrs,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4390654,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3204802,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.125
30724,,19200897,CHEMBL4391675,Antibacterial activity against multi-drug resistant Escherichia coli NMI 3898/15 assessed as reduction in microbial growth incubated for 20 hrs,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4390654,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3204802,>,1,1,>,MIC,ug.mL-1,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,32.0
30725,,19200929,CHEMBL4391676,Antibacterial activity against multi-drug resistant Klebsiella pneumoniae NMI 2697/14 assessed as reduction in microbial growth incubated for 20 hrs,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4390654,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3204802,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,2.0
30726,,19200961,CHEMBL4391677,Antibacterial activity against multi-drug resistant Klebsiella pneumoniae NMI 3081/09 assessed as reduction in microbial growth incubated for 20 hrs,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4390654,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3204802,>,1,1,>,MIC,ug.mL-1,32.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,32.0
30727,,19201521,CHEMBL4391766,Antibacterial activity against Escherichia coli incubated for 24 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4390659,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3204943,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,2.0
30728,,19201557,CHEMBL4391767,Antibacterial activity against Staphylococcus aureus incubated for 24 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4390659,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3204943,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,2.0
30729,,19201593,CHEMBL4391768,Antibacterial activity against Pseudomonas aeruginosa incubated for 24 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4390659,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3204943,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,4.0
30730,,19202224,CHEMBL4391824,Antimicrobial activity against Staphylococcus aureus ATCC 25923 incubated for 24 hrs by microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4390662,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3205002,=,1,1,=,MIC,nM,6000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,uM/ml,UO_0000065,0.006
30731,,19202236,CHEMBL4391825,Antimicrobial activity against Escherichia coli ATCC 25922 incubated for 24 hrs by microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4390662,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3205002,=,1,1,=,MIC,nM,3000.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,uM/ml,UO_0000065,0.003
30732,,19202264,CHEMBL4391827,Antimicrobial activity against Staphylococcus aureus ATCC 25923 incubated for 24 hrs by agar well diffusion assay,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4390662,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,3205002,=,1,1,=,IZ,mm,26.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,DIZ,mm,UO_0000016,26.0
30733,,19202280,CHEMBL4391828,Antimicrobial activity against Enterococcus faecalis ATCC 29212 incubated for 24 hrs by agar well diffusion assay,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4390662,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,3205002,=,1,1,=,IZ,mm,24.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,DIZ,mm,UO_0000016,24.0
30734,,19202296,CHEMBL4391829,Antimicrobial activity against Pseudomonas aeruginosa ATCC 27853 incubated for 24 hrs by agar well diffusion assay,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4390662,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,3205002,=,1,1,=,IZ,mm,40.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,DIZ,mm,UO_0000016,40.0
30735,,19202312,CHEMBL4391830,Antimicrobial activity against Escherichia coli ATCC 25922 incubated for 24 hrs by agar well diffusion assay,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4390662,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,3205002,=,1,1,=,IZ,mm,43.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,DIZ,mm,UO_0000016,43.0
30736,,19214104,CHEMBL4393599,Antibacterial activity against vancomycin-resistant Enterococcus faecalis JMRC:ST:33700 assessed as diameter of promotion of inhibition zone by agar diffusion test (Rvb = 0 millimeter),F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4392881,J Nat Prod,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,3207171,=,1,1,=,IZ,mm,17.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,DIZ,mm,UO_0000016,17.0
30737,,19214107,CHEMBL4393598,Antibacterial activity against Pseudomonas aeruginosa JMRC:ST:337721 assessed as diameter of colonies in inhibition zone by agar diffusion test (Rvb = 0 millimeter),F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4392881,J Nat Prod,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,3207171,=,1,1,=,IZ,mm,36.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,DIZ,mm,UO_0000016,36.0
30738,,19214108,CHEMBL4393597,Antibacterial activity against Pseudomonas aeruginosa JMRC:ST:337721 assessed as diameter of clear inhibition zone by agar diffusion test (Rvb = 0 millimeter),F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4392881,J Nat Prod,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,3207171,=,1,1,=,IZ,mm,28.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,DIZ,mm,UO_0000016,28.0
30739,,19214111,CHEMBL4393596,Antibacterial activity against Pseudomonas aeruginosa JMRC:ST:33772 assessed as diameter of clear inhibition zone by agar diffusion test (Rvb = 0 millimeter),F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4392881,J Nat Prod,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,3207171,=,1,1,=,IZ,mm,26.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,DIZ,mm,UO_0000016,26.0
30740,,19214114,CHEMBL4393595,Antibacterial activity against Escherichia coli JMRC:ST:33699 assessed as diameter of colonies in inhibition zone by agar diffusion test (Rvb = 0 millimeter),F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4392881,J Nat Prod,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,3207171,=,1,1,=,IZ,mm,31.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,DIZ,mm,UO_0000016,31.0
30741,,19214115,CHEMBL4393594,Antibacterial activity against Escherichia coli JMRC:ST:33699 assessed as diameter of clear inhibition zone by agar diffusion test (Rvb = 0 millimeter),F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4392881,J Nat Prod,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,3207171,=,1,1,=,IZ,mm,23.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,DIZ,mm,UO_0000016,23.0
30742,,19214119,CHEMBL4393592,Antibacterial activity against mulitdrug-resistant Staphylococcus aureus JMRC:ST:33793 assessed as diameter of clear inhibition zone by agar diffusion test (Rvb = 0 millimeter),F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4392881,J Nat Prod,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,3207171,=,1,1,=,IZ,mm,0.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,DIZ,mm,UO_0000016,0.0
30743,,19214122,CHEMBL4393591,Antibacterial activity against Staphylococcus aureus JMRC:ST:10760 assessed as diameter of clear inhibition zone by agar diffusion test (Rvb = 0 millimeter),F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4392881,J Nat Prod,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,3207171,=,1,1,=,IZ,mm,19.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,DIZ,mm,UO_0000016,19.0
30744,,19214125,CHEMBL4393590,Antibacterial activity against Bacillus subtilis JMRC:STI:10880 assessed as diameter of clear inhibition zone by agar diffusion test (Rvb = 0 millimeter),F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4392881,J Nat Prod,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,3207171,=,1,1,=,IZ,mm,29.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,DIZ,mm,UO_0000016,29.0
30745,,19214130,CHEMBL4393601,Antibacterial activity against Mycobacterium vaccae JMRC:STI:10670 assessed as diameter of colonies in inhibition zone by agar diffusion test (Rvb = 0 millimeter),F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4392881,J Nat Prod,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,3207171,=,1,1,=,IZ,mm,21.0,CHEMBL613224,Mycolicibacterium vaccae,Mycolicibacterium vaccae,1810.0,,DIZ,mm,UO_0000016,21.0
30746,,19214142,CHEMBL4393606,Antibacterial activity against Bacillus subtilis DSM10 measured after 20 hrs,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4392881,J Nat Prod,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3207171,<,1,1,<,MIC,ug.mL-1,0.25,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,MIC,ug ml-1,UO_0000274,0.25
30747,,19214145,CHEMBL4393607,Antibacterial activity against Escherichia coli DSM 1116 measured after 20 hrs,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4392881,J Nat Prod,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3207171,<,1,1,<,MIC,ug.mL-1,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.25
30748,,19214148,CHEMBL4393608,Antibacterial activity against Escherichia coli BW25113 measured after 20 hrs,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4392881,J Nat Prod,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3207171,<,1,1,<,MIC,ug.mL-1,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.25
30749,,19214151,CHEMBL4393609,Antibacterial activity against Salmonella typhimurium TA100 measured after 20 hrs,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4392881,J Nat Prod,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3207171,<,1,1,<,MIC,ug.mL-1,0.25,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,MIC,ug ml-1,UO_0000274,0.25
30750,,19214154,CHEMBL4393610,Antibacterial activity against Micrococcus luteus DSM 1790 measured after 20 hrs,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4392881,J Nat Prod,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3207171,<,1,1,<,MIC,ug.mL-1,0.25,CHEMBL614421,Micrococcus luteus,Micrococcus luteus,1270.0,,MIC,ug ml-1,UO_0000274,0.25
30751,,19214157,CHEMBL4393611,Antibacterial activity against Mycobacterium phlei DSM 750 measured after 20 hrs,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4392881,J Nat Prod,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3207171,<,1,1,<,MIC,ug.mL-1,0.25,CHEMBL614985,Mycolicibacterium phlei,Mycolicibacterium phlei,1771.0,,MIC,ug ml-1,UO_0000274,0.25
30752,,19237687,CHEMBL4399097,Antibacterial activity against Staphylococcus aureus ATCC 6538 cultured in MH medium assessed as reduction in bacterial growth incubated for 48 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4396913,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3211468,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
30753,,19237710,CHEMBL4399098,Bactericidal activity against Staphylococcus aureus ATCC 6538 cultured in MH medium assessed as reduction in bacterial survival incubated for 48 hrs by microbroth dilution method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4396913,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3211468,=,1,0,=,MBC,ug ml-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MBC,ug ml-1,UO_0000274,0.5
30754,,19237734,CHEMBL4399099,Antibacterial activity against methicillin resistant Staphylococcus aureus N315 cultured in MH medium assessed as reduction in bacterial growth incubated for 48 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4396913,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3211468,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.0
30755,,19237757,CHEMBL4399100,Bactericidal activity against methicillin resistant Staphylococcus aureus N315 cultured in MH medium assessed as reduction in bacterial survival incubated for 48 hrs by microbroth dilution method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4396913,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3211468,=,1,0,=,MBC,ug ml-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MBC,ug ml-1,UO_0000274,1.0
30756,,19237781,CHEMBL4399101,Antibacterial activity against Staphylococcus epidermidis ATCC 14990 cultured in MH medium assessed as reduction in bacterial growth incubated for 48 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4396913,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3211468,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.25
30757,,19237804,CHEMBL4399102,Bactericidal activity against Staphylococcus epidermidis ATCC 14990 cultured in MH medium assessed as reduction in bacterial survival incubated for 48 hrs by microbroth dilution method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4396913,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3211468,=,1,0,=,MBC,ug ml-1,0.25,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MBC,ug ml-1,UO_0000274,0.25
30758,,19237828,CHEMBL4399103,Antibacterial activity against Enterococcus hirae ATCC 1052 cultured in BHI medium assessed as reduction in bacterial growth incubated for 48 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4396913,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3211468,=,1,1,=,MIC,ug.mL-1,128.0,CHEMBL614623,Enterococcus hirae,Enterococcus hirae,1354.0,,MIC,ug ml-1,UO_0000274,128.0
30759,,19237844,CHEMBL4399104,Bactericidal activity against Enterococcus hirae ATCC 1052 cultured in BHI medium assessed as reduction in bacterial survival incubated for 48 hrs by microbroth dilution method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4396913,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3211468,=,1,0,=,MBC,ug ml-1,128.0,CHEMBL614623,Enterococcus hirae,Enterococcus hirae,1354.0,,MBC,ug ml-1,UO_0000274,128.0
30760,,19237863,CHEMBL4399105,Antibacterial activity against Bacillus subtilis ATCC 6633 cultured in MH medium assessed as reduction in bacterial growth incubated for 48 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4396913,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3211468,=,1,1,=,MIC,ug.mL-1,0.032,CHEMBL613907,Bacillus spizizenii,Bacillus spizizenii,96241.0,,MIC,ug ml-1,UO_0000274,0.032
30761,,19237886,CHEMBL4399106,Bactericidal activity against Bacillus subtilis ATCC 6633 cultured in MH medium assessed as reduction in bacterial survival incubated for 48 hrs by microbroth dilution method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4396913,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3211468,=,1,0,=,MBC,ug ml-1,0.063,CHEMBL613907,Bacillus spizizenii,Bacillus spizizenii,96241.0,,MBC,ug ml-1,UO_0000274,0.063
30762,,19237910,CHEMBL4399107,Antibacterial activity against Escherichia coli ATCC 8739 cultured in MH medium assessed as reduction in bacterial growth incubated for 48 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4396913,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3211468,=,1,1,=,MIC,ug.mL-1,0.032,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.032
30763,,19237933,CHEMBL4399108,Bactericidal activity against Escherichia coli ATCC 8739 cultured in MH medium assessed as reduction in bacterial survival incubated for 48 hrs by microbroth dilution method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4396913,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3211468,=,1,0,=,MBC,ug ml-1,0.032,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MBC,ug ml-1,UO_0000274,0.032
30764,,19237957,CHEMBL4399109,Antibacterial activity against Pseudomonas aeruginosa ATCC 9027 cultured in MH medium assessed as reduction in bacterial growth incubated for 48 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4396913,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3211468,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.5
30765,,19237980,CHEMBL4399110,Bactericidal activity against Pseudomonas aeruginosa ATCC 9027 cultured in MH medium assessed as reduction in bacterial survival incubated for 48 hrs by microbroth dilution method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4396913,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3211468,=,1,0,=,MBC,ug ml-1,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MBC,ug ml-1,UO_0000274,0.5
30766,,19238004,CHEMBL4399111,Antibacterial activity against Proteus vulgaris NCTC 4635 cultured in MH medium assessed as reduction in bacterial growth incubated for 48 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4396913,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3211468,=,1,1,=,MIC,ug.mL-1,0.008,CHEMBL614450,Proteus vulgaris,Proteus vulgaris,585.0,,MIC,ug ml-1,UO_0000274,0.008
30767,,19238028,CHEMBL4399112,Bactericidal activity against Proteus vulgaris NCTC 4635 cultured in MH medium assessed as reduction in bacterial survival incubated for 48 hrs by microbroth dilution method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4396913,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3211468,=,1,0,=,MBC,ug ml-1,0.008,CHEMBL614450,Proteus vulgaris,Proteus vulgaris,585.0,,MBC,ug ml-1,UO_0000274,0.008
30768,,19238052,CHEMBL4399113,Antibacterial activity against methicillin resistant Staphylococcus aureus 6347 cultured in MH medium assessed as reduction in bacterial growth incubated for 48 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4396913,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3211468,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
30769,,19238075,CHEMBL4399114,Bactericidal activity against methicillin resistant Staphylococcus aureus 6347 cultured in MH medium assessed as reduction in bacterial survival incubated for 48 hrs by microbroth dilution method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4396913,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3211468,=,1,0,=,MBC,ug ml-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MBC,ug ml-1,UO_0000274,0.5
30770,,19238099,CHEMBL4399115,Antibacterial activity against methicillin resistant Staphylococcus epidermidis ATCC 13199 cultured in MH medium assessed as reduction in bacterial growth incubated for 48 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4396913,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3211468,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.125
30771,,19238122,CHEMBL4399116,Bactericidal activity against methicillin resistant Staphylococcus epidermidis ATCC 13199 cultured in MH medium assessed as reduction in bacterial survival incubated for 48 hrs by microbroth dilution method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4396913,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3211468,=,1,0,=,MBC,ug ml-1,0.125,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MBC,ug ml-1,UO_0000274,0.125
30772,,19238146,CHEMBL4399117,Antibacterial activity against Streptococcus pneumoniae cultured in MH medium assessed as reduction in bacterial growth incubated for 48 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4396913,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3211468,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,8.0
30773,,19238162,CHEMBL4399118,Bactericidal activity against Streptococcus pneumoniae cultured in MH medium assessed as reduction in bacterial survival incubated for 48 hrs by microbroth dilution method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4396913,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3211468,>,1,0,>,MBC,ug ml-1,512.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MBC,ug ml-1,UO_0000274,512.0
30774,,19238184,CHEMBL4399119,Antibacterial activity against Serratia marcescens ATCC 12795 cultured in MH medium assessed as reduction in bacterial growth incubated for 48 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4396913,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3211468,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,MIC,ug ml-1,UO_0000274,0.125
30775,,19238207,CHEMBL4399120,Bactericidal activity against Serratia marcescens ATCC 12795 cultured in MH medium assessed as reduction in bacterial survival incubated for 48 hrs by microbroth dilution method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4396913,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3211468,=,1,0,=,MBC,ug ml-1,0.125,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,MBC,ug ml-1,UO_0000274,0.125
30776,,19238227,CHEMBL4399125,Inhibition of Escherichia coli DNA gyrase super-coiling activity using relaxed pNO1 DNA as substrate assessed as enzyme residual activity at 1 uM incubated for 30 mins by fluorescence assay relative to control,B,BAO_0001103,BAO_0000223,protein complex format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4396913,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,3211468,=,1,0,=,Activity,%,7.0,CHEMBL2094139,Escherichia coli,DNA gyrase,562.0,,Activity,%,UO_0000187,7.0
30777,,19238232,CHEMBL4399126,Inhibition of Escherichia coli DNA gyrase super-coiling activity using relaxed pNO1 DNA as substrate incubated for 30 mins by fluorescence assay,B,BAO_0000190,BAO_0000223,protein complex format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4396913,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3211468,=,1,1,=,IC50,nM,122.0,CHEMBL2094139,Escherichia coli,DNA gyrase,562.0,,IC50,uM,UO_0000065,0.122
30778,Active,19238234,CHEMBL4399127,Induction of inner membrane permeabilization in Escherichia coli ATCC 8739 assessed as increase in release of cytoplasmic beta galactosidase using ONPG as substrate at 128 ug/ml incubated for 90 mins compound added with bacterial cells after lag time of about 10 mins by spectrophotometry,B,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4396913,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3211468,,1,0,,Activity,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,,,
30779,,19238356,CHEMBL4399128,Antibiofilm activity against Pseudomonas aeruginosa ATCC 9027 assessed as biofilm formation at antibacterial MIC incubated for 24 hrs compound added prior to bacterial biofilm formation by total biomass crystal violet staining-based method relative to control,F,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4396913,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,3211468,=,1,0,=,Activity,%,3.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,%,UO_0000187,3.0
30780,,19238357,CHEMBL4399129,Antibiofilm activity against Staphylococcus aureus ATCC 6538 assessed as biofilm formation at antibacterial MIC incubated for 24 hrs compound added prior to bacterial biofilm formation by total biomass crystal violet staining-based method relative to control,F,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4396913,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,3211468,=,1,0,=,Activity,%,3.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,3.0
30781,,19238358,CHEMBL4399130,Antibiofilm activity against Pseudomonas aeruginosa ATCC 9027 assessed as biofilm formation at 0.5 times antibacterial MIC incubated for 24 hrs compound added prior to bacterial biofilm formation by total biomass crystal violet staining-based method relative to control,F,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4396913,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,3211468,=,1,0,=,Activity,%,7.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,%,UO_0000187,7.0
30782,,19238359,CHEMBL4399131,Antibiofilm activity against Staphylococcus aureus ATCC 6538 assessed as biofilm formation at 0.5 times antibacterial MIC incubated for 24 hrs compound added prior to bacterial biofilm formation by total biomass crystal violet staining-based method relative to control,F,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4396913,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,3211468,=,1,0,=,Activity,%,5.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,5.0
30783,,19238360,CHEMBL4399132,Biofilm degradation activity against Pseudomonas aeruginosa ATCC 9027 assessed as biofilm formation at antibacterial MIC incubated for 24 hrs compound added post-biofilm formation by total biomass crystal violet staining-based method,F,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4396913,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,3211468,=,1,0,=,Activity,%,76.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,%,UO_0000187,76.0
30784,,19238361,CHEMBL4399147,Biofilm degradation activity against Pseudomonas aeruginosa ATCC 9027 assessed as biofilm formation at 2 times antibacterial MIC incubated for 24 hrs compound added post-biofilm formation by total biomass crystal violet staining-based method,F,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4396913,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,3211468,=,1,0,=,Activity,%,72.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,%,UO_0000187,72.0
30785,,19238362,CHEMBL4399148,Biofilm degradation activity against Pseudomonas aeruginosa ATCC 9027 assessed as biofilm formation at 4 times antibacterial MIC incubated for 24 hrs compound added post-biofilm formation by total biomass crystal violet staining-based method,F,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4396913,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,3211468,=,1,0,=,Activity,%,64.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,%,UO_0000187,64.0
30786,,19238363,CHEMBL4399149,Biofilm degradation activity against Staphylococcus aureus ATCC 6538 assessed as biofilm formation at antibacterial MIC incubated for 24 hrs compound added post-biofilm formation by total biomass crystal violet staining-based method,F,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4396913,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,3211468,=,1,0,=,Activity,%,21.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,21.0
30787,,19238364,CHEMBL4399150,Biofilm degradation activity against Staphylococcus aureus ATCC 6538 assessed as biofilm formation at 2 times antibacterial MIC incubated for 24 hrs compound added post-biofilm formation by total biomass crystal violet staining-based method,F,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4396913,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,3211468,=,1,0,=,Activity,%,17.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,17.0
30788,,19238365,CHEMBL4399151,Biofilm degradation activity against Staphylococcus aureus ATCC 6538 assessed as biofilm formation at 4 times antibacterial MIC incubated for 24 hrs compound added post-biofilm formation by total biomass crystal violet staining-based method,F,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4396913,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,3211468,=,1,0,=,Activity,%,31.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,31.0
30789,Active,19238366,CHEMBL4399152,Antibiofilm activity Staphylococcus aureus ATCC 25923 pre-formed mature biofilm assessed as reduction in biofilm viability at 10 to 40 uM incubated for 24 hrs compound added post-biofilm formation by resazurin staining based assay relative to control,F,BAO_0000201,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4396913,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,3211468,,1,0,,Inhibition,%,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,INH,,UO_0000187,
30790,Active,19238367,CHEMBL4399153,Antibiofilm activity Staphylococcus aureus ATCC 25923 pre-formed mature biofilm assessed as reduction in biofilm biomass at 10 to 40 uM incubated for 24 hrs compound added post biofilm formation by crystal violet staining based assay relative to control,F,BAO_0000201,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4396913,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,3211468,,1,0,,Inhibition,%,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,INH,,UO_0000187,
30791,,19239605,CHEMBL4399376,Antibacterial activity against Escherichia coli K-12 BW25113 incubated for 18 hrs by broth microdilution method,F,BAO_0000188,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4396918,Bioorg Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3211626,=,1,1,=,EC50,nM,22.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,EC50,uM,UO_0000065,0.022
30792,,19239627,CHEMBL4399377,Antibacterial activity against Staphylococcus aureus SH1000 incubated for 18 hrs by broth microdilution method,F,BAO_0000188,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4396918,Bioorg Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3211626,=,1,1,=,EC50,nM,350.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,EC50,uM,UO_0000065,0.35
30793,,19239649,CHEMBL4399378,Antibacterial activity against methicillin resistant Staphylococcus aureus USA300 JE2 incubated for 18 hrs by broth microdilution method,F,BAO_0000188,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4396918,Bioorg Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3211626,=,1,1,=,EC50,nM,8300.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,EC50,uM,UO_0000065,8.3
30794,,19239704,CHEMBL4399382,Inhibition of Escherichia coli DNA gyrase (A2B2 tetramer) using relaxed pBR322 as substrate preincubated for 30 mins followed by enzyme addition by SYBR staining-based agarose gel electrophoresis method,B,BAO_0000190,BAO_0000223,protein complex format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4396918,Bioorg Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3211626,=,1,1,=,IC50,nM,280.0,CHEMBL2094139,Escherichia coli,DNA gyrase,562.0,,IC50,uM,UO_0000065,0.28
30795,Active,19239708,CHEMBL4399384,Inhibition of Escherichia coli DNA topoisomerase IV using supercoiled pQE80L as substrate at 12.5 uM incubated for 30 mins by ethidium bromide staining-based agarose gel electrophoresis method,B,BAO_0000201,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4396918,Bioorg Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,3211626,,1,0,,Inhibition,%,,CHEMBL612545,,Unchecked,,,INH,,UO_0000187,
30796,,19239718,CHEMBL4399388,Antibacterial activity against methicillin resistant Staphylococcus aureus USA300 JE2 incubated for 17 hrs by growth rate method,F,BAO_0000188,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4396918,Bioorg Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3211626,=,1,1,=,EC50,nM,5300.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,EC50,uM,UO_0000065,5.3
30797,Active,19239744,CHEMBL4399389,Inhibition of AddAB in Staphylococcus aureus USA300 JE2 transformed with pCN34 PrecA-gfp reporter plasmid assessed as decrease in cell number at 66 uM measured at 15 mins interval for 17 hrs by GFP reporter gene assay,B,BAO_0000201,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4396918,Bioorg Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,3211626,,1,0,,Inhibition,%,,CHEMBL612545,,Unchecked,,,INH,,UO_0000187,
30798,Active,19239745,CHEMBL4399390,Inhibition of AddAB in Staphylococcus aureus USA300 JE2 transformed with pCN34 PrecA-gfp reporter plasmid assessed as growth inhibition by measuring increase in green fluorescence per cell at 66 uM measured at 15 mins interval for 17 hrs by GFP reporter gene assay,B,BAO_0000201,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4396918,Bioorg Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,3211626,,1,0,,Inhibition,%,,CHEMBL612545,,Unchecked,,,INH,,UO_0000187,
30799,,19241486,CHEMBL4399760,Antibacterial activity against Bacillus subtilis MTCC 121 assessed as reduction in bacterial growth incubated for 24 hrs by agar well diffusion method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4396937,Bioorg Med Chem Lett,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3211964,=,1,1,=,MIC,ug.mL-1,0.9,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,MIC,ug ml-1,UO_0000274,0.9
30800,,19241509,CHEMBL4399761,Antibacterial activity against Staphylococcus aureus MLS-16 MTCC 2940 assessed as reduction in bacterial growth incubated for 24 hrs by agar well diffusion method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4396937,Bioorg Med Chem Lett,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3211964,=,1,1,=,MIC,ug.mL-1,0.9,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.9
30801,,19241532,CHEMBL4399762,Antibacterial activity against Micrococcus luteus MTCC 2470 assessed as reduction in bacterial growth incubated for 24 hrs by agar well diffusion method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4396937,Bioorg Med Chem Lett,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3211964,=,1,1,=,MIC,ug.mL-1,0.9,CHEMBL614421,Micrococcus luteus,Micrococcus luteus,1270.0,,MIC,ug ml-1,UO_0000274,0.9
30802,,19241555,CHEMBL4399763,Antibacterial activity against Staphylococcus aureus MTCC 96 assessed as reduction in bacterial growth incubated for 24 hrs by agar well diffusion method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4396937,Bioorg Med Chem Lett,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3211964,=,1,1,=,MIC,ug.mL-1,0.9,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.9
30803,,19241578,CHEMBL4399764,Antibacterial activity against Escherichia coli MTCC 739 assessed as reduction in bacterial growth incubated for 24 hrs by agar well diffusion method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4396937,Bioorg Med Chem Lett,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3211964,=,1,1,=,MIC,ug.mL-1,0.9,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.9
30804,,19241601,CHEMBL4399765,Antibacterial activity against Pseudomonas aeruginosa MTCC 2453 assessed as reduction in bacterial growth incubated for 24 hrs by agar well diffusion method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4396937,Bioorg Med Chem Lett,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3211964,=,1,1,=,MIC,ug.mL-1,0.9,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.9
30805,,19241624,CHEMBL4399766,Antibacterial activity against Klebsiella planticola MTCC 530 assessed as reduction in bacterial growth incubated for 24 hrs by agar well diffusion method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4396937,Bioorg Med Chem Lett,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3211964,=,1,1,=,MIC,ug.mL-1,0.9,CHEMBL613271,Raoultella planticola,Raoultella planticola,575.0,,MIC,ug ml-1,UO_0000274,0.9
30806,Not Active,19241647,CHEMBL4399767,Antifungal activity against Candida albicans MTCC 3017 assessed as reduction in fungal growth incubated for 24 hrs by agar well diffusion method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4396937,Bioorg Med Chem Lett,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3211964,,1,0,,MIC,,,CHEMBL366,Candida albicans,Candida albicans,5476.0,,MIC,,,
30807,,19241670,CHEMBL4399768,Bactericidal activity against Bacillus subtilis MTCC 121 assessed as reduction in bacterial survival incubated for 24 hrs followed by transfer of microbial suspension to agar plates and measured at 24 hrs post transfer by agar well diffusion method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4396937,Bioorg Med Chem Lett,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3211964,=,1,0,=,MBC,ug ml-1,1.9,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,MBC,ug ml-1,UO_0000274,1.9
30808,,19241693,CHEMBL4399769,Bactericidal activity against Staphylococcus aureus MLS-16 MTCC 2940 assessed as reduction in bacterial survival incubated for 24 hrs followed by transfer of microbial suspension to agar plates and measured at 24 hrs post transfer by agar well diffusion method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4396937,Bioorg Med Chem Lett,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3211964,=,1,0,=,MBC,ug ml-1,1.9,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MBC,ug ml-1,UO_0000274,1.9
30809,,19241716,CHEMBL4399770,Bactericidal activity against Micrococcus luteus MTCC 2470 assessed as reduction in bacterial survival incubated for 24 hrs followed by transfer of microbial suspension to agar plates and measured at 24 hrs post transfer by agar well diffusion method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4396937,Bioorg Med Chem Lett,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3211964,=,1,0,=,MBC,ug ml-1,1.9,CHEMBL614421,Micrococcus luteus,Micrococcus luteus,1270.0,,MBC,ug ml-1,UO_0000274,1.9
30810,,19241739,CHEMBL4399771,Bactericidal activity against Staphylococcus aureus MTCC 96 assessed as reduction in bacterial survival incubated for 24 hrs followed by transfer of microbial suspension to agar plates and measured at 24 hrs post transfer by agar well diffusion method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4396937,Bioorg Med Chem Lett,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3211964,=,1,0,=,MBC,ug ml-1,1.9,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MBC,ug ml-1,UO_0000274,1.9
30811,,19241762,CHEMBL4399772,Bactericidal activity against Escherichia coli MTCC 739 assessed as reduction in bacterial survival incubated for 24 hrs followed by transfer of microbial suspension to agar plates and measured at 24 hrs post transfer by agar well diffusion method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4396937,Bioorg Med Chem Lett,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3211964,=,1,0,=,MBC,ug ml-1,1.9,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MBC,ug ml-1,UO_0000274,1.9
30812,,19241785,CHEMBL4399773,Bactericidal activity against Pseudomonas aeruginosa MTCC 2453 assessed as reduction in bacterial survival incubated for 24 hrs followed by transfer of microbial suspension to agar plates and measured at 24 hrs post transfer by agar well diffusion method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4396937,Bioorg Med Chem Lett,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3211964,=,1,0,=,MBC,ug ml-1,1.9,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MBC,ug ml-1,UO_0000274,1.9
30813,,19241808,CHEMBL4399774,Bactericidal activity against Klebsiella planticola MTCC 530 assessed as reduction in bacterial survival incubated for 24 hrs followed by transfer of microbial suspension to agar plates and measured at 24 hrs post transfer by agar well diffusion method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4396937,Bioorg Med Chem Lett,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3211964,=,1,0,=,MBC,ug ml-1,1.9,CHEMBL613271,Raoultella planticola,Raoultella planticola,575.0,,MBC,ug ml-1,UO_0000274,1.9
30814,Not Active,19241831,CHEMBL4399775,Fungicidal activity against Candida albicans MTCC 3017 assessed as reduction in fungal survival incubated for 24 hrs followed by transfer of microbial suspension to agar plates and measured at 24 hrs post transfer by agar well diffusion method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4396937,Bioorg Med Chem Lett,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3211964,,1,0,,MFC,,,CHEMBL366,Candida albicans,Candida albicans,5476.0,,MFC,,,
30815,,19241838,CHEMBL4399776,Antibiofilm activity against Bacillus subtilis MTCC 121 assessed as inhibition of biofilm formation by crystal violet staining-based microtitre plate assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4396937,Bioorg Med Chem Lett,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3211964,=,1,1,=,IC50,ug.mL-1,6.6,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,IC50,ug ml-1,UO_0000274,6.6
30816,,19241844,CHEMBL4399777,Antibiofilm activity against Staphylococcus aureus MLS-16 MTCC 2940 assessed as inhibition of biofilm formation by crystal violet staining-based microtitre plate assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4396937,Bioorg Med Chem Lett,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3211964,=,1,1,=,IC50,ug.mL-1,6.6,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,IC50,ug ml-1,UO_0000274,6.6
30817,,19241850,CHEMBL4399778,Antibiofilm activity against Micrococcus luteus MTCC 2470 assessed as inhibition of biofilm formation by crystal violet staining-based microtitre plate assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4396937,Bioorg Med Chem Lett,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3211964,=,1,1,=,IC50,ug.mL-1,6.8,CHEMBL614421,Micrococcus luteus,Micrococcus luteus,1270.0,,IC50,ug ml-1,UO_0000274,6.8
30818,,19241856,CHEMBL4399779,Antibiofilm activity against Staphylococcus aureus MTCC 96 assessed as inhibition of biofilm formation by crystal violet staining-based microtitre plate assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4396937,Bioorg Med Chem Lett,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3211964,=,1,1,=,IC50,ug.mL-1,6.7,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,IC50,ug ml-1,UO_0000274,6.7
30819,,19241862,CHEMBL4399780,Antibiofilm activity against Escherichia coli MTCC 739 assessed as inhibition of biofilm formation by crystal violet staining-based microtitre plate assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4396937,Bioorg Med Chem Lett,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3211964,=,1,1,=,IC50,ug.mL-1,7.3,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,IC50,ug ml-1,UO_0000274,7.3
30820,,19241868,CHEMBL4399781,Antibiofilm activity against Pseudomonas aeruginosa MTCC 2453 assessed as inhibition of biofilm formation by crystal violet staining-based microtitre plate assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4396937,Bioorg Med Chem Lett,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3211964,=,1,1,=,IC50,ug.mL-1,7.4,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,IC50,ug ml-1,UO_0000274,7.4
30821,,19241874,CHEMBL4399782,Antibiofilm activity against Klebsiella planticola MTCC 530 assessed as inhibition of biofilm formation by crystal violet staining-based microtitre plate assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4396937,Bioorg Med Chem Lett,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3211964,=,1,1,=,IC50,ug.mL-1,8.6,CHEMBL613271,Raoultella planticola,Raoultella planticola,575.0,,IC50,ug ml-1,UO_0000274,8.6
30822,,19241880,CHEMBL4399787,Antibiofilm activity against Staphylococcus aureus MTCC 96 assessed as inhibition of biofilm formation incubated for 48 hrs in presence of Escherichia coli MTCC 739 by FE-SEM analysis,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4396937,Bioorg Med Chem Lett,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3211964,=,1,1,=,IC50,ug.mL-1,11.6,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,IC50,ug ml-1,UO_0000274,11.6
30823,,19241882,CHEMBL4399785,Antibiofilm activity against Escherichia coli MTCC 739 assessed as inhibition of biofilm formation incubated for 48 hrs in presence of Staphylococcus aureus MTCC 96 by FE-SEM analysis,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4396937,Bioorg Med Chem Lett,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3211964,=,1,1,=,IC50,ug.mL-1,11.6,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,IC50,ug ml-1,UO_0000274,11.6
30824,,19243415,CHEMBL4400232,Antitubercular activity against Mycobacterium tuberculosis H37Rv incubated for 5 days by microplate alamar blue assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4396954,Bioorg Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3212297,=,1,1,=,MIC,nM,9430.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,uM,UO_0000065,9.43
30825,,19248196,CHEMBL4401007,Antibacterial activity against Enterococcus faecium,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4400520,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3213164,=,1,1,=,MIC90,ug.mL-1,8.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC90,ug ml-1,UO_0000274,8.0
30826,,19248224,CHEMBL4401006,Antibacterial activity against Enterococcus faecalis,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4400520,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3213164,=,1,1,=,MIC90,ug.mL-1,0.5,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC90,ug ml-1,UO_0000274,0.5
30827,,19248252,CHEMBL4401005,Antibacterial activity against methicillin-resistant Staphylococcus aureus,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4400520,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3213164,=,1,1,=,MIC90,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC90,ug ml-1,UO_0000274,0.25
30828,,19248280,CHEMBL4401004,Antibacterial activity against methicillin-sensitive Staphylococcus aureus,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4400520,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3213164,=,1,1,=,MIC90,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC90,ug ml-1,UO_0000274,0.25
30829,,19248308,CHEMBL4401003,Antibacterial activity against methicillin-resistant Staphylococcus epidermidis,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4400520,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3213164,=,1,1,=,MIC90,ug.mL-1,4.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC90,ug ml-1,UO_0000274,4.0
30830,,19248336,CHEMBL4401002,Antibacterial activity against methicillin-sensitive Staphylococcus epidermidis,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4400520,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3213164,=,1,1,=,MIC90,ug.mL-1,0.125,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC90,ug ml-1,UO_0000274,0.125
30831,,19248365,CHEMBL4401001,Antitubercular activity against multidrug resistant Mycobacterium tuberculosis isolate 2,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4400520,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3213164,=,1,1,=,MIC,ug.mL-1,0.27,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,ug ml-1,UO_0000274,0.27
30832,,19248385,CHEMBL4401000,Antitubercular activity against multidrug resistant Mycobacterium tuberculosis isolate 1,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4400520,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3213164,=,1,1,=,MIC,ug.mL-1,0.39,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,ug ml-1,UO_0000274,0.39
30833,,19248405,CHEMBL4400999,"Selectivity index, ratio of CC50 for African green monkey Vero cells to MIC for Mycobacterium tuberculosis H37Rv",T,BAO_0000179,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4400520,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3213164,=,1,0,=,Selectivity Index,,1759.0,CHEMBL612545,,Unchecked,,,Selectivity Index,,,1759.0
30834,,19248435,CHEMBL4400998,Cytotoxicity against African green monkey Vero cells assessed as reduction in cell viability after 72 hrs by MTT assay,A,BAO_0000187,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4400520,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3213164,=,1,1,=,CC50,ug.mL-1,512.0,CHEMBL391,Chlorocebus sabaeus,Vero,60711.0,,CC50,ug ml-1,UO_0000274,512.0
30835,,19248465,CHEMBL4400997,Antitubercular activity against Mycobacterium tuberculosis H37Rv,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4400520,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3213164,=,1,1,=,MIC,ug.mL-1,0.291,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,ug ml-1,UO_0000274,0.291
30836,,19248493,CHEMBL4401008,Antibacterial activity against Escherichia coli,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4400520,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3213164,=,1,1,=,MIC90,ug.mL-1,0.06,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC90,ug ml-1,UO_0000274,0.06
30837,,19248520,CHEMBL4401009,Antibacterial activity against Klebsiella pneumoniae,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4400520,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3213164,=,1,1,=,MIC90,ug.mL-1,0.5,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC90,ug ml-1,UO_0000274,0.5
30838,,19248547,CHEMBL4401010,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4400520,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3213164,=,1,1,=,MIC90,ug.mL-1,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC90,ug ml-1,UO_0000274,0.25
30839,,19248574,CHEMBL4401011,Antibacterial activity against Acinetobacter calcoaceticus,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4400520,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3213164,=,1,1,=,MIC90,ug.mL-1,0.5,CHEMBL614426,Acinetobacter calcoaceticus,Acinetobacter calcoaceticus,471.0,,MIC90,ug ml-1,UO_0000274,0.5
30840,,19248601,CHEMBL4401012,Antibacterial activity against Enterobacter cloacae,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4400520,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3213164,=,1,1,=,MIC90,ug.mL-1,0.06,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,MIC90,ug ml-1,UO_0000274,0.06
30841,,19248628,CHEMBL4401013,Antibacterial activity against Enterobacter aerogenes,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4400520,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3213164,=,1,1,=,MIC90,ug.mL-1,0.06,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,MIC90,ug ml-1,UO_0000274,0.06
30842,,19248655,CHEMBL4401014,Antibacterial activity against Proteus mirabilis,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4400520,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3213164,<=,1,1,<=,MIC90,ug.mL-1,0.03,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,MIC90,ug ml-1,UO_0000274,0.03
30843,,19248682,CHEMBL4401015,Antibacterial activity against Citrobacter freundii,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4400520,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3213164,=,1,1,=,MIC90,ug.mL-1,0.03,CHEMBL612615,Citrobacter freundii,Citrobacter freundii,546.0,,MIC90,ug ml-1,UO_0000274,0.03
30844,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,19248685,CHEMBL4401016,"Cmax in ICR mouse at 25 mg/kg, po",A,BAO_0002119,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4400520,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3213164,=,1,1,=,Cmax,nM,9443.19,CHEMBL612558,,ADMET,,,Cmax,ng/ml,UO_0000065,3129.0
30845,,19248688,CHEMBL4401017,"Half life in ICR mouse at 25 mg/kg, po",A,BAO_0002115,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4400520,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Hour,3213164,=,1,1,=,T1/2,hr,5.2,CHEMBL612558,,ADMET,,,t1/2,hr,UO_0000032,5.2
30846,,19248694,CHEMBL4401019,"AUC (0 to infinity) in ICR mouse at 25 mg/kg, po",A,BAO_0002120,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4400520,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3213164,=,1,1,=,AUC,ng.hr.mL-1,17835.0,CHEMBL612558,,ADMET,,,AUC,ng.hr/ml,,17835.0
30847,,19248703,CHEMBL4401026,Metabolic stability in mouse assessed as half life,A,BAO_0002115,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4400520,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Hour,3213164,>,1,1,>,T1/2,hr,1.0,CHEMBL612558,,ADMET,,,t1/2,min,UO_0000032,60.0
30848,,19249159,CHEMBL4401160,Antibacterial activity against Staphylococcus aureus ATCC 6538 measured after overnight incubation,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4400526,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3213292,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,8.0
30849,,19249179,CHEMBL4401161,Antibacterial activity against Bacillus subtilis ATCC 6633 measured after overnight incubation,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4400526,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3213292,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL613907,Bacillus spizizenii,Bacillus spizizenii,96241.0,,MIC,ug ml-1,UO_0000274,8.0
30850,,19249199,CHEMBL4401162,Antibacterial activity against Escherichia coli ATCC 25922 measured after overnight incubation,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4400526,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3213292,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,8.0
30851,,19249219,CHEMBL4401163,Antibacterial activity against Pseudomonas aeruginosa ATCC 15442 measured after overnight incubation,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4400526,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3213292,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,8.0
30852,,19249248,CHEMBL4401165,Antibacterial activity against methicillin-resistant Staphylococcus aureus clinical isolates measured after overnight incubation,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4400526,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3213292,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,32.0
30853,,19249258,CHEMBL4401166,Antibacterial activity against Streptococcus hemolyticus clinical isolates measured after overnight incubation,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4400526,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3213292,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC,ug ml-1,UO_0000274,4.0
30854,,19249269,CHEMBL4401167,Antibacterial activity against Escherichia coli clinical isolates measured after overnight incubation,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4400526,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3213292,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,4.0
30855,,19249280,CHEMBL4401168,Antibacterial activity against Pseudomonas aeruginosa clinical isolates measured after overnight incubation,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4400526,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3213292,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,4.0
30856,,19279332,CHEMBL4408658,Antibacterial activity against multidrug-resistant Pseudomonas aeruginosa CCARM 2095 assessed as reduction in bacterial growth incubated for 72 hrs by spectrophotometry,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4406836,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3219426,=,1,1,=,MIC,nM,512000.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,uM,UO_0000065,512.0
30857,,19279349,CHEMBL4408720,Antibacterial activity against methicillin-resistant Staphylococcus aureus CCARM 3089 assessed as reduction in bacterial growth incubated for 72 hrs by spectrophotometry,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4406836,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3219426,=,1,1,=,MIC,nM,1024000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,uM,UO_0000065,1024.0
30858,,19303891,CHEMBL4414301,Antibiofilm activity against tetracycline-resistant Bacillus subtilis assessed as disruption of biofilm at 200 ug/ml after 24 hrs by crystal violet staining based ELISA relative to control,F,BAO_0000201,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4411338,Bioorg Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,3223427,=,1,1,=,Inhibition,%,23.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,INH,%,UO_0000187,23.0
30859,,19303906,CHEMBL4414300,Antibiofilm activity against ofloxacin-resistant Bacillus megaterium assessed as disruption of biofilm at 200 ug/ml after 24 hrs by crystal violet staining based ELISA relative to control,F,BAO_0000201,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4411338,Bioorg Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,3223427,=,1,1,=,Inhibition,%,56.3,CHEMBL613071,Priestia megaterium,Priestia megaterium,1404.0,,INH,%,UO_0000187,56.3
30860,,19303921,CHEMBL4414302,Antibiofilm activity against carbapenem-resistant Escherichia coli assessed as disruption of biofilm at 200 ug/ml after 24 hrs by crystal violet staining based ELISA relative to control,F,BAO_0000201,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4411338,Bioorg Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,3223427,=,1,1,=,Inhibition,%,45.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,INH,%,UO_0000187,45.0
30861,,19303936,CHEMBL4414303,Antibiofilm activity against tetracycline-resistant Pseudomonas fluorescens assessed as disruption of biofilm at 200 ug/ml after 24 hrs by crystal violet staining based ELISA relative to control,F,BAO_0000201,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4411338,Bioorg Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,3223427,=,1,1,=,Inhibition,%,38.0,CHEMBL612500,Pseudomonas fluorescens,Pseudomonas fluorescens,294.0,,INH,%,UO_0000187,38.0
30862,,19303951,CHEMBL4414304,Antibiofilm activity against carbenicillin-resistant Pseudomonas aeruginosa assessed as disruption of biofilm at 200 ug/ml after 24 hrs by crystal violet staining based ELISA relative to control,F,BAO_0000201,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4411338,Bioorg Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,3223427,=,1,1,=,Inhibition,%,49.7,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,INH,%,UO_0000187,49.7
30863,,19303966,CHEMBL4414305,Antibiofilm activity against carbapenem-resistant Klebsiella pneumoniae assessed as disruption of biofilm at 200 ug/ml after 24 hrs by crystal violet staining based ELISA relative to control,F,BAO_0000201,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4411338,Bioorg Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,3223427,=,1,1,=,Inhibition,%,25.5,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,INH,%,UO_0000187,25.5
30864,,19303981,CHEMBL4414306,Antibiofilm activity against tetracycline-resistant Klebsiella pneumoniae assessed as disruption of biofilm at 200 ug/ml after 24 hrs by crystal violet staining based ELISA relative to control,F,BAO_0000201,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4411338,Bioorg Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,3223427,=,1,1,=,Inhibition,%,43.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,INH,%,UO_0000187,43.0
30865,,19306814,CHEMBL4415191,Antibacterial activity against Haemophilus influenzae type b ATCC 49247 incubated for 24 hrs by M7-A9 microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4414555,J Nat Prod,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3223814,=,1,1,=,MIC,ug.mL-1,1.6,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MIC,ug ml-1,UO_0000274,1.6
30866,,19306828,CHEMBL4415192,Bactericidal activity against Haemophilus influenzae type b ATCC 49247 incubated for 24 hrs followed by transferring to freshly prepared broth medium and measured after 24 hrs by M7-A9 microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4414555,J Nat Prod,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3223814,=,1,0,=,MBC,ug ml-1,1.6,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MBC,ug ml-1,UO_0000274,1.6
30867,,19306842,CHEMBL4415193,Ratio of MBC to MIC for Haemophilus influenzae type b ATCC 49247 by M7-A9 microdilution method,F,BAO_0000193,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4414555,J Nat Prod,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3223814,=,1,0,=,Ratio,,1.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,Ratio,,,1.0
30868,,19314399,CHEMBL4416747,Antibacterial activity against Escherichia coli K-12 assessed as reduction in bacterial growth incubated for 16 hrs,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4414638,J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3225249,=,1,1,=,MIC,ug.mL-1,0.01,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.01
30869,Non-Toxic,19314459,CHEMBL4416768,Cytotoxicity in human HS5 cells assessed as reduction in cell viability at 0.5 to 50 uM incubated up to 72 hrs relative to chloramphenicol,A,BAO_0000375,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4414638,J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3225249,,1,0,,Activity,,,CHEMBL612545,,Unchecked,,,Activity,,,
30870,,19362984,CHEMBL4423272,Antitubercular activity against Mycobacterium tuberculosis H37Rv after 7 days by Alamar blue assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4422620,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3240694,=,1,1,=,MIC,ug.mL-1,1.56,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,ug ml-1,UO_0000274,1.56
30871,,19400848,CHEMBL4425360,Antibacterial activity against Bacillus subtilis ATCC 6633 after 24 hrs by MTT based microbroth dilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4425091,J Nat Prod,2016.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3242558,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL613907,Bacillus spizizenii,Bacillus spizizenii,96241.0,,MIC,ug ml-1,UO_0000274,0.25
30872,,19400861,CHEMBL4425362,Antibacterial activity against Staphylococcus aureus ATCC 25923 after 24 hrs by MTT based microbroth dilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4425091,J Nat Prod,2016.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3242558,=,1,1,=,MIC,ug.mL-1,0.13,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.13
30873,,19400873,CHEMBL4425364,Antibacterial activity against Escherichia coli ATCC 25922 after 24 hrs by MTT based microbroth dilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4425091,J Nat Prod,2016.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3242558,=,1,1,=,MIC,ug.mL-1,0.13,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.13
30874,,19406514,CHEMBL4426537,Inhibition of wild type Staphylococcus aureus topoisomerase 4 assessed as compound concentration causing 50% induction of cleavage of covalently closed DNA substrate,B,BAO_0000187,BAO_0000223,protein complex format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4425125,J Med Chem,2016.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3243525,=,1,1,=,CC50,nM,400.0,CHEMBL3038508,Staphylococcus aureus,Topoisomerase IV,1280.0,,CC50,uM,UO_0000065,0.4
30875,,19406517,CHEMBL4426538,Inhibition of wild type Staphylococcus aureus gyrase assessed as compound concentration causing 50% induction of cleavage of covalently closed DNA substrate,B,BAO_0000187,BAO_0000223,protein complex format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4425125,J Med Chem,2016.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3243525,=,1,1,=,CC50,nM,5000.0,CHEMBL3038482,Staphylococcus aureus,DNA gyrase,1280.0,,CC50,uM,UO_0000065,5.0
30876,,19406520,CHEMBL4426539,Inhibition of FQ-resistant Staphylococcus aureus topoisomerase 4 ParC S80F mutant assessed as compound concentration causing 50% induction of cleavage of covalently closed DNA substrate,B,BAO_0000187,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4425125,J Med Chem,2016.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3243525,=,1,1,=,CC50,nM,31000.0,CHEMBL612545,,Unchecked,,,CC50,uM,UO_0000065,31.0
30877,,19406523,CHEMBL4426540,Inhibition of FQ-resistant Staphylococcus aureus GyrA S84L mutant assessed as compound concentration causing 50% induction of cleavage of covalently closed DNA substrate,B,BAO_0000187,BAO_0000357,single protein format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4425125,J Med Chem,2016.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,1,http://www.openphacts.org/units/Nanomolar,3243525,>,1,1,>,CC50,nM,150000.0,CHEMBL2424506,Staphylococcus aureus,DNA gyrase subunit A,1280.0,,CC50,uM,UO_0000065,150.0
30878,,19406532,CHEMBL4426544,Antimicrobial activity against Staphylococcus aureus isogenic forms expressing gyrA S84L mutant,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4425125,J Med Chem,2016.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3243525,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
30879,,19406536,CHEMBL4426546,Antimicrobial activity against wild type Staphylococcus aureus,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4425125,J Med Chem,2016.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3243525,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
30880,,19406542,CHEMBL4426549,Antimicrobial activity against Staphylococcus aureus isogenic forms expressing parC S80F mutant,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4425125,J Med Chem,2016.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3243525,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,2.0
30881,,19406548,CHEMBL4426551,Antimicrobial activity against Staphylococcus aureus isogenic forms expressing gyrA S84L and parC S80F mutant,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4425125,J Med Chem,2016.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3243525,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,16.0
30882,,19406554,CHEMBL4426554,Antimicrobial activity against Staphylococcus aureus isogenic forms expressing rpoB H481Y mutant,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4425125,J Med Chem,2016.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3243525,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
30883,,19406560,CHEMBL4426557,Antimicrobial activity against Staphylococcus aureus isogenic forms expressing rpoB H481Y and gyrA S84L mutant,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4425125,J Med Chem,2016.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3243525,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
30884,,19406566,CHEMBL4426560,Antimicrobial activity against Staphylococcus aureus isogenic forms expressing rpoB H481Y and parC S80F mutant,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4425125,J Med Chem,2016.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3243525,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,2.0
30885,,19406572,CHEMBL4426563,Antimicrobial activity against Staphylococcus aureus isogenic forms expressing rpoB H481Y/gyrA S84L/parC S80F mutant,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4425125,J Med Chem,2016.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3243525,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,16.0
30886,,19406577,CHEMBL4426564,Antimicrobial activity against methicillin-sensitive Staphylococcus aureus clinical isolates by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4425125,J Med Chem,2016.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3243525,>,1,1,>,MIC,ug.mL-1,0.06,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.06
30887,,19406580,CHEMBL4426565,Antimicrobial activity against methicillin-resistant Staphylococcus aureus clinical isolates by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4425125,J Med Chem,2016.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3243525,>,1,1,>,MIC,ug.mL-1,0.12,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.12
30888,,19406583,CHEMBL4426566,Antimicrobial activity against methicillin-sensitive Staphylococcus epidermidis clinical isolates by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4425125,J Med Chem,2016.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3243525,>,1,1,>,MIC,ug.mL-1,0.12,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.12
30889,,19406586,CHEMBL4426567,Antimicrobial activity against methicillin-resistant Staphylococcus epidermidis clinical isolates by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4425125,J Med Chem,2016.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3243525,>,1,1,>,MIC,ug.mL-1,0.12,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.12
30890,,19406589,CHEMBL4426568,Antimicrobial activity against Streptococcus pyogenes clinical isolates by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4425125,J Med Chem,2016.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3243525,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC,ug ml-1,UO_0000274,0.12
30891,,19406592,CHEMBL4426569,Antimicrobial activity against Streptococcus agalactiae clinical isolates by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4425125,J Med Chem,2016.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3243525,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,MIC,ug ml-1,UO_0000274,0.25
30892,,19406595,CHEMBL4426570,Antimicrobial activity against Streptococcus pneumoniae clinical isolates by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4425125,J Med Chem,2016.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3243525,>,1,1,>,MIC,ug.mL-1,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.5
30893,,19406597,CHEMBL4426572,Bacteriostatic activity against Staphylococcus aureus ATCC 29213 assessed as induction of bacterial kill at 0.25 ug/ml in presence of 1 ug/ml rifampin after 24 hrs,F,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4425125,J Med Chem,2016.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,3243525,<,1,0,<,Activity,%,99.9,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,99.9
30894,,19406626,CHEMBL4426597,Antimicrobial activity against methicillin-resistant Staphylococcus aureus 67-0,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4425125,J Med Chem,2016.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3243525,=,1,1,=,MIC,ug.mL-1,16000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/ml,UO_0000274,16.0
30895,,19406631,CHEMBL4426598,Bactericidal activity against methicillin-resistant Staphylococcus aureus 67-0,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4425125,J Med Chem,2016.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3243525,=,1,0,=,MBC,mg/ml,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MBC,mg/ml,,16.0
30896,,19406636,CHEMBL4426564,Antimicrobial activity against methicillin-sensitive Staphylococcus aureus clinical isolates by broth dilution method,F,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4425125,J Med Chem,2016.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3243525,=,1,1,=,MIC50,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC50,ug ml-1,UO_0000274,0.25
30897,,19406639,CHEMBL4426565,Antimicrobial activity against methicillin-resistant Staphylococcus aureus clinical isolates by broth dilution method,F,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4425125,J Med Chem,2016.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3243525,>,1,1,>,MIC50,ug.mL-1,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC50,ug ml-1,UO_0000274,4.0
30898,,19406642,CHEMBL4426566,Antimicrobial activity against methicillin-sensitive Staphylococcus epidermidis clinical isolates by broth dilution method,F,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4425125,J Med Chem,2016.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3243525,=,1,1,=,MIC50,ug.mL-1,0.25,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC50,ug ml-1,UO_0000274,0.25
30899,,19406645,CHEMBL4426567,Antimicrobial activity against methicillin-resistant Staphylococcus epidermidis clinical isolates by broth dilution method,F,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4425125,J Med Chem,2016.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3243525,>,1,1,>,MIC50,ug.mL-1,4.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC50,ug ml-1,UO_0000274,4.0
30900,,19406648,CHEMBL4426568,Antimicrobial activity against Streptococcus pyogenes clinical isolates by broth dilution method,F,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4425125,J Med Chem,2016.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3243525,=,1,1,=,MIC50,ug.mL-1,0.5,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC50,ug ml-1,UO_0000274,0.5
30901,,19406651,CHEMBL4426569,Antimicrobial activity against Streptococcus agalactiae clinical isolates by broth dilution method,F,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4425125,J Med Chem,2016.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3243525,=,1,1,=,MIC50,ug.mL-1,0.5,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,MIC50,ug ml-1,UO_0000274,0.5
30902,,19406654,CHEMBL4426570,Antimicrobial activity against Streptococcus pneumoniae clinical isolates by broth dilution method,F,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4425125,J Med Chem,2016.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3243525,=,1,1,=,MIC50,ug.mL-1,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC50,ug ml-1,UO_0000274,2.0
30903,,19406657,CHEMBL4426564,Antimicrobial activity against methicillin-sensitive Staphylococcus aureus clinical isolates by broth dilution method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4425125,J Med Chem,2016.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3243525,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC90,ug ml-1,UO_0000274,1.0
30904,,19406660,CHEMBL4426565,Antimicrobial activity against methicillin-resistant Staphylococcus aureus clinical isolates by broth dilution method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4425125,J Med Chem,2016.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3243525,>,1,1,>,MIC90,ug.mL-1,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC90,ug ml-1,UO_0000274,4.0
30905,,19406663,CHEMBL4426566,Antimicrobial activity against methicillin-sensitive Staphylococcus epidermidis clinical isolates by broth dilution method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4425125,J Med Chem,2016.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3243525,>,1,1,>,MIC90,ug.mL-1,4.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC90,ug ml-1,UO_0000274,4.0
30906,,19406666,CHEMBL4426567,Antimicrobial activity against methicillin-resistant Staphylococcus epidermidis clinical isolates by broth dilution method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4425125,J Med Chem,2016.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3243525,>,1,1,>,MIC90,ug.mL-1,4.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC90,ug ml-1,UO_0000274,4.0
30907,,19406669,CHEMBL4426568,Antimicrobial activity against Streptococcus pyogenes clinical isolates by broth dilution method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4425125,J Med Chem,2016.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3243525,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC90,ug ml-1,UO_0000274,1.0
30908,,19406672,CHEMBL4426569,Antimicrobial activity against Streptococcus agalactiae clinical isolates by broth dilution method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4425125,J Med Chem,2016.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3243525,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,MIC90,ug ml-1,UO_0000274,1.0
30909,,19406675,CHEMBL4426570,Antimicrobial activity against Streptococcus pneumoniae clinical isolates by broth dilution method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4425125,J Med Chem,2016.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3243525,>,1,1,>,MIC90,ug.mL-1,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,ug ml-1,UO_0000274,4.0
30910,,19429318,CHEMBL4428637,Antibacterial activity against Streptococcus pneumoniae Ery2 incubated for 18 to 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4428042,J Med Chem,2016.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3245357,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,2.0
30911,,19429322,CHEMBL4428636,Antibacterial activity against Streptococcus pneumoniae 1629 incubated for 18 to 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4428042,J Med Chem,2016.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3245357,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.25
30912,,19429326,CHEMBL4428635,Antibacterial activity against Staphylococcus aureus WCUH29 incubated for 18 to 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4428042,J Med Chem,2016.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3245357,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
30913,,19429330,CHEMBL4428634,Antibacterial activity against Staphylococcus aureus OXFORD incubated for 18 to 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4428042,J Med Chem,2016.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3245357,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.125
30914,,19429345,CHEMBL4428638,Antibacterial activity against Streptococcus pyogenes 1307006P incubated for 18 to 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4428042,J Med Chem,2016.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3245357,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC,ug ml-1,UO_0000274,0.5
30915,,19429349,CHEMBL4428639,Antibacterial activity against Moraxella catarrhalis 1502 incubated for 18 to 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4428042,J Med Chem,2016.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3245357,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL614429,Moraxella catarrhalis,Moraxella catarrhalis,480.0,,MIC,ug ml-1,UO_0000274,0.03
30916,,19429353,CHEMBL4428640,Antibacterial activity against Haemophilus influenzae H128 incubated for 18 to 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4428042,J Med Chem,2016.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3245357,<=,1,1,<=,MIC,ug.mL-1,0.008,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MIC,ug ml-1,UO_0000274,0.008
30917,,19429357,CHEMBL4428641,Antibacterial activity against Haemophilus influenzae H128 deficient in AcrA incubated for 18 to 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4428042,J Med Chem,2016.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3245357,<=,1,1,<=,MIC,ug.mL-1,0.008,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MIC,ug ml-1,UO_0000274,0.008
30918,,19429361,CHEMBL4428642,Antibacterial activity against Klebsiella pneumoniae 1161486a deficient in tolC incubated for 18 to 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4428042,J Med Chem,2016.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3245357,<=,1,1,<=,MIC,ug.mL-1,0.008,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,0.008
30919,,19429365,CHEMBL4428643,Antibacterial activity against Escherichia coli 120 deficient in AcrAB incubated for 18 to 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4428042,J Med Chem,2016.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3245357,<=,1,1,<=,MIC,ug.mL-1,0.008,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.008
30920,,19429369,CHEMBL4428644,Antibacterial activity against Pseudomonas aeruginosa PAO322 deficient in MexA/B/C/D/E/F incubated for 18 to 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4428042,J Med Chem,2016.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3245357,<=,1,1,<=,MIC,ug.mL-1,0.008,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.008
30921,,19429373,CHEMBL4428645,Antibacterial activity against Acinetobacter baumannii ACM1010 incubated for 18 to 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4428042,J Med Chem,2016.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3245357,>,1,1,>,MIC,ug.mL-1,8.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,8.0
30922,,19436016,CHEMBL4430442,Antituberculosis activity against Mycobacterium tuberculosis H37Rv after 5 days by MABA method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4428093,Bioorg Med Chem Lett,2016.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3246447,=,1,1,=,MIC,nM,9400.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,10'-6 mol/L,UO_0000065,9.4
30923,Active,19440460,CHEMBL4431466,Inhibition of wild type Escherichia coli DNA gyrase subunit A2B2 using supercoiled pBR322 DNA as substrate assessed as stabilization of enzyme-DNA cleavage complex by measuring linear DNA bands at 0.3 uM incubated for 30 mins in presence of proteinase K/SDS and in absence of ATP by ethidium bromide staining based agarose gel electrophoresis,B,BAO_0000201,BAO_0000223,protein complex format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4431297,Medchemcomm,2016.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,3247409,,1,0,,Inhibition,%,,CHEMBL2094139,Escherichia coli,DNA gyrase,562.0,,INH,,UO_0000187,
30924,,19440474,CHEMBL4431458,Inhibition of Escherichia coli JMtacA/JMtacB DNA gyrase subunit A2B2 S83W mutant using relaxed pBR322 DNA as substrate incubated for 30 mins in presence of ATP by ethidium bromide staining based agarose gel electrophoresis,B,BAO_0000190,BAO_0000223,protein complex format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4431297,Medchemcomm,2016.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,1,http://www.openphacts.org/units/Nanomolar,3247409,=,1,1,=,IC50,nM,500.0,CHEMBL2094139,Escherichia coli,DNA gyrase,562.0,,IC50,uM,UO_0000065,0.5
30925,,19466545,CHEMBL4477862,Antibacterial activity against Bacillus subtilis 168 trpC2 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4477198,J Nat Prod,2016.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3255181,=,1,1,=,MIC,ug.mL-1,0.008,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,MIC,ug ml-1,UO_0000274,0.008
30926,,19478198,CHEMBL4480005,Antibacterial activity against Acinetobacter baumannii NCTC 13420,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4477259,Bioorg Med Chem Lett,2016.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3257113,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,64.0
30927,,19478199,CHEMBL4480006,Antibacterial activity against Klebsiella pneumoniae ATCC 700603,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4477259,Bioorg Med Chem Lett,2016.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3257113,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,0.25
30928,,19478200,CHEMBL4480007,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4477259,Bioorg Med Chem Lett,2016.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3257113,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,1.0
30929,,19478201,CHEMBL4480008,Antibacterial activity against Staphylococcus aureus ATCC 29213,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4477259,Bioorg Med Chem Lett,2016.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3257113,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
30930,,19478202,CHEMBL4480009,Antibacterial activity against Escherichia coli W4573,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4477259,Bioorg Med Chem Lett,2016.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3257113,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.03
30931,,19478203,CHEMBL4480010,Antibacterial activity against Escherichia coli N43,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4477259,Bioorg Med Chem Lett,2016.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3257113,=,1,1,=,MIC,ug.mL-1,0.004,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.004
30932,,19478207,CHEMBL4480003,Antibacterial activity against wild type Escherichia coli LM179,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4477259,Bioorg Med Chem Lett,2016.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3257113,=,1,1,=,MIC,ug.mL-1,0.016,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.016
30933,,19478208,CHEMBL4480004,Antibacterial activity against Escherichia coli LM625 harboring GyrA S83L/D87N double mutant,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4477259,Bioorg Med Chem Lett,2016.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3257113,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.25
30934,,19478209,CHEMBL4480015,Antibacterial activity against Escherichia coli LM367 harboring delta marR/delta acrR double mutant,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4477259,Bioorg Med Chem Lett,2016.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3257113,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.12
30935,,19478210,CHEMBL4480016,Antibacterial activity against Escherichia coli LM693 harboring GyrA S83L/D87N double mutant/ParC S80I mutant,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4477259,Bioorg Med Chem Lett,2016.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3257113,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,32.0
30936,,19478211,CHEMBL4480017,Antibacterial activity against Escherichia coli LM705 harboring GyrA S83L/D87N double mutant/ParC S80I mutant/delta marR/delta acrR double mutant,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4477259,Bioorg Med Chem Lett,2016.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3257113,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,64.0
30937,,19478212,CHEMBL4480018,Antibacterial activity against Escherichia coli CH440 harboring GyrA S83L/D87N double mutant/ParC S80I E84V double mutant/aac(6')-lb-cr,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4477259,Bioorg Med Chem Lett,2016.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3257113,>,1,1,>,MIC,ug.mL-1,64.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,64.0
30938,,19478213,CHEMBL4480019,Antibacterial activity against Escherichia coli CH460 harboring GyrA S83L/D87N double mutant/ParC S80I E84V double mutant/qepA,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4477259,Bioorg Med Chem Lett,2016.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3257113,>,1,1,>,MIC,ug.mL-1,64.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,64.0
30939,,19478214,CHEMBL4480020,Antibacterial activity against Escherichia coli CH418 harboring GyrA S83L/D87N double mutant/ParC S80I E84G double mutant/qnrA,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4477259,Bioorg Med Chem Lett,2016.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3257113,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,64.0
30940,,19478215,CHEMBL4480021,Antibacterial activity against Escherichia coli CH448 harboring GyrA S83L mutant/qnrS,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4477259,Bioorg Med Chem Lett,2016.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3257113,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,32.0
30941,,19486370,CHEMBL4481648,Antimicrobial activity against methicillin-resistant Staphylococcus aureus ATCC 43300 measured after 18 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4480418,Bioorg Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3258842,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,2.0
30942,,19486388,CHEMBL4481647,Antimicrobial activity against methicillin-resistant Staphylococcus aureus ATCC BAA-41 measured after 18 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4480418,Bioorg Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3258842,>,1,1,>,MIC,ug.mL-1,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,64.0
30943,,19486406,CHEMBL4481646,Antimicrobial activity against penicillin-resistant Staphylococcus aureus ATCC 29213 measured after 18 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4480418,Bioorg Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3258842,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,2.0
30944,,19486424,CHEMBL4481645,Antimicrobial activity against Staphylococcus aureus ATCC 25923 measured after 18 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4480418,Bioorg Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3258842,<,1,1,<,MIC,ug.mL-1,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.125
30945,,19486442,CHEMBL4481644,Antibacterial activity against Bacillus subtilis 168 measured after 18 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4480418,Bioorg Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3258842,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,MIC,ug ml-1,UO_0000274,2.0
30946,,19486464,CHEMBL4481650,Antimicrobial activity against drug-susceptible Enterococcus faecium ATCC 49624 measured after 18 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4480418,Bioorg Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3258842,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,ug ml-1,UO_0000274,32.0
30947,,19486482,CHEMBL4481649,Antimicrobial activity against vancomycin-resistant Enterococcus faecium ATCC 700221 measured after 18 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4480418,Bioorg Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3258842,>,1,1,>,MIC,ug.mL-1,64.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,ug ml-1,UO_0000274,64.0
30948,,19486502,CHEMBL4481651,Antimicrobial activity against Enterococcus faecalis ATCC 29212 measured after 18 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4480418,Bioorg Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3258842,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,4.0
30949,,19486520,CHEMBL4481652,Antimicrobial activity against Escherichia coli ATCC 25922 measured after 18 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4480418,Bioorg Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3258842,<,1,1,<,MIC,ug.mL-1,0.125,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.125
30950,,19486538,CHEMBL4481653,Antimicrobial activity against NDM1 beta -lactamse expressing Escherichia coli ATCC BAA-2469 measured after 18 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4480418,Bioorg Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3258842,>,1,1,>,MIC,ug.mL-1,64.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,64.0
30951,,19486556,CHEMBL4481654,Antimicrobial activity against multidrug-resistant Acinetobacter baumannii ATCC 19606 measured after 18 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4480418,Bioorg Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3258842,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,2.0
30952,,19486574,CHEMBL4481655,Antimicrobial activity against NDM1 beta-lactamase expressing Klebsiella pneumoniae ATCC BAA-2470 measured after 18 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4480418,Bioorg Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3258842,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,64.0
30953,,19486592,CHEMBL4481656,Antimicrobial activity against multidrug-resistant Pseudomonas aeruginosa ATCC BAA-2108 measured after 18 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4480418,Bioorg Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3258842,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,64.0
30954,,19486610,CHEMBL4481657,Antimicrobial activity against Ampc beta-lactamase expressing Enterobacter cloacae ATCC BAA-1143 measured after 18 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4480418,Bioorg Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3258842,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,MIC,ug ml-1,UO_0000274,0.5
30955,,19488388,CHEMBL4481835,Antitubercular activity against Mycobacterium tuberculosis H37Rv ATCC 27294 after 7 days by microplate alamar blue method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4480432,Bioorg Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3259192,=,1,1,=,MIC,nM,4700.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,uM,UO_0000065,4.7
30956,,19958376,CHEMBL4495582,SARS-CoV-2 3CL-Pro protease inhibition percentage at 20µM  by FRET kind of response from peptide substrate,F,BAO_0000201,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4495564,,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,3344794,=,52,1,=,Inhibition,%,16.68,CHEMBL4523582,Severe acute respiratory syndrome coronavirus 2,Replicase polyprotein 1ab,2697049.0,,Inhibition,%,UO_0000187,16.68
30957,,19959883,CHEMBL4495582,SARS-CoV-2 3CL-Pro protease inhibition percentage at 20µM  by FRET kind of response from peptide substrate,F,BAO_0000201,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4495564,,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,3346301,=,52,1,=,Inhibition,%,13.11,CHEMBL4523582,Severe acute respiratory syndrome coronavirus 2,Replicase polyprotein 1ab,2697049.0,,Inhibition,%,UO_0000187,13.10924607
30958,,20150643,CHEMBL4513082,Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging,F,BAO_0000201,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4495565,,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,3362666,=,52,1,=,Inhibition,%,0.08,CHEMBL4303835,Severe acute respiratory syndrome coronavirus 2,SARS-CoV-2,2697049.0,,inhibition,%,UO_0000187,0.08
30959,,20150844,CHEMBL4513082,Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging,F,BAO_0000201,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4495565,,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,3364173,=,52,1,=,Inhibition,%,0.14,CHEMBL4303835,Severe acute respiratory syndrome coronavirus 2,SARS-CoV-2,2697049.0,,inhibition,%,UO_0000187,0.14
30960,,20603096,CHEMBL4604190,Inhibition of Mycobacterium tuberculosis H37Rv ATCC 27294 InhA assessed as bacterial growth inhibition after 5 days by microplate alamar blue assay,B,BAO_0002146,BAO_0000357,single protein format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4602648,Bioorg Med Chem Lett,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3465851,=,1,1,=,MIC,nM,9410.0,CHEMBL1849,Mycobacterium tuberculosis,Enoyl-[acyl-carrier-protein] reductase,1773.0,,MIC,uM,UO_0000065,9.41
30961,,20603167,CHEMBL4604191,Antibacterial activity against Escherichia coli by dilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4602648,Bioorg Med Chem Lett,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3465851,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,2.0
30962,,20603210,CHEMBL4604192,Antibacterial activity against Staphylococcus aureus by dilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4602648,Bioorg Med Chem Lett,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3465851,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,2.0
30963,,20603253,CHEMBL4604193,Antibacterial activity against Pseudomonas aeruginosa by dilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4602648,Bioorg Med Chem Lett,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3465851,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,4.0
30964,,20628729,CHEMBL4610367,Antibacterial activity against Staphylococcus aureus ATCC 25923 assessed as reduction in bacterial growth incubated for 24 hrs by INT dye based assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4609984,Bioorg Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3471237,=,1,1,=,MIC,ug.mL-1,0.156,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.156
30965,,20628738,CHEMBL4610368,Antibacterial activity against Bacillus cereus ATCC 11779 assessed as reduction in bacterial growth incubated for 24 hrs by INT dye based assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4609984,Bioorg Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3471237,=,1,1,=,MIC,ug.mL-1,0.156,CHEMBL613070,Bacillus cereus,Bacillus cereus,1396.0,,MIC,ug ml-1,UO_0000274,0.156
30966,,20628747,CHEMBL4610369,Antibacterial activity against Escherichia coli ATCC 8739 assessed as reduction in bacterial growth incubated for 24 hrs by INT dye based assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4609984,Bioorg Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3471237,=,1,1,=,MIC,ug.mL-1,0.313,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.313
30967,,20628756,CHEMBL4610370,Antibacterial activity against Pseudomonas aeruginosa ATCC 27858 assessed as reduction in bacterial growth incubated for 24 hrs by INT dye based assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4609984,Bioorg Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3471237,=,1,1,=,MIC,ug.mL-1,0.313,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.313
30968,,20638158,CHEMBL4612324,Antibacterial activity against Bacillus subtilis assessed as reduction in microbial growth after 18 hrs by MTT based broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4610105,J Nat Prod,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3473376,=,1,1,=,MIC,ug.mL-1,0.09,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,MIC,ug ml-1,UO_0000274,0.09
30969,,20638159,CHEMBL4612325,Antibacterial activity against Bacillus anthracis assessed as reduction in microbial growth after 18 hrs by MTT based broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4610105,J Nat Prod,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3473376,=,1,1,=,MIC,ug.mL-1,0.19,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,MIC,ug ml-1,UO_0000274,0.19
30970,,20638160,CHEMBL4612326,Antibacterial activity against Bacillus cereus assessed as reduction in microbial growth after 18 hrs by MTT based broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4610105,J Nat Prod,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3473376,=,1,1,=,MIC,ug.mL-1,0.09,CHEMBL613070,Bacillus cereus,Bacillus cereus,1396.0,,MIC,ug ml-1,UO_0000274,0.09
30971,,20638161,CHEMBL4612327,Antibacterial activity against Bacillus megaterium assessed as reduction in microbial growth after 18 hrs by MTT based broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4610105,J Nat Prod,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3473376,=,1,1,=,MIC,ug.mL-1,0.19,CHEMBL613071,Priestia megaterium,Priestia megaterium,1404.0,,MIC,ug ml-1,UO_0000274,0.19
30972,,20638162,CHEMBL4612328,Antibacterial activity against Enterobacter aerogenes assessed as reduction in microbial growth after 18 hrs by MTT based broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4610105,J Nat Prod,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3473376,=,1,1,=,MIC,ug.mL-1,0.05,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,MIC,ug ml-1,UO_0000274,0.05
30973,,20638163,CHEMBL4612329,Antibacterial activity against Escherichia coli assessed as reduction in microbial growth after 18 hrs by MTT based broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4610105,J Nat Prod,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3473376,=,1,1,=,MIC,ug.mL-1,0.78,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.78
30974,,20638164,CHEMBL4612330,Antibacterial activity against Kocuria rhizophila assessed as reduction in microbial growth after 18 hrs by MTT based broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4610105,J Nat Prod,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3473376,=,1,1,=,MIC,ug.mL-1,0.19,CHEMBL1075349,Kocuria rhizophila,Kocuria rhizophila,72000.0,,MIC,ug ml-1,UO_0000274,0.19
30975,,20638165,CHEMBL4612331,Antibacterial activity against Micrococcus lysodeikticus assessed as reduction in microbial growth after 18 hrs by MTT based broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4610105,J Nat Prod,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3473376,=,1,1,=,MIC,ug.mL-1,0.19,CHEMBL614421,Micrococcus luteus,Micrococcus luteus,1270.0,,MIC,ug ml-1,UO_0000274,0.19
30976,,20638166,CHEMBL4612332,Antibacterial activity against Nocardia brasiliensis assessed as reduction in microbial growth after 18 hrs by MTT based broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4610105,J Nat Prod,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3473376,=,1,1,=,MIC,ug.mL-1,0.19,CHEMBL612976,Nocardia brasiliensis,Nocardia brasiliensis,37326.0,,MIC,ug ml-1,UO_0000274,0.19
30977,,20638167,CHEMBL4612333,Antibacterial activity against Proteus vulgaris assessed as reduction in microbial growth after 18 hrs by MTT based broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4610105,J Nat Prod,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3473376,=,1,1,=,MIC,ug.mL-1,0.09,CHEMBL614450,Proteus vulgaris,Proteus vulgaris,585.0,,MIC,ug ml-1,UO_0000274,0.09
30978,,20638168,CHEMBL4612334,Antibacterial activity against Pseudomonas aeruginosa assessed as reduction in microbial growth after 18 hrs by MTT based broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4610105,J Nat Prod,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3473376,=,1,1,=,MIC,ug.mL-1,0.19,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.19
30979,,20638169,CHEMBL4612335,Antibacterial activity against Salmonella typhi assessed as reduction in microbial growth after 18 hrs by MTT based broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4610105,J Nat Prod,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3473376,=,1,1,=,MIC,ug.mL-1,0.09,CHEMBL614448,Salmonella enterica subsp. enterica serovar Typhi,Salmonella typhi,90370.0,,MIC,ug ml-1,UO_0000274,0.09
30980,,20638170,CHEMBL4612336,Antibacterial activity against Salmonella paratyphi B assessed as reduction in microbial growth after 18 hrs by MTT based broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4610105,J Nat Prod,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3473376,=,1,1,=,MIC,ug.mL-1,0.05,CHEMBL2367267,Salmonella enterica subsp. enterica serovar Paratyphi B,Salmonella enterica subsp. enterica serovar Paratyphi B,57045.0,,MIC,ug ml-1,UO_0000274,0.05
30981,,20638171,CHEMBL4612337,Antibacterial activity against Shigella dysenteriae assessed as reduction in microbial growth after 18 hrs by MTT based broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4610105,J Nat Prod,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3473376,=,1,1,=,MIC,ug.mL-1,0.19,CHEMBL612619,Shigella dysenteriae,Shigella dysenteriae,622.0,,MIC,ug ml-1,UO_0000274,0.19
30982,,20638172,CHEMBL4612338,Antibacterial activity against Vibrio parahaemolyticus assessed as reduction in microbial growth after 18 hrs by MTT based broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4610105,J Nat Prod,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3473376,=,1,1,=,MIC,ug.mL-1,0.19,CHEMBL614403,Vibrio parahaemolyticus,Vibrio parahaemolyticus,670.0,,MIC,ug ml-1,UO_0000274,0.19
30983,,20640479,CHEMBL4612947,Inhibition of Staphylococcus aureus DNA gyrase using relaxed pNO1 as substrate by gel based fluorescence assay,B,BAO_0000190,BAO_0000223,protein complex format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4610120,J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,1,http://www.openphacts.org/units/MicrogramPerMilliliter,3473709,=,1,1,=,IC50,ug.mL-1,13.05,CHEMBL3038482,Staphylococcus aureus,DNA gyrase,1280.0,,IC50,mg/L,UO_0000274,13.05
30984,,20640487,CHEMBL4612952,Induction of Escherichia coli K12 MG1655 recA promotor measured at 30 mins interval for 20 hrs by fluorescence assay relative to control,B,BAO_0000179,BAO_0000357,single protein format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4610120,J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3473709,=,1,0,=,FC,,20.0,CHEMBL3434,Escherichia coli K-12,Recombinase A,83333.0,,FC,,,20.0
30985,,20640494,CHEMBL4612953,Induction of Escherichia coli K12 MG1655 lexA promotor measured at 30 mins interval for 20 hrs by fluorescence assay relative to control,B,BAO_0000179,BAO_0000357,single protein format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4610120,J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3473709,=,1,0,=,FC,,5.0,CHEMBL4630871,Escherichia coli,LexA repressor,562.0,,FC,,,5.0
30986,,20640501,CHEMBL4612954,Induction of Escherichia coli K12 MG1655 recN promotor measured at 30 mins interval for 20 hrs by fluorescence assay relative to control,B,BAO_0000179,BAO_0000357,single protein format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4610120,J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3473709,=,1,0,=,FC,,14.0,CHEMBL4630870,Escherichia coli,DNA repair protein RecN,562.0,,FC,,,14.0
30987,,20640508,CHEMBL4612955,Induction of Escherichia coli K12 MG1655 sulA promotor measured at 30 mins interval for 20 hrs by fluorescence assay relative to control,B,BAO_0000179,BAO_0000357,single protein format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4610120,J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3473709,=,1,0,=,FC,,17.0,CHEMBL1287594,Escherichia coli K-12,Cell division inhibitor sulA,83333.0,,FC,,,17.0
30988,,20640511,CHEMBL4612950,Antimicrobial activity against multidrug-resistant Escherichia coli NCTC 12923 assessed as mutation frequency at 4 times MIC measured after 48 hrs,F,BAO_0000181,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4610120,J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3473709,=,1,0,=,Activity,10'-7No_unit,4.4,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,10'-7No_unit,,4.4
30989,,20640512,CHEMBL4612951,Antimicrobial activity against Acinetobacter baumannii ATCC 17978 assessed as mutation frequency at 4 times MIC measured after 48 hrs,F,BAO_0000181,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4610120,J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3473709,=,1,0,=,Activity,10'-7No_unit,8.4,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,Activity,10'-7No_unit,,8.4
30990,,20640514,CHEMBL4612956,Antimicrobial activity against Klebsiella pneumoniae M6 assessed as mutation frequency at 4 times MIC measured after 48 hrs,F,BAO_0000181,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4610120,J Med Chem,2020.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,3473709,=,1,0,=,Activity,10'-7No_unit,8.9,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,Activity,10'-7No_unit,,8.9
30991,,20641985,CHEMBL4613420,Antibacterial activity against Staphylococcus aureus,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4613208,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3474051,<,1,1,<,MIC,ug.mL-1,5.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,5.0
30992,,20641986,CHEMBL4613422,Antibacterial activity against Bacillus subtilis,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4613208,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3474051,<,1,1,<,MIC,ug.mL-1,5.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,MIC,ug ml-1,UO_0000274,5.0
30993,,20641987,CHEMBL4613424,Antibacterial activity against Klebsiella pneumoniae,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4613208,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3474051,=,1,1,=,MIC,nM,2.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,uM,UO_0000065,0.002
30994,,20641988,CHEMBL4613431,Antibacterial activity against Escherichia coli,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4613208,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3474051,<,1,1,<,MIC,ug.mL-1,5.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,5.0
30995,,20641989,CHEMBL4613432,Antibacterial activity against Pseudomonas aeruginosa,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4613208,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3474051,<,1,1,<,MIC,ug.mL-1,5.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,5.0
30996,,20641990,CHEMBL4613433,Antibacterial activity against Salmonella typhi,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4613208,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,3474051,=,1,1,=,MIC,nM,2.0,CHEMBL614448,Salmonella enterica subsp. enterica serovar Typhi,Salmonella typhi,90370.0,,MIC,uM,UO_0000065,0.002
30997,,20641991,CHEMBL4613437,Antibacterial activity against Staphylococcus aureus after 24 hrs by paper disc diffusion technique,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4613208,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3474051,=,1,1,=,MIC,ug.mL-1,3.9,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,3.9
30998,,20641992,CHEMBL4613441,Antibacterial activity against Staphylococcus epidermidis after 24 hrs by paper disc diffusion technique,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4613208,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3474051,=,1,1,=,MIC,ug.mL-1,3.9,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,3.9
30999,,20641993,CHEMBL4613442,Antibacterial activity against Escherichia coli after 24 hrs by paper disc diffusion technique,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL4613208,Eur J Med Chem,2019.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3474051,=,1,1,=,MIC,ug.mL-1,3.9,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,3.9
